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ABSTRACT
The dinoflagellate, Karenia brevis, produces hannful algal blooms in the Gulf of
Mexico that cause extensive marine animal mortalities and human illness nearly annually.
The molecular mechanisms controlling cell cycle entry in this dinoflagellate are
important because bloom development occurs through asexual cell division. The cell
cycle of K. brevis is phased to the diel cycle such that any cells entering the cell cycle on
a given day do so synchronously. However, a microarray study of gene expression over a
diellcell cycle found no change in cell cycle transcript levels in actively dividing
populations, including genes that code for replication fork proteins, typically activated in
eukaryotes by transcription at the G liS transition. There are many examples of posttranscriptional regulation of physiological processes in dinoflagellates and this suggests
that cell cycle progression may also be regulated post-transcriptionally. The studies
presented in this dissertation address the question of whether the cell cycle in K. brevis is
regulated at the level of translation. We first characterized the global pattern of
translation activity over the diel cycle using polysome profiling. We found that, unlike
Lingulodinium polyedrum, a dinoflagellate widely used to study diurnal rhythms,

translation was not limited to the dark phase. We next used a 2-DE gel proteomic
approach to identify diel patterns of global and specific changes in protein expression,
with particular interest in cell cycle proteins. Although a number of proteins displayed
diel patterns of expression, we were unable to characterize the behavior of cell cycle
proteins using this method. We therefore selected four DNA replication fork genes
(PCNA, Replication factor C, Replication protein A, and Ribonucleotide reductase 2 )
that are classically regulated via transcription at the G liS phase transition, and
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characterized their expression by qPCR, western blotting and immunolocalization.
Sequence analysis revealed a 5' spliced leader sequence on each of these transcripts,
indicative that they are likely under post-transcriptional control, and qRT -PCR confirmed
that their transcript levels were indeed unchanged over the cell cycle. Sequence analysis
and protein modeling were next used to develop peptide antibodies for western blotting to
investigate their protein abundance over the cell cycle. The K. brevis replication fork
proteins, PCNA, RFC, RPA and RnR2 were shown to change over the cell cycle with
highest expression at S-phase, suggesting translational control. Furthermore, a posttranslational modification appeared to occur on the K. brevis PCNA protein in S-phase
cells, resulting in a --9 kDa increase in size. We hypothesize that this represents
modification by either SUMO or ubiquitin, two post-translational modifications observed
on PCNA in other eukaryotes during S-phase. The occurrence of this post-translational
modification coincided with a shift in nuclear location of PCNA from peripheral to
chromatin bound, as determined by immunolocalization. Since the expression of
replication fork proteins appears to change over the cell cycle without changes in
transcription, CDKs were investigated to begin to understand how these drivers of the
cell cycle may be controlling S-phase entry at the translational level. Both the CDK4specific inhibitor, fascaplysin, and the pan-CDK inhibitor, olomoucine, inhibited
progression through the G liS transition as well as the production of the PCNA protein.
These results lead us to propose the dinoflagellate utilizes CDK-dependent translational
control of cell cycle entry as opposed to transcriptional control which is seen in most
eukaryotes.

VIlt

Chapter 1: Introduction

1

Dinoflagellates are ancient, unicellular, eukaryotic protists. Dinoflagellates, along
with ciliates and apicomplexans, are members of the superphylum Alveolata. To place
the unusual molecular characteristics of K. brevis in an evolutionary context, it is useful
to note that most of the eukaryotes on the planet are microbial, in terms of abundance and
evolutionary diversity, and make up the vast majority of the phylogenetic tree of
eukaryotes (Lukes et aI., 2009). The position of dinoflagellates in the tree of life (Figure
1), shows that they have a long evolutionary history, of900 million years during which
they have solved biological problems in remarkable ways that often differ from the
models of eukaryotic cell biology (Lukes et aI., 2009). Dinoflagellates possess an
unusually large amount of DNA in their haploid genomes, up to 1 x 10 12 bp, or ",6 times
the human genome (Taylor, 1987). K. brevis has a genome of approximately 1 x 1011 bp
contained within 121 chromosomes (Lidie et aI., 2005 and references therein).
Dinoflagellates represent the only eukaryotic phylum that lacks nucleosomes that
typically aid in chromatin packaging. Their DNA is fully eukaryotic in sequence
organization with large amounts of repetitive DNA(Minguez et aI., 1994), but is unusual
in that many genes occur in large arrays of tandem repeated copies. It is thought that the
high copy number of genes and expansion of the genome is due to gene or whole genome
duplication events as well as possible retroposition of cDNA back into the genome (Lin,
2011). Also, dinoflagellates genomes have undergone extensive horizontal gene transfer
2

which is due to multiple endosymbiotic events where a dinoflagellate ancestor engulfed
both a prokaryote (genes transferred from plastid to nucleus) and eukaryotes (nucleus to
nucleus gene transfer) (Nosenko and Bhattacharya, 2004; Hackett et aI., 2004;
Andersson, 2005). To date, unlike other eukaryotes with large genomes, few introns have
been identified in dinoflagellate genes. The chromosomes of dinoflagellates exist in a
liquid crystal state in which a core is tightly condensedand thought to be made up on noncoding sequence whileperipheral arches of exposed DNA are thought to be areas
undergoing active transcription (Costas and Goyanes, 2005). The large sizes of
dinoflagellates genomes have to date made whole genome sequencing impractical.
However, genes for many conserved cellular processes have been found through
dinoflagellate EST sequencing projects (Amphidinium carterae and Lingulodinuim
polyedrum, Bachvaroff et aI., 2004; K. brevis, Lidie et aI., 2005; Alexandrium tamarense,

Hacket et aI., 2005; Symbiodinium, Leggat et aI., 2007).
The majority of dinoflagellates are marine phytoplankton that are important
contributors to the base of the foodweb and can grow to high abundance or "blooms".
The blooms of certain dinoflagellates are termed harmful algal blooms (HABs) because
potent toxins produced by these species, when present at high concentrations, have
adverse effects on human and ecosystem health. The unarmored, fucoxanthin-containing
dinoflagellate, Karenia brevis, produces the lipophilic neurotoxins known as brevetoxins
andis responsible for causing red tides in the Gulf of Mexico, particularly off the west
coast of Florida. Both humans and marine fauna are detrimentally affected by the
ingestion and inhalation of brevetox ins produced by K. brevis. In Florida, red tides cost
an estimated US$ 20 million in remediation and lost tourism revenue annually (Anderson
3

et aI., 2000). Although toxic red tides have been observed in Florida since the 1840s, the
occurrence of these HABs appears to have increased in frequency and extent over the
past quarter century (Hallegraeff, 1993; Van Dolah, 2000; Anderson et ai., 2002).
Therefore, understanding the mechanisms that control the proliferation of dinoflagellates
is critical in order to develop the capacity to predict the occurrence, monitor the
development, and mitigate the impacts of blooms.
The development of a harmful algal bloom can be divided into four sequential
stages: initiation, growth, maintenance and termination (Steidinger et ai., 1998). K.
brevis is found in background concentrations (1-1000 cells liter-I) throughout the Gulf of
Mexico (Tester and Steidinger 1997; Steidinger et ai., 1998). Initial growth of blooms
occurs offshore at depth where K. brevis can outcompete faster growing phytoplankton
because of its low light adaptation and its ability to swim directionally to acquire
nutrients near the bottom, including inorganic as well as organic sources of nitrogen and
phosphorus (Sinclair et aI., 2009; Stumpf et ai., 2008). Recent studies on circulation
patterns in the Gulf of Mexico suggest that K. brevis blooms may initiate by the transport
of nutrients from the northern Gulf of Mexico onto the West Florida Shelf in the summer
via circulation driven by normal summer northward winds and the Mississippi River is a
source of these nutrients at depth (Stumpf et ai., 2008). Another hypothesis is that
nutrient input from large scale processes such as dust storms originating in the Sahara
desert is involved in bloom initiation (Steidinger et aI., 1998; Walsh and Steidinger,
2001). Once initiated, K. brevis exhibits a low division rate, averaging 0.3 div/day in both
field and laboratory populations (Heil et aI., 2001; Magana and Villareal, 2006;
Richardson, 2000; Richarson et aI., 2006; Redalje et ai., 2008). K. brevis is able to adapt
4

to a broad range of light intensities (Evans et aI., 2001; Schaffer et aI., 2007) and
aggregated cells can occur in daylight where nutrients from coastal water egress or fish
kills can maintain populations in near surface waters (Walsh et aI., 2004). Lab studies
have shown that K. brevis actively seeks nutrients and these findings support the
hypothesis that offshore, near-bottom aggregates of K. brevis cells may be the seed
populations for bloom initiation, since upwelling and winds transport these populations
toward the coast to form near surface blooms (Janowitz and Kamykowski, 2006).
Although extensive research has gone into understanding the oceanographic
conditions that permit the initiation and dispersal of K. brevis blooms, the molecular
mechanisms controlling cell proliferation in this dinoflagellate remain poorly understood.
Since growth of K. brevis results almost entirely from vegetative cell division, cell cycle
entry is a key regulator of bloom progression. Therefore in order to understand factors
affecting the growth of these blooms and to potentially develop a growth specific
biomarker it is necessary to understand the cell cycle of this organism.

The Influence of Photoperiod and Circadian Rhythms in Dinoflagellate Biology
Many dinoflagellate cellular and molecular processes are not only adapted to the
photoperiod, but display circadian entrainment. Numerous studies in dinoflagellates have
shown that the cell cycle is linked to the photoperiod (Sweeney and Hastings, 1958;
Olsen and Chisholm, 1986; Homma and Hastings, 1989; Roenneberg, 1996; TaroncherOldenburg, 1997; Van Dolah and Leighfield, 1999; Leighfield and Van Dolah, 2001,
Litaker et aI., 2002; Dagenais-Bellefuielle et aI., 2008), resulting in synchronous cell
cycle progression in populations dividing at a rate of one division per day. In "phased"
5

populations, cell division rates are <l/day. Either the light/dark or dark/light transition
provides the entraining cue in a species specific manner. In the dinoflagellate
Lingulodiniumpolyedrum (formerly Gonyaulax polyedra), cell division is restricted to the

early hours of the subjective morning (Roenneberg, 1995). In Amphidinium operculalum,
S-phase begins 10 hours after the onset of light and mitosis begins 14-16 hours after this
cue (Leigh field and Van Dolah, 2001). A. operculalum is dawn cued, such that a delay
in the dark/light transition results in an equivalent delay in cell cycle phases. In contrast,
Gambierdiscus loxicus was found to be dusk cued, with mitosis occurring 6 hours after

the onset of the dark phase (Van Dolah et aI., 1995).In K. brevis, the dark to light
transition serves to entrain the cell cycle, with S-phase beginning approximately 6 hours
after onset of light, as determined by flow cytometry (Van Dolah and Leighfield, 1999).
When placed in continuous light K. brevis continues to proceed through the cell cycle in a
phased manner and the amount of the cell population progressing through the cell cycle
increases to 70%. This formally demonstrates that the cell cycle is under control of a
circadian rhythm (Brunelle et aI., 2007).Although the cell cycle behavior of K. brevis has
been characterized, the molecular mechanisms controlling cell cycle progression and the
genes and proteins involved in these processes are not as well described and warrant
further investigation.

The Dinoflagellate Cell Cycle
Dinoflagellates have a eukaryotic cell cycle consisting of a G 1 phase,
characterized by growth, S-phase, consisting of DNA replication, a G2 phase, also
characterized by growth as well as editing of DNA, and mitosis, or cell division (Vaulot
6

et aI., 1986; Van Dolah et aI., 2007, Brunelle et aI., 2007). However, they have acquired
some unique characteristicssuch as permanently condensed chromosomes, a nuclear
envelope that does not break down during mitosis, and a mitotic spindle that is
extranuclear (Taylor, 1987), that suggest that there may be unique adaptations to some of
the classical eukaryotic cell cycle regulatory processes. Nonetheless, many conserved
cell cycle genes appear to be present in dinoflagellates, based on EST library analysis,
including the central cell cycle regulatory complexes made up of cyclins and cyclin
dependent kinases (CDKs).
CDKs regulate two checkpoints in the eukaryotic cell cycle, the G liS transition
and the entry into mitosis. Differential transcript abundance of cell cycle genes is
centrally driven by the phosphorylation activity of CDK at the G liS and G2/M
checkpoints. At S-phase entry, CDKs are activated by the binding of newly expressed
cyclin, upon which both proteins are phosphorylated. The activated CDK/cyclin complex
then initiates DNA synthesis by phosphorylating the retinoblastoma protein (pRb). The
pRb represses gene transcription, required for the G 1 to S phase transition, by binding to
the transactivation domain of the E2F transcription factor (Giacinti and Giordano, 2006).
In late G 1, when the CDKlcyclin complex phosphorylates pRb, pRb releases E2F,
allowing the expression of genes that encode the proteins necessary for S-phase
progression. Surprisingly, a microarray study of the global transcriptome in K. brevis
over the cell cycle reported the absence of any change in the transcript levels of either Sphase or M-phase specific cell cycle genes (Van Dolah et aI., 2007). Further evidence of
post-transcriptional regulation of cell cycle genes in K. brevis comes from PCR data,
which shows that the spliced leader sequence is present in all cell cycle genes examined
7

to date. Additionally, no members of E2F transcription factor family have been
identified in dinoflagellates to date. We therefore hypothesize that the cell cycle of K.
brevis is controlled at the translational or post-translational level.

Post-transcriptional Control of Gene Expression in Dinoflagellates
Processes typically under transcriptional control in most eukaryotes are not in
K.brevis, including stress response genes and cell cycle genes, as demonstrated in

microarray studies (Van Dolah et aI., 2007; Lidie, 2007). A possible explanation for
predominance of translational control in K. brevis came from a study by Lidie and Van
Dolah (2007) that identified an identical 22 bp5' spliced leader sequence on a diverse K.
brevis mRNAs, indicative of a trans-splicing mechanism. The spliced leader trans-

splicing mechanism was first characterized in trypanosomes (Murphy, Atkins and
Agabian, 1986) which are kinetoplastid parasites only distantly related to dinoflagellates.
In trypanosomes, transcription is constitutive and generates polycistronic messages.
These polycistronic transcripts are processed to mature messages when the mRNA
splicing machinery binds to polypyrimidine stretches located in the intergenic regions of
the primary transcripts. Trans-splicing of a 37 nt spliced leader results in these regions
being cleaved and results simultaneously in capping and polyadenylation (Vanhamme
and Pays, 1995). It is during and after these mRNA processing steps that the expression
of individual genes is controlled. Through this process, as well as differential rates of
translation and RNA degradation, rapid changes in protein levels can occur (Archer et aI.,
2011). All mRNAs from trypanosomes are substrates for the trans-splicing reaction.
Since its initial discovery in trypanosomes, a variety of protists and some metazoans
8

display smaller,varying percentages ofmRNAs that are processed throughtrans-splicing
(Davis, 1996). Zhang et aI., 2007, have reported that this spliced leader (SL) sequence is
common to all dinoflagellates, and present on most ifnot all nuclear-encoded mRNAs.
Thus it appears that post-transcriptional control plays a major role in dinoflagellate gene
expreSSIon.

Translational Control in Dinoflagellates
Although there are steps between transcription and translation that are possible
levels of control, such as differential mRNA stability, there are numerous examples of
translational control of specific proteins in dinoflagellates, where mRN A levels are
constant but protein levels change. In L. polyedrum, luciferin-binding protein (Mittag et
aI., 1994), NADP-dependent isocitrate dehydrogenase (Akimoto et aI., 2005) and
GAPDH (Fagan et aI., 1999) are all controlled at the translational level. These processes
are all under circadian control. Iron-superoxide dismutase (Okamoto et aI., 2001) and
nitrate reductase (Ramalho et aI., 1995) were also shown to be regulated at the
translational level by a circadian rhythm in L. polyedrum. To better understand the
dynamics of translational regulation over the circadian cycle, studies have been carried
out investigating circadian rhythms duringtranslation. In L. polyedrum, the bulk
production of polysomes was shown to be under circadian control with bound polysomes
and protein synthesis occurring mainly during the subjective night when placed in
constant dim light (Schroder-Lorenz and Rensing, 1987). The presence of this rhythm in
L. polyedrumfurther complicates understanding how specific cell cycle proteins might be

regulated in a timely manner that does not coincide with circadian controlled pattern of
nighttime bulk translation.
9

The studies presented in this dissertation were undertaken to further our
understanding of cell cycle regulation in the Florida red tide dinoflagellate, Karenia
brevis by addressing three specific aims:

1. To characterize the extent and patterns of changes in the protein expression and
translation over the diel cycle.
2.

To characterize S-phase specific genes and determine if their proteins are
regulated at the level of translation.

3. To identify possible post-translational modifications ofPCNA observed in Sphase,determine if the expression ofPCNA is CDK dependent, and examine its
utility as a biomarker for growth in K. brevis blooms.

To better understand the extent to which gene expression is regulated at the level
of protein synthesis in K. brevis,Chapter 2 first investigated circadian patterns of protein
translation using polysome profiling. A proteomic approach was then used to examine
global changes in protein abundances over the diel cycle and nuclear proteomic methods
were then optimized to improve the study of cell cycle proteins in the future. Chapter 3
then investigates the expression and behavior of specific S-phase proteins involved in the
DNA replication fork, using western blotting and immunolocalization. These studies
revealed that these S-phase proteins are regulated at the level of translation, as opposed to
transcriptional control found in most eukaryotes, and identified some apparent posttranslational modifications to PCNA. The studies in Chapter 4 focus on PCNA, to
determine the CDK dependence of this S-phase protein. Chapter 4 also explores post10

translational modification mechanisms, ubiquitin and SUMO, identified for the first time
in a dinoflagellate, that may be responsible for changes in localization and molecular
weight of K. brevis PCNA during S-phase. Lastly, Chapter 4 demonstrates the potential
ofPCNA as to be employed as a biomarker for the growth status of toxic blooms of K.
brevis. Finally, Chapter 5 provides a synthesis of the above studies, conclusions that can

be drawn from the results, and identifies future directions for this research.
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Figure 1: Tree of life showing the placement of the dinoflagellates within the eukaryotic
crown group Alveolata. This group includes the dinoflagellates (outlined in red), ciliates
and Apicomplexa. Adapted from Baldauf, 2003.

Tree of Life
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Chapter 2: Global protein and translation patterns in Karenia brevis over the diel
cycle
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INTRODUCTION

Many physiological processes appear to be under post-transcriptional control in
dinoflagellates. The best studied examples to date include proteins shown to be under
circadian control, in particular those involved in bioluminescence in the model
dinoflagellate, Lingulodinium polyedrum. In L. polyedrum, circadian expression of genes
involved in bioluminescence, such as luciferin-binding protein and luciferase is
controlled by changes in rates of protein translation while mRNA levels remain constant
(Morse et aI., 1989; Mittag et aI., 1998). Differential expression of luciferin-binding
protein and luciferase over circadian time is controlled by the RNA-binding protein,
CCTR (circadian-controlled translational repressor), which binds to the 3 'untranslated
region (UTR) and prevents translation (Mittag 1996). The binding of CCTR to RNA is
under circadian control and its activity is highest during the light phase. During the dark
phase, CCTR releases the mRNAs of luciferin-binding protein and luciferase, allowing
for translation to occur. Other genes under circadian, translational control in
dinoflagellates include GAPDH (Fagan et aI., 1999), peridinin-chl a-binding protein (Le
et aI., 2001), and superoxide dismutase (Okamoto et aI., 2001). These proteins show
highest abundance during the day. Therefore, it appears that different proteins in
dinoflagellates have distinct circadian patterns.
Circadian Rhythms

Circadian rhythms are defined as oscillations in biochemical, physiological and
behavioral functions of an organism with a periodicity of approximately 1 day (Sancar et
14

aI., 2000). Evolutionarily, circadian rhythms confer adaptive advantage, allowing
organisms to anticipate and prepare for environmental changes (Hastings, 2003) and this
has been demonstrated in some organisms, such as cyanobacteria (Ouyang et aI., 1998)
and ground squirrels (DeCoursey et aI., 1997). Unicellular, photosynthetic, marine
organisms were most likely the first to evolve a circadian clock, utilizing the 24-hour
periodicity of their early environment to optimize their use of energy resources and
minimize their exposure to damaging UV irradiation (Roenneberg et aI., 1997).
Circadian oscillations function at the cellular level, even in multicellular organisms,
where oscillations in one cell type may differ from those in another (Roenneberg and
Mittag, 1996). There are three main components of the circadian clock: a central
oscillator that regulates the 24-hour periodicity, an input pathway that entrains the
oscillator to environmental cues such as light, and an output pathway that couples the
oscillator to circadian responses (Christie and Briggs, 2001). The photoperiod is the
main external signal, or zeitgeber (German = time giver), in setting circadian rhythms
(Roenneberg et aI., 1997). Although light is what entrains the rhythm, a rhythm is
identified as circadian if it continues in the absence of the light cue or other external cues
such as temperature.
A number of intracellular processes have been shown to have a circadian pattern.
In plants, many processes that are controlled by the circadian clock include gene
expression, Ca2+ levels, and some enzyme activities (Somers, 1999). Circadian
regulation of gene expression may occur at the level of transcription, transcript
abundance, translation and/or posttranslational processing (Somers, 1999). A microarray
study of Arabidopsis thaliana showed that expression of approximately 2% of genes
15

cycled with a circadian rhythm (Schaffer et aI., 2001). Circadian rhythms regulate
bioluminescence, cell aggregation, photosynthesis and cell division in dinoflagellates.
Similar to other systems, dinoflagellate RNA and protein synthesisare required for the
maintenance ofcircadian rhythms and protein phosphorylationevents playa role in
determiningperiod length (Wijnen and Young, 2006). Microarray analysis of circadian
gene expression in dinoflagellates Pyrocistis lunula and K. brevis showed approximately
2 and 3% of genes changing, respectively, over 24 h in continuous light (Okamoto and
Hastings, 2003; Van Dolah et aI., 2007). However, the expression patterns did not reveal
any concerted changes in transcript levels associated with many known circadian
processes. Since all circadian regulated genes studied to date are under translational
control in dinoflagellates, it may be that these organisms use translational control for all
circadian regulated functions. The degree to which dinoflagellates use translational
control in the cell overall is not known. Until recently, it was accepted that circadian
rhythms in most eukaryotes are transcriptionally controlled. However, it was recently
found that in the eukaryotic green alga Ostreococcus tauri, circadian rhythms persisted in
the absence of transcription (O'Neill et aI., 2011). The recent discovery of a spliced
leader sequence in dinoflagellates (Lidie and Van Dolah, 2007; Zhang et aI., 2007) which
is used in trypanosomes for post-transcriptional regulation of gene expression also leads
to the idea that dinoflagellates may be using post-transcriptional control as well.

The Central Role of the Photoperiod in Dinoflagellate Physiology
The diel cycle plays a key role in many aspects of dinoflagellate physiology,
including photosynthesis, vertical migration behavior, and bioluminescence. Cells ofK.
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brevis are positively phototactic and negatively geotactic (Kamykowski et aI., 1998)

which results in their concentration in the upper water column during the day where they
can access light for photosynthesis. Therefore, the photoperiod has a strong influence on
K. brevis' swimming behavior. In addition, it has been shown that cell division is

regulated by the diel cycle in many dinoflagellates (Sweeney and Hastings, 1958; Olsen
and Chisholm, 1986; Homma and Hastings, 1989; Roenneberg, 1996; TaroncherOldenburg, 1997; Van Dolah and Leighfield, 1999; Leighfield and Van Dolah, 2001,
Litaker et ai., 2002; Dagenais-Bellefuielle et aI., 2008). The dinoflagellate has a
eukaryotic cell cycle consisting of a G 1 phase, characterized by growth, S-phase,
consisting of DNA replication, a G2 phase, in which cells edit replicated DNA, and
mitosis, or cell division (Vaulot et aI., 1986; Partensky and Vaulot, 1991; Van Dolah et
aI., 2007; Brunelle et aI., 2007). In K. brevis, the dark-to-light transition serves to entrain
the cell cycle, with S-phase beginning approximately 6 hours after onset of light (Van
Dolah and Leighfield, 1999). The persistence of this rhythm in constant light
demonstrated that cell cycle progression is under control of a circadian rhythm, which is
in tum entrained to the diel cycle (Brunelle et aI., 2007).
A global transcriptome analysis in K. brevis using a microarray found
approximately 10% of genes changing with respect to light/dark cycle. However, many
genes involved in diel-dependent processes, including cell cycle genes, did not change
mRNA levels in a diel-dependent fashion (Van Dolah et aI., 2007). This raised the
question as to whether the cell cycle, like other circadian regulated processes in
dinoflagellates, is regulated post-transcriptionally and whether a change in protein
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expression over the cellidiel cycle might be observable using a parallel proteomic
approach.
A complicating aspect to using proteomic analysis of the cell cycle is the
observation in the dinoflagellate, L. polyedrum, of a diurnal rhythm of translation. In this
species, polysome analysis demonstrated that the bulk of messages are translated during
the dark (Schroder-Lorenz and Rensing, 1987). Little actively translated, polysomeassociated RNA was present during the subjective day, and the relative proportion of
messages associated with polysomes increased to reach a maximum during the subjective
night period, which corresponds to G2 phase of the cell cycle (Figure 1). This
corresponds with the time when the rate of protein synthesis reaches its maximum as
measured in a cell-free extracts by in vitro protein synthesis using
[35 S]methionine(Schroder-Lorenz

and Rensing, 1987).

The studies in herein were undertaken to better understand the extent to which
protein levels in Karenia brevis vary over the over the diel cycle, and in particular,
whether cell cycle proteins change in expression. Because there is currently no data on
translation patterns in K. brevis, we first sought to determine if a circadian rhythm
controls the bulk translation of messages over the diel cycle as in Lingulodinium. The
polysome analysis indicates that bulk translation does not change over the diel cycle.
However, this does not preclude the likelihood that specific proteins needed for diel
dependent processes are differentially expressed. A proteomic approach was therefore
taken to assess diel changes in global protein expression and to potentially identify
proteins that were differentially expressed. Few proteomic studies have been attempted
to date in dinoflagellates because the lack of genome sequence information limits the
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ability to make accurate identifications of peptides (Akimoto et aI., 2004; Chan et aI.,
2004; Chan et aI., 2005). With the recent availability of a K. brevis cDNA library
containing approximately 22,671 unique genes to provide a database of K. brevis specific
amino acid sequences (Lidie et aI., 2005), a proteomic approach for investigations into
this organism became feasible for the first time. Protein extraction methods were first
optimized for a two dimensional gel electrophoresis proteomic protocol for K. brevis.
This method was then adapted for difference in-gel electrophoresis (DIGE) analysis for
quantitative comparison between timepoints collected within a diel cycle. DIGE has
been shown to broaden the dynamic range of analysis by detecting low abundance
proteins without saturating the highly abundant ones and provides quantitative results
(Renaut et aI., 2006).

19

METHODS
Cultures and Culturing Conditions

K. brevis (Wilson isolate) was grown in 0.22 Jlm filtered seawater (36%0) obtained

from the seawater system at the Florida Institute of Technology field station, Vero Beach,
Florida, enriched with j/2 nutrients (Guillard, 1973), modified with the use of ferric
sequestrene in place ofEDTA'Na2 and FeCl3 ·6H20 and the addition ofO.OlJlM selenous
acid. Cultures were maintained in 1 liter glass bottles at 2SoC + 1°C with a 16:8
lightdark cycle, and cool white light at SO-60 flmol photons m- 2 sec-I, determined using a
LI-COR LI-2S0 Light Meter (LI-COR BioSciences, Lincoln, NE). Experimental cultures
of K. brevis were grown to mid log phase under nutrient replete conditions in order to
maximize the cell division rate, which has previously been established at ",O.S div/day.
Cultures for Polysome Analysis

Triplicate one liter cultures were harvested on culture day 7, during log phase
growth. Cells were sampled at LDT2, 6, 10, 14, 18 and 22, where LDT refers to lightdark-time, where "lights-on" is LDTO and "lights-off' is at LDT 16. At LDT2 and 6 cells
are in Gl of the cell cycle, LDTI0 and 14 represent S-phase and LDT18 and 22 represent
G2/Mitosis. Cells were harvested by centrifugation at 600 x g for 10 min. and sea water
was removed by aspiration. Cell pellets were then extracted for polysome analysis (see
below).
Cultures for 2-Dimensional Electrophoresis

Cultures for 2-DE analysis were harvested in triplicate during log phase on day 7
at LDT 2, 10 and 18, corresponding with G 1, S phase and G2/Mitosis of the cell cycle,
respectively, for initial proteomic analysis. Cells were harvested by centrifugation at 600
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x g for 10 min. and sea water was removed by aspiration. Protein was then extracted
from cell pellets (see below).
Cultures for Difference In-Gel Electrophoresis
One liter cultures were harvested in quadruplicate during log phase on day 7 at
LDT2, 8, 14, 20 to increase statistical power. Again, cells were harvested by
centrifugation at 600 x g for 10 min. and sea water was removed. Protein was then
extracted from cell pellets ( see below).
Cultures for Nuclear Isolations
One liter cultures of cells were harvested from mid log phase cultures to study the
nuclear proteome during Gland S-phase. Cells were harvested by centrifugation at 600
x g for 10 min. and sea water was removed. Protein was then extracted from nuclear
pellets as described below. Nuclear proteins from two liters were pooled due to the low
protein concentration of lysates.

Cell Cycle Analysis
Samples for flow cytometric analysis were taken fromall experimental cultures to
verify their progressionstatus through the cell cycle. At each experimental time point,
15mL of culture were fixed with 2% gluteraldehyde and stored at 4°C for at least 24
hours. Cells were then centrifuged 10 min at 600 x g. To extract cellular pigments, cells
were resuspended in -20°C methanol for a minimum of 4 hours. The cells were then
centrifuged 10 min. at 2000 x g and DNA was stained by the addition of 1oJlg/mL
propidium iodide (PI, Sigma, St. Louis, Missouri) (final concentration) in 1 mL PBS
containing 10mg/mL RNase (Sigma) and 0.5% Tween 20. Flow cytometry was
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perfonned on an Epics MXL4 flow cytometer (Beckman Coulter, Miami, Florida).
Multicycle software (Phoenix Flow Systems, San Diego, CA) was used to obtain the
percentages of cells in each stage of the cell cycle, or cell cycle distribution.

Polysome profiles
One liter cultures of K. brevis were harvested by centrifugation, 600 x g for 10
min., and cell pellets were resuspended in 1 ml of resuspension buffer (0.2 M Tris, pH
7.5, 2.5M KCI, 100 mM MgCI 2 , 0.5% (v/v) Triton X-lOa, 1 mM DTT, and 100 mg/ml
cycloheximide). The resuspended cells were homogenized by pipettingwith a PIOOO
pipetman (Gilson Inc., Washington, GA) on ice and drawing the suspension through a
syringe 10 times using a 10 cc syringe with a 22 g needle. Homogenates were
centrifuged for 10 min. at 10,000 xg to pellet nuclei, mitochondria, and chloroplasts. To
prepare polysomes, supernatants were layered onto 15-50% linear sucrose gradients and
centrifuged for 100 min. at 40,000 rpm in an SW-55Ti rotor (Beckman Instruments) at
4°C. Gradients were profiled using an ISeO fractionation system equipped with a flow
cell and UV detector (A254). Based on the A 254 profiles, absorbance peaks were identified
as the 40s and 60s ribosomal RNA, monosome (80s), and polysomes containing
increasing numbers of ribosomes. Confirmation of the identity of the monosome and
polysomes was obtained by running an identical gradient in the presence of EDTA, which
causes ribosomal runoff and consequently the absence of monosome and polysome
peaks.

Protein Extraction
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A matrix was designed to test multiple homogenization and rehydration
(solubilization) buffers that are typically used in two-dimensional electrophoresis in order
to optimize conditions for K. brevis proteins. Urea-detergent based homogenization
buffers, Gooley (5.8M urea, 2.3% CHAPS (3-[(3-cholamidopropyl)dimethylammonioJ-l
-propane sulphonate ), 2mM tributyl phosphine and 40mM Tris) and Modified
Whitzman's (9M urea, 4% NP-40, and 1% dithiothreitol (OTT)) were tested as well as
trifluoroethanol buffer (11.6mM Tris-HCI, 5.8M urea, 2.3M thiourea, 2.3% CHAPS, 65
mM 1,4-dithioerythritol in a 50:50 mixture oftrifluoroethanol). Other homogenization
buffers tested included SDS boil buffer (5% sodium dodecyl sulfate, 5%

p-

mercaptoethanol, 10% glycerol, 60 mM Tris, pH 6.8), 1M sucrose in triethanolamine, and
a 10% trichloroacetic acid/acetone precipitation. In each case the protein pellet from one
1L culture, containing about 106 cells total, was suspended in the rehydration buffer and
applied to the isoelectric focusing strip to run in the first dimension followed by SDSPAGE.
Proteins were also extracted using TRIzol® Reagent (Invitrogen, Carlsbad, CA)
(phenollchlorofonn reagents) following the manufacturer's protocol with slight
modifications. Four mLs ofTRIzol® Reagent were used per 10 6 cells to ensure removal
of pigments which interfere with 2D analysis. RNA was then removed by chloroform
extraction, followed by DNA precipitation with ethanol, and subsequently proteins were
precipitated with isopropanol. After washing 4 times with 8 mLs of 0.3 M guanidine
hydrochloride, protein pellets were dried and resuspended a "DIGE buffer" consisting of
7M urea, 2M thiourea, 4% w/v. CHAPS, 30 mM Tris, pH 8.5.

23

2D Gel Analysis
Following optimization (above), proteins were extracted using TRIzol® Reagent
as described above. Protein concentrations were determined using the Bradford (BioRad, Inc., Hercules, CA) assay. One hundred micrograms of protein were rehydrated in
DIGE buffer with 1M DTT and 0.2% Biolytes (Bio-Rad) for a total volume of 155JlL and
isoelectrically focused on 11 cm Bio-Rad ReadyStrip IPG (Immobilized pH Gradient)
strips pH 3-10 using a Bio-Rad Protean IEF Cell. The IPG strips were then loaded and
run in the second dimension on 8-16% acrylamide Criterion gels (Bio-Rad, Inc ..,
Hercules., CA).
Gels were then fixed with 10% methanol/ 7% acetic acid for 30 minutes at room
temperature and stained with SYPRO Ruby (Bio-Rad, Inc., Hercules, CA) protein stain
overnight, then destained with 10% methanol! 7% acetic acid for 30 minutes at room
temperature before imaging in PDQuest 2-D Analysis software (Bio-Rad Laboratories,
UK). After imaging gels, protein spots were matched using PDQuest software. A G I

(LDT2) sample was chosen as the master gel against which protein abundances on all
gels were compared within. A t-test was used in PDQuest to analyze any potential
changers relative to LDT2. Significantly changing proteins were then determined using a
I-way ANOVA of spot intensities in Microsoft Excel.

Difference In-Gel Electrophoresis (DIGE)
TRIzolTM Reagent was used to isolate protein from each sample as described
above. After extraction, protein pellets were dried and resuspended in 200JlL DIGE
labeling buffer (7M urea, 2M thiourea, 4% w/v. CHAPS, 30 mM Tris, pH 8.5). The
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Bradford protein (Bio-Rad, Inc., Hercules, CA) assay was then used to obtain protein
sample concentration.For the CyDye labeling, twenty-five micrograms of whole cell
protein lysate from each replicate at each time point were labeled with fluorescent
cyanine dyes, Cy5 or Cy3, following the manufacturer's recommended protocols (GE
Healthcare, Piscataway, NJ). A pooled sample containing equal amounts of protein from
all samples was used as a normalizer, or internal control run on each gel, which improves
gel-to-gel repeatability in differential expression calculation. Two hundred micrograms of
the pooled sample was labeled with Cy2 (twenty five micrograms per each of the 8
experimental gels). All protein samples were labeled with 400 pmol of the amine
reactive cyanine dyes, freshlydissolved in anhydrous dimethyl formamide. The labeling
reaction was incubated on ice in the dark for 30 minutes and the reaction was terminated
by addition of 1Onmollysine. Twenty-five micrograms of experimental protein samples
labeled with Cy3 and Cy5 were mixed with 25 micrograms of the Cy2 labeled pooled
normalizer, and focused on 11 cm Bio-Rad ReadyStrip IPG (Immobilized pH Gradient)
strips, pH 4-7, using a Bio-Rad Protean IEF Cell. After isoelectric focusing, the strips
were run in the second dimension on 8-16% Criterion acrylamide gels (Bio-Rad
Laboratories, Hercules, CA). Gels were then fixed in 100/0 methanol/ 7% acetic acid for
30 minutes. The gels were imaged using an Fx laser imager equipped with a blue laser.
The image files were imported into DeCyder software (GE Healthcare, Piscataway, NJ)
for analysis and the scanned gel images were processed to find all possible protein spots.
A master gel was determined using the software and all gels were matched to the master
gel for mobility in both dimensions. Difference In-gel Analysis was used to normalize
and quantify protein spots in all gels. Biological Variation Analysis (BVA) was then
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used for statistical analysis (one-way ANOV A) to test for significantly changing proteins
across gels and a t-test for proteins changing between LDT2 and each of the other three
time points with a Bonferroni correction. BVA processes multiple gel images, performs
gel-to-gel matching of spots, allowing for quantitative comparison of protein expression
across multiple gels. Once significantly changing protein spots were determined, all gels
were post stained with SYPRO Ruby (Bio-Rad Laboratories) and spots of interest were
excised using a Bio-Rad Spot Cutter (Bio-Rad Laboratories., Hercules, CA) for protein
isolation.

Gel plugs were washed with 50 mM ammonium bicarbonate/50% acetonitrile,
vortexed for 20 min. and sonicated 3 times for 20 min. at room temperature in a water
bath. After dehydrating with 1000/0 acetnonitrile for 5 min., gel plugs were digested with
O.lJlg/JlL trypsin (Promega Trypsin Gold) overnight at 37°C to produce peptides. The

peptides were then extracted from the gel plugsand washed with 50 mM ammonium
bicarbonate and dried using a Savant speed vacuum (Thermo scientific, Waltham, MA).
After the peptide samples were dried, they were resuspended in 10 uL 0.1 %
trifluoroacetic acid. Samples were vortexed for 20 min., sonicated for 20 min. to
solubilize and applied to C I8 ZipTips® (Millipore, Billerica, MA) to further concentrate.
Samples were then elutedin 2 uL of a matrix consisting of 10mg of a-cyano-4hydroxycinnamic acid (Sigma-Aldrich, St. Louis, MO) in 500/0 acetonitrile and 0.5%
trifluoroacetic acid for MALDI-TOF analysis. After applying the samples in matrix to a
MALDI-TOF target plate, MALDI-TOF analysis was performed at MUSC by A. Bland.
MALDI-TOF-TOF target plates similarly prepared were sent to the MUSC Mass
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Spectrometry Core Facility and data was acquired using aMALDI TOF TOF (Applied
Biosystems 4800 Proteomics Analyzer TOF -TOF).

Mass spectra results from the MALDI-TOF were used for peptide mass
fingerprinting, using the K. brevis EST library and NCBI (GenBank) non-redundant
sequence database as sources of theoretical peptide masses of proteins stored in the
databases. The K. brevis eDNA library was translated in 6 frames by Dr. John Schwacke
(Dept. of Epidemiology and Biostatistics, MUSC) using the EMBOSS (European
Molecular Biology Open Software Suite) program Transeq that translates nucleotide
sequences to amino acid sequences using the standard coding table and uploaded into the
MASCOT search engine (Matrix Science, Boston, MA). Tandem mass spectra from the
MALDI-TOF TOF were searched against the K. brevis database and non-redundant
sequences on GenBank using MASCOT using the fixed modification of
carboxamidomethylation of cysteine (+57) software for identification of proteins.
Fragment ion scores were generated using MALDI-TOF TOF analysis. Protein scores for
MS data and ion scores for MS/MS data above 95% C.1. (confidence interval) were
considered a significant match.

Nuclear Isolations
Cells were harvested by centrifugation at 600 x g for 10 minutes. Cell pellets
were then resuspended in 10mL of buffer consisting ofO.25M sucrose, 10 mM Tris and 5
mM CaC12 . Cells were allowed to equilibrate in buffer for 20 minutes on ice and
homogenized with a Dounce homogenizer 10 times. Homogenized cells were then
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centrifuged at 2200 x g for 6 minutes at 4°C and the pellets were resuspended in the
aforementioned buffer. This homogenization step was repeated, followed by
centrifugation for 5 minutes at 3000 x gat 4°C. Pellets were resuspended in 5 mLs of 10
mM Tris, with 5 mM MgCI 2 . This resuspension was layered over a gradient of 4 mL of
2.2 M sucrose and 12 mL of 1.6 M sucrose. The gradients were then centrifuged at
12,000 x g for 25 minutes at 4°C. The bottom of the tube contained a pellet of purified
nuclei. The sucrose was removed by aspiration and an aliquot of the nuclei was brought

°

up in phosphate buffered saline and stained with 1 Jlg/mL propidium iodide for
examination under a fluorescent microscope to assess purity_ One mL TRIzol® Reagent
was then added to the nuclear fraction for protein extraction following the manufacturer's
protocol. After washing 4 times with 8 mLs of 0.3 M guanidine hydrochloride, protein
pellets were dried and resuspended in 100uL ofDIGE buffer for 2D gel analysis. One
hundred micrograms of protein were rehydrated and run using the 2D gel methods
described above. Nuclear proteins were also cut from the 2D gels using the Bio-Rad Spot
cutter and trypsin digested and these samples were run on a Finnigan L TQ (linear ion trap
mass spectrometer) at the MUSC Proteomics Core Facility. The resulting spectra were
searched using SEQUEST software (Thermo Finnigan, West Palm Beach, FL) using the
variablemodification oxidation of methionine (+ 16) and the fixed modification
carboxamidomethylation of cysteine (+57) against the translated K. brevis database and
the GenBank non redundant species database. Spectra were also manually inspected for
band y ions.
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RESULTS
Global Translational Activity over the Diel Cycle
In order to determine whether protein translation occurs primarily during the dark
phase as observed in L. polyedrum, active translation in K. brevis over the diel cycle was
investigated using polysome profiling. Polysome extraction and profiling methods were
first optimized for K. brevis and the initial studies examined light (LOTS) vs. dark
(LDT20) phase cultures in mid log phase growth (Figure 2). We were able to clearly
distinguish fractions containing free ribosomes, represented by 40S and 60S ribosomal
RNA, RNA present as monosomes (80S), and polysomal RNA containing up to six
ribosomes (Figure 2A). The identity of the monosome and polysome peaks was
confirmed by treating the ribosome preparation with 30 mM EDTA, which causes the
release of ribosomes from the mRNA and thereby the loss of monosome and polysome
peaks (Figure 2C). There did not appear to be any major difference in the polysome peak
sizes between light (Figure 2A) and dark (Figure 2B) phase polysome profiles. (The
difference in slopes is due to variability in the sucrose gradients). This is dramatically
different from the nighttime ribosomal loading reported in L. polyedrum (Figure 1).
However, since this preliminary experiment investigated only two time points over the 24
hour diel cycle, it is possible that we missed a window of more active translational
activity. Therefore we next obtained polysome profiles from triplicate cultures harvested
every 3 hours throughout the diel cycle. To more closely mimic conditions in the L.
polyedrum study, cells were kept in continuous light, which enabled us to assess if any

resulting pattern is circadian in nature. To confirm that the cells in this experiment were
actively growing, and therefore requiring the expression of known diel-dependent
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metabolic processes, we performed cell cycle analysis on the cell populations used for
polysome preparations (Figure 3). Approximately 40% of the cell population of all
cultures was synchronously proceeding through the cell cycle. However, no major
changes in polysome loading were observed at any time point (Figure 4). Thus, it does
not appear that a circadian rhythm of translation occurs in K. brevis. Instead, K. brevis
may be producing individual proteins as demanded by physiological and metabolic
processes over the die! cycle. Since these polysome studies did not show a pattern of
bulk translation, a proteomic approach was used to investigate patterns of total cellular
protein expression on 2-DE gels to investigate the behavior of individually resolved
proteins.

Optimization of Protein Extraction Methods for K. brevis 2-DE analysis
Numerous buffers are used for proteomic studies depending on the type of tissue
(plant, animal, etc) and the proteins of interest (membrane, nuclear, cytoso lic, etc.).
Therefore, optimization of protein extractions for 2-DE analysis of K. brevis was first
necessary since there are limited studies employing these techniques in dinoflagellates.
Traditional buffers that are often used in 2-DE proteomic analyses were tested for
efficiency in extracting proteins from K. brevis. For 2-DE analysis, it is necessary to
obtain protein extracts that will produce the highest number of protein spots and
minimize nucleic acid contamination so that the proteins will be clearly resolved on the
gels without streaking patterns. Multiple buffers for homogenization of proteins were
tested, including: Gooley buffer, Modified Witzmann's buffer, SDS Boil buffer,
trifluoroethanol buffer,sucrose/triethanolamine buffer, a trichloroacetic acid/acetone
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precipitation, and phenol/chloroform (TRIzol® Reagent; Invitrogen, Carlsbad, CA).
Many of the buffers tested were not suitable for protein isolation as evidenced by a lack
of protein spots on the 2-0E gels. Three extraction buffers (Gooley, modified
Witzmann's, and TRIzol® Reagent) were successful for protein extraction as evidenced
by protein spots on a 2-0E gel. Of the three best results, protein extracts using TRIzol®

Reagentclearly resulted in gels containing a greater number of protein spots compared to
gels run with traditional urea/detergent based homogenization buffers (Figure 5). This
extraction method was therefore used in further studies in K. brevis.

Global Analysis of Protein Expression over the Diel Cycle using 2D and SYPRO
Ruby
F or initial insight into the K. brevis proteome over the diel cycle, protein samples
were obtained from triplicatecultures at 3 time points, LDT 2, LOTIO and LOTI8. These
time points were chosen since LOT2 displays the highest proportion of cells in G I,
LDTIO represents early S-phase when cell cycle proteins necessary for S-phase
progression should be abundant and LOT 18 is a dark phase time point when the cycling
cell population is in G2 or mitosis. Flow cytometry data shows that approximately 50%
of the cell population was proceeding through the cell cycle in this experiment (Figure 6)
and therefore if changes in the proteome were to occur over the cell cycle they might be
visible on the 2-0E gels. When G I (LOT2), S-phase (LOTIO) and G2/Mitosis (LOTI8)
protein profiles on the 20 gels were compared using PDQuest software and a built-in
student's t-test, 47 protein abundances, out of 304 protein spots detected,
changedsignificantly over the diellcell cycle. Figure 7 illustrates changing intensities of 3
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protein spots between G 1, S phase and G2/Mitosis time points. Although these 2DE gels
showed promise in terms of spot resolution, these preliminary results from the 2-DE
using SYPRO did not provide adequate matching between gels for powerful statistical
analysis. The difficulty in protein spot matching using PDQuest in this initial study
warranted the use of a more stringent and quantitative approach with additional
replication at each time point.

Global Proteomic Analysis over the Diel Cycle Using DIGE

For the next set of analyses, DIGE was used to increase the quality of matching of
proteins between gels, facilitated by the use of a normalizer sample on each gel, which
allows for a higher accuracy of statistical analysis and increased sensitivity. For the
DIGE studies, samples were collected for flow cytometry and proteins were extracted
from quadruplicate cultures at 4 time points (every 6 hours) over the diel cycle: LDT2
(G 1), LDT8 (early S-phase), LDTI4 (mid-S-phase) and LDT20 (late G2/early mitosis).
Flow cytometry results show that --50% of the cell population was proceeding through
the cell cycle (Figure 8). Proteins were labeled with Cy3 or Cy5, run pairwise in two
dimensions in the presence of the pooled normalized labeled with Cy2 and analyzed
using DeCyder software. A minimum of 470 proteins were reproducibly detected on
each 2-DE gel (Figure 9). Of these, 21 proteins were found to change significantly
(ANOVA, p<O.05) over the diel cycle (Table I).This accounts for 4.5% of the proteome
represented in this study.Many of these significant changeswere observed between LDT8
and LDTI4, with protein abundances either increasing or decreasing. Individual proteins
changing in abundance between LDT8 and 14 are shown in Figure 10. Because all initial
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gels compared either LDT2 to LDT8 or LDT14 to LDT20, thereported changes in protein
abundances were verified by running the same samples in gels that compared LDT8 and
LDTI4 directly, and 83.3% were shown to have the same trend (Table 1).
After statistical analysis was carried out using DeCyder, all gels were stained with
SYPRO Ruby for total protein (Figure 11). Proteins were matched and compared to the
matching pattern in DeCyder software in order to pick the significantly changing proteins
for identification by mass spectrometry. Fourteen of the significantly changing proteins
were sent to the MUSC Mass Spectrometry Core for analysis by MALDI-TOF-TOF. The
other 7 significantly changing proteins did not have high enough abundance for mass
spectrometry analysis. Comparison of the peptide sequences obtained from MALDI TOF
TOF with the translated K. brevis EST library provided putative matches; however, none
of these met the generally accepted significance cut-offs of greater than C.1. 95%. This
may be because there was a mixture of proteins samples in the gel pugs that were not able
to be separated using MALDI- TOF TOF or the proteins may have been of low
abundance. Although no proteins could confidently be assigned identity, this study
identified several trends in protein abundance over the diel cycle, in which the most
dramatic changes occurred late in the light phase from LDT8 to LDTI4, which also
corresponds to S-phase of the cell cycle. The three general trends that were observed
over the diel cycle in these proteins are shown in Figure 12.

Proteomic Analysis of Isolated Nuclei
Because 2D gel analysis of whole celllysates detected only ----500 of the most
highly expressed proteins in the cell, subcellular fractionation wasnext used to increase
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the possibility of identifying proteins that localized to the nucleus, particularly those
involved in cell cycle regulation, by removing highly expressed proteins from other
cellular compartments. Nuclear isolations should facilitate the analysis of both proteins
that are differentially expressed and proteins that are imported to and exported from the
nucleus over the cell cycle.
A wider range of isoelectric points, 3-10 pI, was used to allow for better
separation of potentially basic proteins, as expected for nuclear proteins. SYPRO Ruby
was used for staining and PDQuest software was used to identify spots and analyze
intensity. Twenty-six prominent nuclear spots were then picked, extracted, and trypsin
digested. Nuclear peptides were sent to MUSe Mass Spectrometry Core Facility for
analysis on the LTQ MS/MS to determine if these proteins could be identified using
SEQUEST softwareto search the translated K. brevis EST library and GenBank nr
database.
The number of nuclear proteins detected was much smaller ('"" 100) than that found
in whole celllysates (Figure 13). Positive matches to the K. brevis EST library were
obtained for eighteen nuclear proteins by L TQ MS/MS, or approximately 18% of the
proteins detected on the gels (Table 3). Ten of the 18 proteins had hits to contigs in the
EST library that have significant homology to known genes on GenBank. Of the proteins
with known function, most of these proteins are of known nuclear localization. Table 3
shows the number of peptides identified in each sample and the total ion score generated
from the identification of these peptides. The total ion score is calculated by weighting
the ion scores for all individual peptides nlatched to the protein that is associated \vith
this peptide and the MS/MS spectrUlTI. The ion score is calculated for each peptide
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matched fronl MS/MS peak lists and is significant if it meets the 95% confidence
interval. The substantially improved success rate for identifying proteins from the
nuclear preparations is most likely a combination of the highly conserved nature of many
nuclear proteins and the use of reverse phase C 18 LC-MS/MS which is moresensitive and
permits separatation of peptide mixtures.
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DISCUSSION
The studies in Chapter 2 were undertaken to gain insight into diel patterns of
protein expression in K. brevisand, in particular, whether a proteomic approach would be
infonnative of changes in the expression of cell cycle proteins since the cell cycle is
tightly linked to the diel cycle. Mounting evidence from studies of circadian rhythms
(Mittag, 1996; Fagan et aI., 1999; Le 2001; Okamoto et aI., 2001), microarray studies
(Okamoto and Hastings 2003; Van Dolah, 2007; Lidie 2007) and the identification of
spliced leader trans-splicing in dinoflagellates (Lidie and Van Dolah, 2007; Zhang et aI.,
2007) point to a predominance of translational control in this group of protists.
Schroder-Lorenz and Rensing (1987) demonstrated that translational activity in
the dinoflagellate L. polyedrum occurs almost exclusively during the night based on
polysome profiles (Figure 2D). In that species, little RNA was associated with ribosomes
at the time of cell division, ---CTO. By CT6, a large monosome peak appears suggesting
the initiation of translation has occurred, but little RNA is present in the polysome pool.
However, by CTI2, which corresponds with the beginning of dark in the circadian day,
polysome peaks increase in size relative to the monosome and by CT17 much of the
RNA is found in the larger polysome classes with 3 or more ribosomes. This time
corresponds roughly to when cells are exiting S-phase and entering G2 phase in the dielphased (LD 8: 16) cell cycle of Lingulodinium (Dagenais-Bellefeuille et aI., 2008). By
CT24, when cells have once again moved into mitosis, little translation activity is
evident. Using protein synthesis in cell free extracts, it was also shown that the protein
degradation displayed the same circadian rhythm as the synthesis rate (Schroder-Lorenz
and Rensing, 1987). This suggests concerted protein turnover and replacement prior to
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cell division. The polysome experiments in this chapter were undertaken to determine if
a similar pattern of protein synthesis is evident in K. brevis. Somewhat surprisingly, the
polysome profiles in K. brevis over the diellcell cycle did not show any time point where
"bulk translation" was evident (Figures 2 and 4). A large monosome peak was present at
all timepoints examined over the diel cycle, with the peaks corresponding to messages
containing two ribosomes always being the dominant form of polysome. At no time point
did the larger polysomes dominate, although peaks representing up to six ribosomes were
resolved at most time points. We are confident that the absence of a time point
representing "bulk translation" is not an artifact due to ribosomal runoff, because
increasing the cycloheximideconcentration two-fold to 200 mg/ml did not alter the
profiles (data not shown). Furthermore, flow cytometry demonstrated that approximately
50% of the cell population was proceeding through the cell cycle on the day the study
was performed; therefore the absence of a strong protein synthesis peak cannot be related
to the lack of metabolic activity although it could be diminished by out-of-phase cells.
There are limited studies on diel and circadian translation patterns in
dinoflagellates which mostly have been carried out in Lingulodinium. The study by
Schroder-Lorenz and Rensing (1987) which identified a circadian rhythm of polysome
production, was based on previous findings that a circadian rhythm of protein synthesis
occurs in this dinoflagellate (Volknandt and Hardeland, 1984; Donner et aI., 1985;
Cornelius et aI., 1985) and that the bulk of total protein appeared to be synthesized
mainly during the phase corresponding to the night period (Rensing and Schill, 1985).
However, a study in Alexandriumfundyense measuring total protein concentration every
2 hours over the diel cycle showed a protein production pattern where protein
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concentration peaked at the end of the light phase and reached a minimum at the end of
the dark phase (Taroncher-Oldenburg, 1997), the opposite of what was observed in L.

polyedrum. In eukaryotes such as yeast and mammals, there does not appear to be a time
point of bulk translation during the cell cycle. However, during mitosis, 5'cap-dependent
translation is turned off (Pyronnet and Sonenberg, 2001). During this process, translating
ribosomes are stalled on mRNAs to protect the messages from degradation during mitosis
and this allows for the cells to rapidly resume active translation upon entry into the next
G 1 phase of the following cell cycle, which is energy efficient for the cell (Sivan and
Stein, 2008). K. brevis undergoes mitosis during the dark phase of the diel cycle with the
peak occurring from LDT18-LDT22. There was a small decrease in polysomes at the
LDT22 time point relative to the preceding time points that may reflect mitosis; however,
with only 50% of the cells proceeding through the cell cycle, the other 50% must still be
in Gland this may account for the continued presence of translationally active RNA at
this time point. However there was no evidence of bulk translation at any time during the
diel cycle, leaving open the question of whether we might expect diel dependent changes
in individual proteins, based on their needs at different times during the photoperiod or
cell cycle.
The analysis of proteomes using 2D gel separation of proteins followed by
identification using MALDI-TOF mass spectrometry has been used successfully in many
organisms for which whole genome sequences have been obtained (Gevaert and
Vandekerckhove, 2000). Although a complete genome of a dinoflagellate is not currently
feasible due to their massive sizes and complexity (5 x 10 10 bp for K. brevis, or almost
30x the human genome), recent large scale EST sequencing projects in dinoflagellates
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provide the first tools to investigate global protein products using MALDI-TOF based
peptide mass fingerprinting or MALDI-TOF/TOF analysis of peptide sequences. In the
current project, an EST database of K. brevis was used that contained 22,671 unique
genes. Based on the analysis of dinoflagellate genome sizes (Hou and Lin, 2010) we
estimate that that this database contains at approximately one-half of the expressed
sequences in this organism (Brunelle and Van Dolah, 2011). The traditiona12-DE gel
analysis with SYPRO Ruby staining used in this study allowed for resolution of
approximately 300 K. brevis proteins from 10 - 200 kDa and pI 4 t07 (Figures 5 and 7).
Preliminary data from using this method to compare protein profiles from G 1, S -phase
and G2/Mitosis showed that there did appear to be changes in abundant proteins over the
cell cycle (Figure 7). This preliminary analysis suggested we pursue the question of diel
dependent proteome changes using a method that results in less intergel variability and
offers higher sensitivity, DIGE.
The use of an internal standard in DIGE, run on every gel, allows for less inter-gel
variability and a lower limit of detection. This also allows for more statistically accurate
analysis across multiple gels by normalizing individual samples compared with the
internal standard (Renaut et aI., 2006). Using the DIGE approach, ----470 protein spots
were detected (Figure 9) and 4.5% of these proteins were found to change significantly.
This percentage is somewhat lower than anticipated, based on the prevalence of circadian
as controlled processes in dinoflagellates. There are limited published studies using
proteomics in dinoflagellates. However, a study using traditional 2-DE methods in L.
polyedrum on larger format gels showed that only 3.1 % of detected proteins (28 of900)

changed over the course of the diel cycle (Akimoto et at, 2004). Of these, Rubisco made
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up the majority of the spots identified, with the other nine proteins representing largely
chloroplast functions. The behavior of the differentially expressed proteins in
Lingulodinium fell into three patterns: 1) increasing during early day, with maximum
abundance during late day and into night, 2) increasing during late day with maximum
abundance during night, and 3) decreasing during the day, absent or minimal in late day,
then increasing to maximum abundance in late night. This is interesting in light of the
previous observations of bulk translation and protein turnover at night in this species.
The patterns of abundance among eight of the twenty-one changing proteins in K. brevis
showed similar trends: 1) decreasing during early day, increasing during late day and into
the night with maximal abundance in late night, 2) decreasing in early day with
maximum abundance attained in late day and maintaining at night, 3) proteins decreasing
during the day and minimal at night (Figure 11). Fourteen of twenty-one significantly
changing proteins from the K. brevis DIGE study were analyzed by MALDI-TOF TOF
mass spectrometry but nosignificant matches were found to either the K. brevis EST
library or to the GenBank database. Our current limitation due to incomplete ESTs to
provide peptide mass fingerprints, in addition to the incomplete coverage of the
expressed genome in any dinoflagellate to date is the likely source of our limitations in
identifying proteins. Additionally, protein spots extracted from gels often contain a
mixture of proteins; therefore a liquid chromatography step such as using LC-MS will
provide better separation of peptides. Efforts to develop full length cDNA libraries from
dinoflagellates using the spliced leader sequence to amplify from the 5' ends may
improve the quality of the existing sequence data available for peptide analysis (Lin et aI.,
2010).
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Since our particular focus for this study was cell cycle related proteins, we
reasoned that nuclear proteomics may be a more successful approach for identification of
proteins of interest since high abundance cytoplasmic and chloroplast proteins are
removed from the sample. Nuclear proteomics have been used to successfully identify
DNA replication proteins under cell cycle regulation such as replication factor C (subunit
5), proliferating cell nuclear antigen, and replication protein A (14 kDa subunit) in human
lymphoma cells (Henrich et aI., 2007). It has been estimated using a bioinformatic
approach that 31.5%,21.9%,26.3%,25.7% and 25% of the proteins in the total cell
proteome are nuclear in S. cerevisiae,C. elegans, D. melanogaster, mouse and human,
respectively (Kumar and Raghava, 2009). Therefore, the 2D analysis of nuclear proteins
in K. brevisin the current study most likely grossly underestimates the number of nuclear
proteins since only --100 protein spots were detected. This number was also much
smaller than the number of nuclear proteins detected in plants using 2D gels, MALDI
TOF and peptide mass fingerprinting, which has been reported as 500-700 proteins in
Arabidopsis (Bae et aI., 2003). However, the --100 proteins detected on the gels
containing K. brevis nuclear protein, eighteen proteins were significantly matched to
sequences in the K. brevis EST library when using when analyzed by LC-LTQ MS/MS
after tryptic digestion (Table 3). Seven of these proteins have been experimentally shown
to have nuclear localization. Eight of the proteins are hypothetical; therefore little can be
said of their function in the nucleus. One of the seven nuclear proteins identified
included a eukaryotic initiation factor (eIF4A-3). This translation factor has been shown
to be nuclear in mammalian cells (Holzmann et aI., 2000; Ferrailuolo et aI., 2004) and
plant cells (Koroleva et aI., 2009). Since eIF4A-3 interacts with translation initiation
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factors elF4G and eIF4B, and is localized to the nucleus, Ferrailuolo et aI., 2004, suggest
that this elF is involved in the "pioneer round" of translation and show that this protein is
a nucleocytoplasmic shuttling protein. The pioneer round of translation refers to the first
time the reading frame of an mRNA is read, possibly occurring in the nucleus (lshigaki et
aI., 2001). Additionally, nuclear proteomic studies in mammalian systems, specifically
human Raji lymphoma cells, have identified elF3 subunit 2, and elF6 in the nucleus and
eIF4B, elF2 subunit 3, elF 4H, elF 5A and elF lA in the DNA binding proteome isolated
from nuclei (Henrich et aI., 2007). Two of the significantly identified proteins in the K.
brevis proteome, tropomodulin and a calpain family cysteine protease containing protein,

have cytosolic localization. These proteins are both involved in actin organization and
cytoskeletal remodeling (Sung et eI., 1992; Smith et aI., 2000) and may reflect
contamination of other cellular components. Cytoskeleton components, such as tubulin,
have been identified in nuclear proteomic studies; therefore this does not seem to be an
unusual result (Henrich et aI., 2007). To be most informative, subcellular proteomics
requires highly purified fractions; however cross-contamination is a common problem
(Schirmer and Gerace, 2002). In order to identify a higher number of nuclear proteins, a
larger of number of nuclei will need to be isolated from K. brevis and likely other
dinoflagellates. Obtaining a pure, concentrated sample is non-trivial and will be
necessary for successful dinoflagellate proteomics. The use of large format gels would
also be beneficial for separating an increased number of spots. Additionally, since the
nucleus is a dynamic cellular structure with proteins constantly moving in and out with a
short residence time, a time course study using nuclear proteomics may be a way to
identify more nuclear proteins. Chromatin associated proteins should be able to be
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identified since the extraction method used here (phenoVchloroform: TriZol or
TriReagent) has been used to extract such proteins as PCNA, which binds to chromatin,
in K. brevis. The proteins selected for mass spectrometry analysis were the most
abundant proteins within the nuclear gels, therefore it will be interesting to see what other
proteins can be identified that may be involved in gene regulation, cell cycle, and other
metabolic processes involving the nucleus in K. brevis. However, the use of a sensitive
mass spectrometry method, and separation chemistry prior to MS/MS such as LCMS/MS, as well as additional sequence information from large scale sequencing projects
in dinoflagellates will yield more biological data.
The presence of eukaryotic initiation factors in dinoflagellates indicates that these
organisms have the eukaryotic protein synthesis machinery. Eukaryotic IF -5A has been
identified in Crypthecodinium cohnii (Chan et aI., 2002); and eIF4A, eIF3-8 as well as an
elongation factor (1 alpha) are present in Amphidinium carterae (Bachvaroff and Place,
2008). Also, a gene data set from Alexandrium catenella identified eIF4A and 3
elongation factors (Toulza et aI., 2010). The K. brevis cDNA library has 9 ESTs to eIFs,
with differing homology scores or e-values, including eIF2B (low homology), eIF5 (high
homology) and as mentioned above eIF4A-3 (high homology) (marinegenomics.org).
Therefore, although dinoflagellates may be using translational machinery to regulate
cellular processes in a manner that is divergent from other well-studied eukaryotes, the
necessary components appear to be present within the dinoflagellate genome/proteome.
Further investigation into the translational machinery of dinoflagellates should yield
information about how these factors that are similar to other eukaryotes are being used in
these unusual protists.
43

The few dinoflagellate proteomic studies for which published data exists have
used a traditiona12-0E approach for species identification between different HAB
species including Prorocentrum micans, P. minimum, P. sigmoides, P. den tatum,
Scrippsiellatrochoidea, Karenia longicanalis, K. digitata, K. mikimotoi, as well as K.
brevis (Chan et aI., 2004). This study focused only on species specific 2D gel spot
patterns and no protein identifications were attempted for any of the above species.
Another study in a dinoflagellate investigated the protein profiles between toxic and nontoxic strains of Alexandrium minutum (Chan et aI., 2005). Although the protein profiles
between the toxic and non-toxic strains differed, no protein identifications were made.
Lastly, a study investigating protein profiles of P. triestinum under different
environmental stress conditions showed that they were indeed different, but again
proteins were not identified (Chan et aI., 2004b). Akimoto et ai. (2005) is the only study
published to date that successfully identified any dinoflagellate proteins, or attempted to
assign meaningful physiological inference from their expression, although the proteins
identified were dominated by different forms of rubisco, a highly expressed chloroplast
protein. The current study demonstrates that isolation of the cellular compartment of
interest is a useful approach to enrich for proteins of interest.
For the proteomic analysis in this chapter, three different mass spectrometers were
used: MALOI-TOF, MALDI-TOF TOF and LTQ (LC/MS). Unfortunately, the peptide
mass finger printing using the MALO I-TO F did not provide useful data since protein
coverage is low from K. brevis ESTs. When more complete sequence information is
available for dinoflagellates, peptide mass finger printing may become be a useful tool
since it is a fast, single mass spectrometry approach based on known peptide sequences.
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Although the MALDI-TOF TOF is more sensitive providing another layer of identifying
data and yields sequences information, since peptides are generated and then MS/MS
spectra from these peptides are produced, we were still unable to identify K. brevis
proteins. However, this may be due to low abundance or again, mixtures that were not
able to be separated. LC/MS using an LTQ is sensitive, can separate mixtures that may
be present in sample proteins, and can detect post-translational modifications using high
resolution and accurate mass. The fact that peptides are separated and concentrated
before they are introduced to the ion source greatly enhances the ability to obtain useful
sequence information. Using this technique, significant matches of nuclear proteins to
the K. brevis EST library were successfully made. This approach is more costly and time
consuming, but appears to be essential for successful identification of proteins in an
organism for which genome sequence data is not available.

SUMMARY

The studies presented in Chapter 2 provide the first analysis of the proteome of K.
brevis with respect to one of its most important physiological drivers, the diel cycle.

Unlike L. polyedrum, the only other dinoflagellate studied, K. brevis does not display diel
pattern of bulk translation. Rather, it appears that proteins are differentially expressed
over the diel cycle, with patterns that likely reflect their daytime or nighttime peak in
activity. Using DIGE, we found 4.5% of total cellular protein significantly changing in
expression, although we were not successful in identifying them based on peptide mass
fingerprints. For the analysis of cell cycle related proteins, proteomic analysis of isolated
nuclei proved to be more productive, with 18 of ~ 100 proteins being matched to ESTs in
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the K. brevis library when analyzed by LTQ MS/MS. Although limited significant
matches were made using the K. brevis EST library, these studies show the feasibility and
usefulness of proteomics in this dinoflagellate, even in the absence of genomic sequence
data. Although transcriptomic studies have contributed a wealth of information to
dinoflagellate molecular biology, mRNA levels are even less likely to correlate well with
protein levels in dinoflagellates than in most eukaryotes, due to the presence of
widespread post-transcriptional regulation of gene expression. Proteomics studies, as well
as those studies investigating translational activity and post-translational modifications,
can begin to address the cellular state in a more accurate capacity. Genome sequencing
or the large scale production of full length eDNA libraries in dinoflagellates will provide
the means for increased protein identifications in the future.
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Increasing # of Ribosomes

Figure 1: Polysome profile of L. polyedrum over circadian time (Schroder and Lorenz,
1987). This study served as a positive control for the K. brevis polysome analysis. Shown
are the 80S, or monosome fraction (arrow). To the right of the monosomes are the
polysomes, or those mRNAs with increasing number of ribosomes. On the x-axis is
increasing number of ribosomes present in the polysome factions, based on sedimentation
in a sucrose gradient and on the y-axis is optical density at 254 nm. CT= Circadian Time
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Figure 2: (A) Polysome profile of a K. brevis culture during the light phase, or subjective
day. Shown are the 80S, or monosome fraction, the 40S and the 60S ribosomal subunits;
and bracketed to the right of the monosomes are the polysomes, or those mRNAs with
increasing number of ribosomes. (B) Polysome profile of a dark phase culture. (C)
Polysome profile of a K. brevis culture treated with 30mM EDTA which causes
ribosomal run-off (negative control). On the x-axis is increasing number of ribosomes
present in the polysome factions, based on sedimentation in a sucrose gradient and on the
y-axis is optical density at 254 nm. LDT=Light Dark Time
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Figure 3: Flow cytometry over the K. brevis cell cycle showing that approximately 50%
of the cell population was proceeding through the cell cycle in this study. LDT, or
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LDT22=mitosis.
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Figure 4: Analysis of translational activity over the cell cycle/diet cycle of K. brevis,
using polysome fractionation. The arrow shows the 80S or monosome fraction
(combination of the 408 and the 608 ribosomal subunits) and to the right of the
monosome are the polysomes, or those mRNAs with increasing number of ribosomes.
LDT2 and 6 represent GI, LDTIO and 14, S-phase, and LDT18 and 22, G2/Mitosis.
LDT18 and 22 are dark phase samples.
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Figure 5: 2D gels using traditional urea/detergent based homogenization buffers: (A)
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Figure 10: Significantly changing proteins as determined by DIGE. Dotted lines depict
the change in log abundance of a protein spot labeled with Cy3 vs Cy5 at two time points
within a given gel. The solid lines represent the average intensity of the same across all
gels. Where dotted lines are missing, the spot was absent from individual gels. A) Spot
333 decreases during the light phase, appears to increase during the dark phase and is
present in all 16 experimental samples and 8 normalizer, or pooled, samples. (B) Spot
189 increases from LDT8 to LDT14 and in present in 12 of24 samples. (C) Spot 396
follows a similar trend to spot 333 and is present in all 24 samples. (D) Spot 235
increases during the light phase and is present in all 24 samples. (E) Spot 627 increases
from LDT8 to 14 and is present in all samples. (F) Spot 204 also increases during the
light phase (LDT8 to 14) present in all samples. (G) Spot 43 is present in all samples and
increase during the light phase. (H) Spot 117 steadily increase during the light phase and
appears to decrease at night being present in 21 of 24 samples.
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Figure 12: Trends of significantly changing proteins in K. brevis. Trend 1, proteinsdecreased during early day, increased during late day and into the night with maximal
abundance in late night; Trend 2, proteins decreased in early day with maximum
abundance attained in late day and maintaining at night; Trend 3, proteins decrease
during the day and are minimal at night.
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were compared. Approximately 100 protein spots were detected.
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Table 1: Proteins found to significantly change over the diel cycle using OIGE. Shown
are the master spot numbers assigned by OeCyder software, the number of samples in
which the spot was present (of 24, including Cy2, Cy3 and Cy5 from each of 8 gels), the
results from a Student's t-test comparing each time point to LOT2, the average ratio
compared to LOT 2, and the results from a one-way ANDVA comparing the means
across all time points. Note: Not all spots were detected by SYPRO Ruby staining in
order to be cut from gels. Additional gels were run, swapping the original Cy dyes, in
order to verify the trend that was occurring between LOT 8 and 14 and 15 of 18 protein
abundances agreed (83.3%).
T-Test
(LOT2 VS. other time
points)
Master No. Appearance

A NOVA
Pvalue

Original Trend
LOT8-14

Repeated with dye
swap

Note

333

24(24}

0.00073

0.00015

down

down (2/3)

189

12(24}

0.056

0.00062

up

up

369

24(24}

0.11

0.0016

down

down

235

24(24}

0.77

0.0032

up

up

8

6(24)

627

24(24}

0.58

0.0092

up

up

204

24(24}

0.21

0.0099

up

up (2/3)

43

24(24)

0.89

0.011

up

up

117

21(24}

0.06

0.012

up

down

340

24(24}

0.69

0.014

down

down (2/3)

573

9(24}

314

24(24)

0.85

0.016

up

up (2/3)

367

24(24)

0.47

O.Ola

down

down

223

12(24}

339

24(24)

0.14

0.026

down

down (2/3)

192

24(24)

0.73

0.035

up

up (2/3)

608

24(24)

0.92

0.036

up

up

595

18(24)

0.34

0.042

down

up

not confi rmed with SYPRO

629

21(24)

0.44

0.042

up

up (2/3)

not confirmed with SYPRO

176

15(24)

0.82

0.045

up

up

not confirmed with SYPRO

271

24(24)

0.91

0.045

up

down

not confirmed with SYPRO

not confirmed with SYPRO

0.0041

not confirmed with SYPRO

0.014

not confirmed with SYPRO

0.022
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Table 2: Nuclear protein identifications using tandem MS (LTQ). Shown are the number
of peptides identified in each sample, the peptide sequences of each peptide, the total ion
scores, the match to the contig sequence in the K. brevis cDNA library using SEQUEST,
the protein ID of the top hit to the K. brevis Contig from GenBank with BLASTx e-value,
and the species to which the sequence has the highest homology. Shown in bold are the
proteins known to have known nuclear localization.
# Peptides
Identified

Total
Ion

BLAST
Protein 10

Peptide Sequences

Score

Contig from Librarv

e-value of
contig

Organism

APSILDLK, IDLQLLR, LLDVRICR, DPGAILPDER,
ATHELSEGIYN, QKLLDVRICR, ICRQCLHQLR,
HSGQILQRHVCVALR, LLDVRICRQCLHQLR

9

33

Contig 6616

tropomodulin

Contig 5255

eukaryotic initiation factor 4A-3
(eIF4A-3)

3.00E-11

beetle

3.00E-102

apicomplexan

DELTLEGI, ELAEQSQK, FMNNPFR, RDELTLEGI, VFHMIQQR,
EQVYDIYR, DVIVQAQSGTGK, DPQVLFLSPTR,
FMNNPFRVlVK, AlEAGVHIVSGTPGR, FMNNPFRVLVKR,
VKGQIVCLNVLAGMASKMFVLDEADEMLNR

13

66
GVAGQRARR, SSATGEQTGSI, GCRVSESSPR, SARQNTRCTR,
SlPGASlSRRER, VSESSPRDERSAR,
GPGITE HARG HQPGAAHTK, PPGSCRPMEPGESRVAS,
AGGGQPDPGLSSPAWR

9

58
RELTCH, RKCMQR, CLTKVHR, ARCRCl TK, AWGAQHHR,

6
2

29

KCMQRIPR

33

GQALTLPR, ARGQALTLPR

Contig 5491
contlg 3533,
Rev 6675
(.;ontlg l~ll.
Rev 3965

hypothetical protein
UnaJ domam protem
(transcriptional regulator)

0.57

0. sativa

3.00E-05

bacteria

hypothetical protein

1.00E-15

M. musculus

Rev 25

Major basic nuclear protein

2.00E-32

Karlodinim

Contig 3542

hypothetical protein

5.00E-07

M. musculus

NACPSLPR, LHDCLGR, LQTMLLCK, QAHSSPVLLGR,
TVSKCSENLR, LLQTMLlCKCCC, TVSKCSENLRSDIQK,
CSENLRSDIQKTPll,SAFGHDLGTCLHALHR,
LHDCLGRLGLDDNLLAK, ANRLLQTMLLCKCCC,
AANHLRANRLLQTMLLCK

12

33
GLPPCSKG, SSPQSLPR, GPALASFSR, SSPQSlPRHR

4

38

6

35

NLQQMR, SRISNCK, ISNCKVK, ERLSlPR, TALSSKER,
VKDGAQSTGIDWAK

4

38

LSAQELR, DRWVDK, ASTDALPR, ETRTAMK

4727

YQPTVGR, QEQRKR, CVIRLSR, VAEVSPLR, LLGVRCWSVKR,

.... UIIUY VV.:JV.

6

32

5

38
39

2

HCDDVHDWPLK
LSAQElR, DRWVDK, ASTDALPR, ETRTAMK, ETRTAMKDR

SSPQSLPR,SSPQSLPRHR

\JUIILlYi U,J""tL,

Rev 2952
VVIILl~

vVoJ,

hypothetical protein

0.096

platypus
M. musculus

J'\'VY

hypothetical protein

0.021

Rev 1495

hypothetical protein

0.001

Paramecium

Contig 305
Contig 3542

hypothetical protein
hypothetical protein

0.021
5.00E-07

M. musculus

Rev 7203

similar to SOX3 (DNA binding)

1.00E+00

platypus

Contig 9679

Calpain family cysteine protease
containing protein

3.00E-12

ciliate

Contig 9664,
Rev 832

DJ-1 family protein (pos.
regulator of transcription)

6.00E-34

Arabidopsis

Contig 5255

eukaryotic initiation factor 4A-3
(eIF4A-3)

Contig 4790,
Rev 4075

SNF2 family chromodomainhelicase (chromatin assembly)

2.00E-05

Chlamydomonas

Rev7117

Apo-Eif4aiii (eIF4A-3)

O.OOE+OO

H. sapiens

M. musculus

GSLCTLAR, KRGGSPGGR, GTPPCPRWR,
GSLFEGSVPCECRHlEK, RGSGASLGCGEIliHANCSGTMSR

5

33
CKSAELR, EDWQLFR, ERHQTLR, WQVQMGEGR,
CPMCGTVQPR, GKPQAQMMMR, LGESVPSASAASAR,
TQWAEAlREGR, AKRTQWAEALR, AVRTISEQMMGGK,
KERPIRLGESVPSASAASAR, FQARGFEYEVLLDRlVQR,
WQVQMGEGRWEDFAESEQR

13

34
IVEKLYGDDK, ETMAEGMWQDAK, DCEElKTLLAEQTSKSK,
NIIIVTFARGLKVTADCHIK, AGAKVVTASVMPDKNIIIVTFAR,
VVADGHIITSQGPGTSLQFALK, YVAYAATAQQLlSIPAFTFEVRR,
VLVPIADGSEDIETACITDVLVRAGAK

8

15
DELTLEGI, HAEQSQK, FMNNPFR, RDELTLEGI, VFHMIQQR,
EQVYDIYR, DVIVQAQSGTGK, DPQVLFLSPTR, FMNNPFRVlVK,
ALEAGVHIVSGTPGR, MFVLDEADEMLNR,
VKGQIVCLNVLAGMASK

12

89

3.00E-102

apicomplexan

RDGRFR, ACYDQR, NFKVWR, EQCGKRGS, VWRGDCTR,
DGAGTQGADCGR, CASLSEIASAAR, HSGASSRLQCR,
DGCREQCGKR, DGRFRALPNLR, YAWSWAISQPR

11

32
RALHCGR, SLSCEHS, CCDIRR, RLLHHR, QAPAIVCR, CNSELDPR,
IIIRCCDIR, FLVLQRNR, CIIITSVTDPIIIR, AHDlLLTIGKV,
LHEASCSRGSK, HQIIIRllCRVD, PWLRCIIITSVTDPIliR

13

37
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Chapter 3: Characterization and regulation of S-phase genes and proteins
inK. brevis
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INTRODUCTION

The dinoflagellate cell cycle is typical of that in other eukaryotic organisms, with
distinct G 1, S, G2, and M phases. In K. brevis, the cell cycle is under circadian control
(Brunelle et aI., 2007), and is thereby entrained to the lightldark cycle, with S-phase
beginning approximately 6 hours after onset of light, and mitosis occurring late in the
dark, peaking at 20-22 hours of a 24 hour diel cycle (Van Dolah and Leighfield, 1999).
Conserved eukaryotic cell cycle regulatory proteins, cyclins and cyclin dependent kinases
(CDK) are present in dinoflagellates (Liu et aI., 2005, Zhang et aI., 2006, Toulza et aI.,
2010, Bertomeu et aI., 2007, Bertomeu and Morse, 2004, Barbier et aI., 2003) and appear
to be necessary for cell cycle progression through G liS and G2/M (Van Dolah and
Leighfield, 1999; Bertomeu and Morse 2004). In higher eukaryotes, CDK-dependent
phosphorylation at G liS activates the transcription of a core set of S-phase genes in a cell
cycle dependent manner, thereby ensuring that specific processes are limited to the
appropriate cell cycle phase (Rustici et aI., 2004; Spellman et aI., 1998). Late in the cell
cycle, CDK dependent phosphorylations trigger entry into mitosis, including nuclear
envelope breakdown and chromatin condensation. However, dinoflagellates have a
number of unusual features that suggest modification of some of these cell cycle control
mechanisms.
Dinoflagellate chromosomes are permanently condensed and lack nucleosomes
that typically control the degree of chromatin condensation and thereby access for
transcription and replication. Instead, the chromatin occurs throughout the cell cycle in a
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tightly packed liquid crystal state, with peripheral arches of exposed DNA thought to be
areas undergoing active transcription (Costas and Goyanes, 2005). Several lines of
evidence point to the possibility that transcription in dinoflagellates is constitutive (Van
Dolah et aI., 2007). No recognizable promoter sequences (e.g., TATA boxes or other)
have been identified in dinoflagellate genes. Further, all nuclear encoded gene transcripts
examined in K. brevis possess an identical 22 nucleotide leader sequence on their 5' end
termed the spliced leader (SL; Lidie and Van Dolah, 2007; Zhang et aI., 2007). SL
trans-splicing was first observed in trypanosomes, an early diverging branch of
unicellular eukaryotes that carry out constitutive transcription and produce polycistronic
messages (Murphy et aI., 1986). Trans-splicing of the SL about 100 nucleotides
upstream of an open reading frame serves to process these polycistronic pre-mRNAs into
individual mature messages, each with a 5' capped SL and a 3' poly A tail. With
messages produced constitutively, differential gene expression in trypanosomes is
regulated by differential rates ofmRNA turnover and differential rates of trans-splicing
(Vanhamme and Pays, 1995). The presence of the SL mechanism in dinoflagellates
suggests that their transcription may take place constitutively as well. Indeed, many
physiological processes in dinoflagellates appear to be under translational control,
including bioluminescence (Morse et aI., 1989; Mittag et aI, 1998), carbon fixation
(RUBISCO, Nassoury et aI., 2001), glycolysis (GAPDH, Fagan et aI., 1999), and
photosynthesis (PCP, Le et aI., 2001). In K. brevis, a microarray study of diel dependent
gene expression suggested that cell cycle control is also post-transcriptional, based on the
absence of differential expression of cell cycle gene transcripts (Van Dolah et aI., 2007).
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During the cell cycle of animals and plants, the G 1IS phase transition is triggered
by CDK phosphorylation of the retinoblastoma protein (Rb), a "pocket protein" that
serves to sequester the transcription factor E2F in inactive cytosolic complexes during
G 1. Phosphorylation of Rb results in the release of E2F, which translocates to the
nucleus and orchestrates the transcription of genes required for DNA synthesis. The
Rb/E2F pathway is present in green algae(Robbens et al. 2005, Umen and Goodenough

2001) and diatoms (Huysman et al. 20 1O),but is absent from Apicomplexa (Gardner et al.
2005), the nearest relatives to dinoflagellates, and has not been identified in
dinoflagellates. Nonetheless, S-phase entry in K. brevis appears to be CDK dependent, as
inhibiting CDK activity with the inhibitor, olomoucine, causes a G 1 cell cycle block (Van
Dolah and Leighfield, 1999). Given the current paradigm for CDK controlled S-phase
entry, it is unclear how transcription-independent S-phase entry might be achieved.
The study in Chapter 3 therefore investigates the regulation of a suite of S-phase
specific genes and their protein products that are critical to the DNA synthesis phase of
the cell cycle. A survey of S-phase genes present in an extensive EST collection from K.
brevis was first carried out to gain insight into how conservedthe dinoflagellate S-phase

processes are in comparison with other eukaryotes. From this survey, four S-phase genes
that have strong sequence homology with orthologs in other eukaryotes were selected for
study, all of which are typically under CDK-dependent transcriptional control at the G liS
transition through its activation of E2F. The genes investigated include: proliferating cell
nuclear antigen (PCNA), replication factor C (RFC), replication protein A (RPA), and
ribonucleotide reductase (RnR2). PCNA, RFC, and RPA are members of the replication
fork complex where PCNA is a sliding clamp that forms a homotrimeric ring structure
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around DNA, endowing DNA polymerase 8 with a high degree ofprocessivity (Kuriyan
and O'Donnell, 1993). RFC is a complex of 5 subunits that loads PCNA onto the 3'
hydroxyl end of the primer strand of the DNA primer-template in an ATP-dependent
process (Loor et aI., 1997). RP A is a trimeric single stranded DNA binding protein that
stabilizes the replication fork, stimulates DNA polymerase 8 activity in the presence of
the PCNAlRFC complex and is involved in both initiation and elongation of DNA
replication (Lee and Hurwitz, 1990). Ribonucleotide reductase is a tetramer, consisting
of two large and two small subunits, that reduces ribonucleotides to deoxyribonucleotides
during S-phase and in response to DNA damage.
To assess the regulation of these genes, their transcript levels were first analyzed
over the course of the cell cycle using quantitative PCR. Peptide antibodies designed
from these sequences were next employed in western blotting and immunolocalization to
investigate cell cycle specific changes in protein abundance and/or localization.
Although there were no significant changes in transcript levels of these S-phase genes,
there were S-phase specific increases in protein abundances. Furthermore, in the case of
PCNA, an S-phase specific -"-J9 kDa increase in molecular weight was observed that may
be attributed to a post-translational modification. This S-phase specific shift in the
molecular weight ofPCNA coincided with its chromatin association as determined by
immunolocalization. Together these results suggest that the expression of S-phase
specific proteins in K. brevis is independent of their transcription upon entry into S phase.
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METHODS
Survey of Cell Cycle Genes in K. brevis

Sequences with significant homology (BLASTx E-value < 10-04 ) to cell cycle
genes were identified from a K. brevis expressed sequence tag (EST) database containing
65,292 sequences housed at NOAA (Charleston, SC) and available at
marinegenomics.org. ESTs were previously assembled into 22,671 unigene contigs using
Cap3, with a minimum 30 bp overlap and 70% identity set as assembly criteria.
Annotation of contigs and gene ontology analysis were performed in Blast2Go.
Analysis of Selected S-phase Gene Sequences

Among the cell cycle genes, sequences for several genes with significant
homology (E-value < 10-5°) to S-phase genes on GenBank were selected for further
analysis. These include PCNA, RFC, RPA and RnR. To confirm the presence of the
spliced leader on contigslacking the 5' end of the transcripts, PCR was carried out using
gene specific reverse primers (Table 1) in conjunction with a truncated primer for the
dinoflagellate-specific spliced leader (TCCGTAGCCATTTTGGCTCA). Total RNA
(200 ng) was reverse transcribed (Ambion RETROscript kit, Austin, TX) using an oligo
(dT) primer (Ambion, Austin, TX). PCR was conducted using Qiagen HotStar master
mix (Qiagen, Valencia, CA) with a 400 nM final concentration of each primer. PCR
parameters were as follows: 95°C for 1 min; 25 cycles: 94°C for 1 min, 60°C for 1 min,
and 72°C for 1 min.; and 72°C for 10 min. PCR products were analyzed on an Agilent
Bioanalyzer 2100. Amplicons were cloned using a TopoTA cloning kit (Invitrogen,
Carlsbad, CA), and purified plasmid DNA was sequenced in both forward and reverse
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directions using the universal M13 primer (Seqwright, Houston, TX). Sequenced
products were aligned with existing sequences using Bioedit software.
Multiple Alignments of Amino Acid Sequences
In silico translationsofthe full length open reading frames of K. brevis PCNA,

RPA1, RFC3, RFC5, RnRland RnR2 were performed using BioEdit software. To obtain
the predicted theoretical molecular weight for each protein, the amino acid sequences
were analyzed using the Compute pIlMw tool on the ExP ASy Proteomics server
(http://expasy.org/tools/pi tool.html). For multiple alignments of each protein sequence,
the amino acid sequences from other eukaryotes were obtained from GenBank. Species
used for this analysis included: Trypanosoma brucei, Chlamydomonas reinhardtii,
Arabidopsis thaliana,Saccharomyces cerevisiae, and Homo sapiens, to include

representatives across multiple diverse phyla. Once imported into BioEdit software,
multiple alignments of the 6 species were done using the ClustalW Multiple Alignment
application.
Cultures and Culture Conditions
K. brevis (Wilson isolate) was grown in 0.22 f.lm filtered seawater (36%0) obtained

from the seawater system at the Florida Institute of Technology field station, Vero Beach,
Florida, enriched with j/2 nutrients (Guillard, 1973), modified with the use of ferric
sequestrene in place ofEDTA'Na2 and FeC13·6H20 and the addition of 0.01 f.lM selenous
acid. Cultures were maintained in 1 liter glass bottles at 25°C + 1°C with a 16:8
light:dark cycle, and cool white light at 50-60 f.lmol photons m-2 sec-I, determined using
aLI-COR LI-250 Light Meter (LI-COR BioSciences, Lincoln, NE). To compare the
transcript abundance and protein expression levels of the S-phase genes over the cell
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cycle, replicate 1 L cultures were grown to mid-log phase when cell concentrations were
approximately 104 cells/mL. Cells were harvested at times corresponding to G 1 (LDT2
and LDT6), S phase (LDTIO and LDT14), and G2/Mitosis (LDT18 and LDT22), where
"LDT" designates "light-dark" time, or hours after lights-on in a 24 hour light-dark cycle.
A total of five independent cultures were harvested at each time point for qPCR and

Western blot analysis. At least three independent cultures at each time point were used
for immunolocalization studies. From each culture, a 10 mL aliquot of cells was
processed for flow cytometric cell cycle analysis while the remaining cells were used for
RNA and protein extractions.

Cell Cycle Analysis
Ten milliliters of culture were collected from each 1L biological replicate culture
(n=5) at each time point Cells were fixed in 2% gluteraldehyde by adding 50%
gluteraldehyde directly to culture medium containing cells and stored at 4°C for at least
12 hours. Cells were then centrifuged at 1750 x g to remove fixative and growth
medium. To extract cellular pigments, cells were stored in -20°C methanol for a
minimum of 4 hours, centrifuged at 1000 x g and methanol was removed. The cells were
then stained with 10 Jlg/mL propidium iodide (final concentration) in phosphate buffered
saline (PBS) containing 10 mg/mL RNase and 0.5% Tween 20. DNA analysis was
performed on an Epics MXL4 flow cytometer (Beckman Coulter, Miami, FL) using a 5
W argon laser with a 488 nm excitation wavelength and 635 nm emission wavelength.
Multicycle software (Phoenix Flow Systems, San Diego, CA) was used to obtain the
percentages of cells in each stage of the cell cycle.
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qPCR

Forward and reverse primers sets were designed for concensus PCNA, RFC,
RPAl and RnR2 cDNA sequences (Tablel) and optimum annealing temperatures were
determined prior to the analysis of experimental samples. The specificity of each primer
set was verified by analysis of amplicon size determination on an Agilent Bioanalyzer
(Santa Clara, CA)and by melt curve analysis. Efficiencies of the primer sets were
determined using a standard curve of cDNA produced from K. brevis. Experimental
samples were harvested at the aforementioned timepoints from the five independent
cultures by centrifugation at 600 x g for 10 minutes and medium was removed. Total
RNA was isolated by the addition of 1 mL of TriReagent to the cell pellet (Molecular
Research Center, Inc., Cincinnati, OH) and processed according to manufacturer's
instructions. Residual DNA contamination was removed by incubation with 27.3 units
RNase-free DNAse and processed through a Qiagen RNeasy mini-column (Valencia,
CA). RNA was quantified using a Nanodrop spectrophotometer (Wilmington, DE, USA)
and qualified using anAgilent Bioanalyzer.For each sample, 200 ng of total RNA was
reverse -transcribed (Ambion RETROscript kit, Austin, TX) with oligo (dT) primers in
triplicate. Duplicate real-time assays were performed on each reverse-transcribed sample
on an Applied Biosystems 7500 Real-Time PCR system (Foster City, CA, USA). A
sample volume of25 f.lL was used for all assays, consisting of ABI SYBR green (Applied
Biosystems) PCR master mix, nuclease-free water, gene-specific primers (400 nM final
concentration), and If.lL eDNA. Assays were run using the following protocol: 95°C for
15 min, 40 cycles of 94°C for 15 s, gene-specific annealing temperature (58°C-62°C) for
40 s, and 72°C for 1 min. To quantify the fold change in mRNA expression ofPCNA,
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RFC, RP A and RnR2, one cDNA sample from K. brevis was used to develop a standard
curve for all primer sets relating efficiencies and slope values. PCR products were
subjected to melt curve analysis to confirm the presence of a single amplicon. Statistical
analysis of the fold-change values (log2 ratio= C-E, where C is the control and E is the
experimental samples) was evaluated using a one-way ANOVA in GraphPad Prism 4 (La
Jolla, CA).

PCNA Phylogenetic Analysis
Fourteen K. brevis PCNA contigs were aligned with a dinoflagellate (Pyrocystis

lunula) PCNA and 4 higher plant PCNAs to generate a preliminary alignment in BioEdit.
However, for simplicity of analysis, only one K. brevis contig was used for the final
alignment. Contig 2450 was chosen for this analysis since it contained the full open
reading frame and had a high e-value by BLASTx analysis. Sixty-four PCNA amino acid
sequences were then obtained from NCBI's GenBank from the Archaea and Eucarya
domains to produce the final alignment. Eukaryotes represented in the final alignment
include animals (vertebrates and invertebrates), fungi, plants and various protists,
including other algal species. The prokaryotic Eubacteria were not included in this
alignment due to the low level of sequence identity of their clamp-loading protein
sequences with Archaea and Eucarya (Indiani and O'Donnell, 2006). Archaeabacteria
were included in this analysis because PCNA sequences from this domain have known
sequence identity to eukaryotes. Alignments were performed in BioEdit to manually
search for conserved domains.ProtTest 1.2.7 software was used to determine the best fit
model for amino acid replacement. The JTT substitution model was used for PCNA
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(Jones et aI., 1992). ClustalX and MEGA Software packages were used to perfonn
phylogenetic analysis. MEGA software was used to generate a Neighbor-joining tree with
1000 bootstrap replicates.

PCNA Protein Homology Model
K. brevis PCNA Contig 2450 was used to build a protein homology model. This
protein, or amino acid, sequence was BLASTed (protein-protein) against NCBI's
GenBank using the SwissProt database which is smaller and better annotated than the
non-redundant. Cn3D 4.1 software was then used to detect the conserved domains in the

K. brevis sequences. The K. brevis sequence was then loaded into SwissPBD Viewer
software. A template upon which to build the model was chosen from the SwissModel
database (http://swissmodel.expasy.org/cgi -binlhlastexpdb.cgi) of known crystal
structures of proteins. Human PCNA was chosen as the template since the K. brevis
PCNA sequence (Contig 2450) had the highest homology to this protein. The homology
model was built after threading and aligning the K. brevis sequence with the template.
This alignment was then submitted to the Swiss PBD Viewer Server for model
refinement. Additionally, the exP ASY Proteomics
(http://www.expasy.org/tools/pi_tool.html) server was used to calculate the theoretical pI
(isoelectric point) and molecular weight of K. brevis PCNA.

Antibody Development
In order to study protein expression, it was necessary to obtain antibodies that
specifically cross-react with proteins of interest in the organism under investigation.
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Although the S-phase genes are highly conserved in eukaryotes, the dinoflagellates
represent a distinct group of primitive eukaryotes, the alveolates, and commercial cell
cycle antibodies tested did not cross-react with K. brevis proteins, with the exception of
anti-RnR2 (Calbiochem). For PCNA, in silica translated sequences and the above protein
model were analyzed to determine an optimal region for peptide antibody production
suitable for use in immunolocalization, specifically, one occurring in an exposed area of
the native folded protein. The resulting short peptide (DRIADFDLKLMQIESE) was
BLASTed against an in-house K. brevis EST database and GenBank to ensure specificity.
The resulting peptide sequence was submitted to EZBiolab (Carmel, IN, USA) for
polyclonal antibody production. Affinity purification was carried out using a SulfoLink
Immobilization kit (Thermo Scientific, Rockford, IL, USA). All other peptide antibodies
(Table 2) were designed by ProSci, Inc. (Poway, CA, USA)using standard algorithms for
hydrophilicity, antigenicity and surface probabilityand affinity purified polyclonal
antibodies were generated. The peptides used for development of each antibody are
listed in Table 2.

Protein Extraction and Western Blotting

Protein was extracted from the same experimental samples used for qPCR using
TriReagent, following the manufacturer's protocol. A Bradford protein assay (Bradford,
1976) was used to quantify protein concentration using the Bio-Rad Protein Assay Dye
Reagent (Bio-Rad, Hercules, CA, USA). For Western blotting, 10

~g

of protein extract

were loaded on a 4-12% Bis-Tris gradient gel (Invitrogen Corporation, Carlsbad, CA)
and then transferred to a 0.2 J-tm polyvinylidene fluoride (PVDF) membrane using the
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Invitrogen iBlot system (Invitrogen Corporation, Carlsbad, CA). The PVDF membrane
was then blocked in 5% non-fat milk in Tris buffered saline (TBS) with 0.1 % Tween 20
for 1 hour at room temperature. Membranes were then incubated in primary antibodies
overnight at 4°C. Peptide antibodies developed against translated K. brevis cDNAs were
used at the following dilutions (v/v) in TBS with 0.1 % Tween 20 and 5% non-fat milk:
anti-KbPCNA, 1:5000; anti-KbRFC5, 1:2000; and anti-RPA1, 1:2000 (Table 2). A
commercial antibody was used for the detection of ribonucleotide reductase 2 at a
dilution of 1:60 (v/v) (Calbiochem, San Diego, CA). Membranes were washed 3 x 10
minutes in TBS with 0.1 % Tween 20. Horseradish peroxidase-linked donkey anti-rabbit
Ig was then incubated with the PVDF membrane at 1:2000 in TBS with 0.1 % Tween20
for 1 hour at room temperature. After rinsing membranes in TBS with 0.1 % Tween 20 (2
x 10 minutes) and TBS (Ix 10 minutes), the Pierce ECL Super Signal West Pico Kit
(Pierce, Rockford, IL) was used for detection. Membranes were exposed to film (Pierce
CL-XPosure Film, Thermo Scientific, Rockford, IL) and developed for visualization.
Densitometry of the bands of the biological replicates (n=5) was carried out using Alpha
Innotech (San Leandro, CA) FluorChem 8900 software. The band intensities of all time
points were normalized to LDT2 and significant differences were determined with a oneway ANOV A using GraphPad Prism 4 (La Jolla, CA) software.

Peptide Competition Assay
Ten micrograms of protein extract from cells in S-phase (LDT 10 andLD14) were
used for the PCNA peptide competition experiment. The anti-K. brevis PCNA antibody
(3.6Jlg) was incubated with 1DO-fold excess ofthe peptide (360f.lg) to which the antibody
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was developed, in TBS with 0.1 % Tween 20 and 5% milk for 1 hour at 4°C. The
experimental membrane was incubated overnight at 4 °C with the peptide blocked antiPCNA. The control blot was incubated overnight at 4°C in the anti-K. brevisPCNA
antibody at 1:5000 (v/v) in TBS with 0.1 % Tween20 and 5% non-fat milk. Western blot
procedures were then followed as described above.

Immunolocalization
Triplicate cell samples were fixed in 2% paraformaldehyde in seawater for 10
minutes and centrifuged for 10 minutes at 250 x g. Cell pellets were then washed in
Phosphate Buffered Saline (PBS), resuspended in 2 mL of -20°C methanol and incubated
at 4°C for 10 minutes. The pelleted cells were incubated with normal goat serum (Vector
Laboratories, Inc., Burlingame, CA) at 4°C for 45 minutes and then incubated overnight
at 4°C with the K. brevis anti-PCNA antibody diluted at 1: 100 in PBS with 0.1 %
Tween20. Cells were also incubated with the K. brevis anti-PCNA antibody blocked
with 100-fold excess of peptide ( above) to test for specificity. All cells were then
incubated with fluorescein isothiocyanate (FITC)-labeled goat anti-rabbit (SigmaAldrich Corp., St. Louis, MO, USA) at 1: 100 for 1 hour at room temperature. After 3 X
5 minutes washes in PBS with 0.1 % Tween20, cells were counterstained with 0.1 Ilg/mL
DAPI (4',6-diamidino-2-phenylindole) (Molecular Probes) in PBS for 5 min at room
temperature to visualize nuclei. The cells were mounted in Fluoromount-G (Southern
Biotech, Birmingham, AL, USA). An Olympus Fluorescent Microscope with a FITC
filter set was used for imaging. One hundred individual cells from each replicate were
counted to determine the percentage of cells stained positively for PCNA.
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RESULTS
Survey of Cell Cycle Genes in K. brevis
In order to gain insight into the conservation of genesinvolved in the K. brevis cell
cyclea survey ofgenes present in a K. breviswas carried out on a cDNA sequence
database containing 65,292 ESTs. Based on the genome size prediction of Hou and Lin
(2009), we predict that this EST database contains approximately half of the K. brevis
expressed genes. A total of 130 cell cycle genes were identified based on BLASTx and
Gene Ontology,assigned using Blast2Go (Appendix 1). This is the largest sampling of
cell cycle genes in a dinoflagellate to date and provides preliminary insight into the
conservation of the eukaryotic cell cycle in this divergent protist. These included
conserved eukaryotic genes involved in central cell cycle control, pre-replication
complexes, such as mini chromosome maintenance proteins, S-phase specific genes
involved in DNA replication, and mitotic genes, such as centrins and members of the
anaphase promoter complex. Genes directly involved in DNA replication are shown in
gray. Six highly conserved S-phase genes were chosen for further analysis in this study
and are shown in bold: PCNA, RFC3, RFC5, RPAl, RnRI and RnR2. The conservation
and diversity of these transcripts in K. brevis is shown in Table 3.

Characterization of Selected S-phase genes
PCNA
PCNA gene transcripts were among the most highly expressed ESTs in the

°.

library, with 10 1identified using an expect value <10- 1

Among the PCNA ESTs,

significant sequence variability exists, as previously reported in other dinoflagellates
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(Zhang et aI., 2006), with the 10 lK. brevis ESTs assembling into 11 unique contigs.
These sequences have been submitted to Genbank as KbPCNAs (Accession Numbers
IF491177-1F491185). Most of the sequence differences between these contigs reside in
single nucleotide substitutions found in third codon positions, resulting in synonymous
substitutions. Thus the 11 contigs encode nine unique proteins with substitutions found
at only 20 conserved sites among 259 amino acids (Table4). None of the amino acid
sequences was identical to any of the nine K. brevis PCNA sequences previously
submitted to GenBank (Accession numbers FJ1805026.1 - FJI805034.1), although all
represent different combinations of substitutions at the same 20 sites. Altogether, a
minimum of20 unique PCNA genes have been described from K. brevis. All PCNA
open reading frames for which full length sequences were obtained are of the same
length, 780 nucleotides, with a predicted protein molecular weight of 28 kDa. This
predicted molecular weight is similar to what has been identified in other eukaryotes and
K. brevis shows a high degree of conservation with model eukaryotes across phyla

(Figure lA).
A neighbor-joining tree ofPCNA sequences from diverse eukaryotic phyla and
archaea found the K. brevis PCNA to be distant from animals and higher plants, each of
which formed monophyletic clades with moderate bootstrap support (81 and 74%,
respectively). The dinoflagellates similarly formed a monophyletic group with 99%
bootstrap support and fell out most closely with other protists, the kinetoplastids and
Apicomplexa, although these deeper branches are not strongly supported (Figure 2).
After several unsuccessful attempts to use commercial antibodies for PCNA (made to
metazoans), we used this information, along with the multiple alignment in Figure lA to
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guide antibody development. A conserved 16 amino acid peptide
(DRIADFDLKLMQIESE) was identified in all K. brevis PCNA sequences and
BLASTed against the K. brevis EST database and GenBank to ensure its specificity. The
full length PCNA protein sequence (from Contig 2450) was next used to produce a
computational 3D protein model in order to determine where on the protein the antibody
would bind (Figure 3, top). The K. brevis PCNA monomer has the conserved structure
seen in archaea and yeast (Figure 3, bottom) that enables it to form a trimeric DNA
clamp. From the computational model of PCNA, it appears that the peptide
DRIADFDLKLMQIESE is located on the outside surface of the protein, making this
good candidate for use in immunolocalization.

Replication Protein A

Expressed sequence tags with homology to RPA were analyzed next. RPA is a
single strand DNA binding protein that typically consists of three subunits. Only ESTs
for RPA1, the largest subunit, responsible for DNA binding, were identifiable in the K.
brevis library (Table 3). Twenty-eightESTs were found, which fold into three contigs.

The two full length contigs were submitted to Genbank as KbRP A 1a and KbRPAlb
(Accession numbers JF491189 and JF491176). These encode for proteins of 464 and 465
amino acids, respectively, and have highest homology to Perkins us (e-value 1.0-129;
GenBank Accession number XP002779439). The predicted molecular weight of these
proteins is 51 kDa. This is somewhat smaller than the 70 kDa RP A 1 protein identified as
RPAI in mammals, but is similar in size to that found in trypanosomes (Zicket at, 2005)
and other protists. This can be seen in the multiple alignment of RP A 1 (Figure 1B).
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Consistent with this finding, a peptide antibody made to K. brevis RPA1 recognizes a
protein of 51 kDa.

Replication Factor C
RFC is made up of five subunits in eukaryotes, of which only subunits 3 and 5
were identified in the K. brevis library. A single EST was identified for RFC subunit 3.
The K. brevis RFC3 protein sequence shows high conservation when aligned with other
eukaryotes (Figure IC). The predicted molecular weight of K. brevis RFC3, ---39kDa, is
also highly conserved. This sequence was submitted to GenBank as KbRFC3 (GenBank
accession number JF491186). Seven ESTs for RFC subunit 5 folded into two unique
contigs, one of which is full length. Similar to RFC3, the K. brevis RFC5 protein
sequence also shows homology and all species investigated in the multiple alignment
have an amino acid sequence of approximately the same size, with a predicted molecular
weight of 39 kDa (Figure ID). A peptide antibody developed to RFC5 using the
translated sequence indeed recognizes a band at 39 kDa (below). These sequences have
been submitted to GenBank as KbRFC5a and KbRFC5b (GenBank accession numbers
JF491187 and JF491188).

Ribonucleoside Diphosphate Reductase
The two subunits that make up the RnR tetramer, interestingly, are not equally
represented in the K. brevis library. RnRl is highly expressed, with 54 ESTs that fold
into 12 unique contigs, encoding at least 3 unique proteins (Table 3). RnRI shows a very
high degree of homology with other eukaryotes until the C-terminus (Figure IE). C.
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reinhartii and S. cerevisiae have longer sequences with predicted molecular weights of

98 and 97.5 kDa, respectively, whereas, unexpectedly, the K. brevis sequence has a
molecular weight (--90 kDa) more similar to that of H. sapiens (90kDa) and A. thaliana
(92 kDa). In contrast to RnR1, sequence representation of its partner RnR2 is much
lower in the K. brevis EST library, with only 2 ESTs present, which form a single contig
(submitted to GenBank as KbRnR2 (Accession No. JF699608). RnR2 is also highly
conserved (Figure IF). There is some sequence variation in the N-terminus between the
species investigated; however, the predicted molecular weights of all sequences are
within a tight range of ---40-45kDa. Sufficient conservation is present in K. brevis RnR2
that we were able to successfully use an antibody made to human RnR2 for studies in K.
brevis (Figure IF, boxed region), which recognizes a doublet of bands at --40, as also

found in yeast (Hurd et aI., 1987) (below).

Identification of the Spliced Leader Sequence on S-phase Genes
Given the widespread presence of the SL of dinoflagellate gene transcripts, and
its importance to gene expression, we next sought to determine ifit is present on the Sphase genes under study. Several of the PCNA contigs were found to possess the 5' SL
sequence (Table 4) and where the SL was missing, the full 5' UTR sequence is lacking
(i.e., this represents incomplete sequence data, not the absence of the SL on a full-length
sequence). To confirm the presence of the SL on the other S-phase genes, PCR
amplification was carried out on one representative of each using a spliced leader primer
and gene-specific primer. We found that the SL was present on each representative
examined, in each case approximately 50-100 nucleotides 3' of the start codon (Figure 4).
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Th,ese sequences have been submitted to GenBank (Accession numbers: KbRPAla IF491189; KbRFC3 - JF491186; RnRl -lF491190).

Cell Cycle Dependent Expression of S-phase Gene Transcripts
Flow cytometry (Figure 5) was first carried out to confirm that the cells used in
this experiment were actively cycling through the cell cycle. The flow cytometric cell
cycle distribution indicated that approximately 50% of the cells were actively proceeding
through the cell cycle in a diel phased manner as previously described (Van Dolah and
Leighfield, 1999). Essentially all cells ('"-'95%) were in G 1 at LDT2. The peak of Sphase occurred at LDT14 with the peak ofG2+M at LDTI8, which accounted for
approximately 50% of the cell population proceeding through the cell cycle (viewed most
easily as the minimum in % G 1). Most cells had completed mitosis and returned to G 1
by LDT22. Since the cultures were not 100% synchronous, some variability in the rate at
which cultures entered S-phase is evidenced by the variability at the LDTIO time point.
Transcript abundance of the S-phase genes was next assessed by quantitative PCR
in five replicate cultures at each time point. There was no significant change in
expression of any of the S-phase genes over the cell cycle relative to LDT2 (ANOVA,
p>0.05; Figure 6). In particular, during S-phase (LDTIO-LDT14) expression levels were
either level or lower than at LDT2, the opposite behavior from that found in most
eukaryotes. These results are consistent with their post-transcriptional regulation in Sphase and confirm previous observations in K. brevisfrom in a microarray study (Van
Dolah et aI., 2007).
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Abundances of S-phase Proteins Over the K. brevis Cell Cycle
Given the absence of S-phase specific transcription of these genes, their
proteinswere next investigated to determine if they are differentially expressed,
suggesting S-phase specific translation, or if they are constitutively produced and their
activity is regulated post-translationally. Protein abundances were compared in cultures
during Gl (LDT2 and LDT6), S-phase (LDTI0 and LDTI4) and G2+M (LDTI8 and
LDT22) (Figure7). The Western blots shown are representative of five replicate cultures
at each time point with the mean + S.E.M. of the band intensities normalized to the mean
intensity at LDT2. Although averaged densitometry of RP Al (Figure7 A) did not indicate
a significant increase in band intensity, the blots generally showed that a small increase in
abundance typically appeared around LDTI0-LDT14, with the protein sometimes, but
not always, largely absent by LDT22. RnR2 (Figure 7B) peaked during S-phase, with
highest abundance at LDT14 and LDT18. RFC also typically peaked at LDT14 (Figure
7C), but the levels of RFC late in the ceB cycle varied. In some replicates, RFC remained
nearly as high late in the cell cycle as at LDT 14, but in others it was nearly absent.
PCNA (Figure7D and E) showed both increased protein abundance during S-phase and
an increase in molecular weight of ---9 kDa beginning at LDTI0, with the larger band
maximally expressed at LDT14 and LDTI8, and both the 28 kDa form and the 37 kDa
forms largely disappearing at LDT22.
Since 28 and 37 kDa bands appeared consistently during S-phase in the PCNA
Western blots, a peptide blocking experiment was performed to ensure that both bands
were specific to PCNA. Figure8shows that both bands represent specific binding to the
K. brevis PCNA antibody. Therefore, this larger band may be due to a post-translational
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modification since the 28 kDa band is the expected size of eukaryotic PCNA and
detennination of the amino acid sequence on http://expasy.orgltools/pi_too1.html also
predicts K. Brevis PCNA to have a mass of approximately 28 kDa.

Subcellular Localization of PCNA
The subcellular localization pattern ofPCNA in GI (LDT 2), S-phase (LDTI4)
and G2+M (LDT18) was examined next to detennine if there was a correlation between
localization and the appearance ofthe 37 kDa PCNA band observed by Western blotting.
Immunofluorescence showed that, unlike most eukaryotic cells, PCNA was present in the
nucleus at all timepoints investigated, with 53% of the cells staining positive for PCNA
in G 1 (LDT2). There was an increased percentage of PCNA positive cells (70%) at the
peak ofS-phase (LDTI4), and 52% remained positive in G2+M at CTl8 (Figure9A).
Qualitatively, the S-phase cells stained more brightly and showed a distinctive punctate
pattern of chromatin-associated PCNA suggestive of localization to replication forks
(Figure 9C), whereas staining in the LDT2 cells was frequently more intense around the
periphery of the nucleus (LDT2, arrow) and at LDT18 cells staining was more diffuse
rather than punctate. PCNA was not observed in the cytosol.
In the experiment above, the cells at LDT2 showed 52% positive for PCNA
(Figure 9B). What is not clear is whether these represent cells that, although they are in
G 1 as assessed by flow cytometry, have already passed the restriction point and thus have
started expressing PCNA. Therefore, to further synchronize the cells in G 1, cultures
were placed in constant darkness for two and a half light cycles, such that any residual
cells "primed" to enter the cell cycle would have completed their cycle. The idea was
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that when the dark-synchronized cells, arrested in G I, are released into light, PCNApositive cells would represent only cells proceeding into S-phase unless PCNA is
constitutively expressed. Flow cytometry of the dark synchronized cells showed that
approximately 20% of the cell population entered S-phase by LDTI4 following release
into the light (Figure lOA). Both the total percentage ofPCNA positive cells and the
percentage of cells with chromatin-associated PCNA increased significantly as cells
proceeded into S-phase (LDTI4; Figure lOB). The results suggest both that PCNA was
newly synthesized and that the chromatin association ofPCNA corresponds temporally
with appearance of the 37 kDa form ofPCNA during S-phase as observed by Western
blot.
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DISCUSSION
Eukaryotic cell cycle progression is controlled largely by the transcriptional
and/or post-translational activation of highly conserved protein complexes precisely
during the cell cycle stage at which they are needed. In humans, yeast, and Arabidopsis,
several hundreds of genes are differentially transcribed over the cell cycle, yet recent
comparative analyses reveal that which genes are regulated by transcription or by posttranslational mechanisms varies considerably among eukaryotic lineages (Jensen et aI.,
2006). Thus there is not one universal mechanism for eukaryotic cell cycle regulation.
Instead, it appears that transcription and post-translational regulation have co-evolved,
yielding different solutions to achieve the cell cycle dependent activation of orthologous
protein complexes (Jensen et aI., 2006). Trypanosomes, which lack transcriptional
control, have evolved yet a different level of regulation, in which differential expression
of cell cycle genes is achieved post-transcriptionally by increasing the stability of phasespecific messagesthrough the binding of RNA binding proteins (Archer et aI., 2009). Sphase genes possess a conserved octameric post-transcriptional control element,
CATAGAAG, in either the 5' or 3' UTR that regulates cell cycle-dependent
accumulation of these mRNAs (Brown and Ray, 1997; Zick et aI., 2005). Since
dinoflagellates, although evolutionarily distant from trypanosomes, also appear to rely
largely on SL mediated post-transcriptional regulation of gene expression,we investigated
whether K. brevis also uses a post-transcriptional solution to S-phase gene expression. In
the current study, no changes were observed in message abundance of four S-phase
genes, but increases in their protein expression levels during DNA replication were
observed, suggesting that in the dinoflagellate regulation of S-phase takes place at the
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level of translation. It is possible that the absence of observable increases in S-phase
associated transcript levels reflects the fact that only about 50% of the population was
proceeding through the cell cycle (Figure 5). However, even when cell cycle synchrony
of70% (the maximum attained for K. brevis) was achieved whenK. brevis was placed
under continuous light, there were no changes in any cell cycle transcripts (Van Dolah et
aI., 2007).
Three of the genes investigated in this study, PCNA, RFC5, and RPA1, work
together as components of the replication fork complex that facilitates DNA synthesis,
while the fourth, RnR2 converts ribonucleotides to deoxyribonucleotide substrates for
DNA synthesis. Given the coordinated roles of their proteins in DNA synthesis, their
relative expression levels in the cDNA library revealed some surprising differences.
Dinoflagellates are well known for gene amplifications, with many genes being present in
high copy numbers, often in tandem repeat units (Le et aI., 1997; Zhang and Lin, 2003;
Bertomeu and Morse, 2004; Liu and Hastings, 2006; Bachvaroff and Place, 2008).
PCNA is a highly amplified gene, present in 41 copies in Pfiesteria (Zhang et aI., 2006).
In the K. brevis library, 101ESTs assembled into 11 unique contigs, all of which are
unique from the 9 sequences in GenBank, for a minimum of20 unique PCNA genes in K.

brevis. RnRI ESTs were similarly highly expressed, with a minimum of 12 unique genes
represented. In contrast, RnR2, RFC and RPA appear to be low-copy genes and their
expression levels in the library are similarly low. Although expression ofESTs cannot be
considered a quantitative measure of relative expression, the sampling of 65,292 ESTs
should be sufficient that this difference in representation is not random. Such
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mismatches in expression levels of functionally related genes have previously been noted
in K. brevis, e.g., 0 a and ~ 0 and tubulin (Lidie et aI., 2005).

Cell Cycle Dependent Expression

Replication Protein A
Replication Protein A, the single strand DNA binding protein that serves to hold
the replication fork open, is an example of a cell cycle protein whose cell cycle regulation
differs among eukaryotic lineages. In Saccharomyces cerevisiae, all three subunits are
differentially transcribed., whereas in Schizosaccharomyces pombe only subunit ssbl
changes at the transcript level, and only RPA2 is differentially expressed in humans. In
this study., the behavior of the large subunit ofRPA (RPAl) was investigated, the only
subunit identified in the K. brevis EST library. The data presented here suggest that the
RPAI gene has not undergone the extensive gene duplication as seen in PCNA. No
changes in transcript level were observed. There was no statistically significant change
in RPAI expression although visual inspection of the Western blots suggests a trend
toward higher expression during S-phase and minimal expression in mitosis.

Ribonucleotide Reductase
The activity of ribonucleotide reductase., a tetramer consisting of two large and
two small subunits that reduces ribonucleotides to deoxynucleotides., is maximal during
S-phase in all eukaryotes and in the yeasts, human, and Arabidopsis its activity is
regulated in part by the S-phase dependent transcription of its large subunit (Trachana et
aI., 2010). In K. brevis, neither RnRl (Van Dolah et aI., 2007) nor RnR2 (this study)
show a cell cycle-dependent change in transcript levels. Cell cycle activity of RnR in
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mammalian cells is further controlled post-translationally by an S-phase specific
stabilization of the RnR2 subunit lasting until cells pass into mitosis, when it is
polyubiquitinated for degradation (Chabes et aI., 2003). This stabilization ofRnR2
ensures a sufficient supply of dNTPs for replication as well as repair during G2 (Chabes
and Thelander, 2000). In K. brevis, the RnR2 protein was present throughout the cell
cycle with a significant increase during S phase (LDTI4, p<O.05) and G2 (LDTI8,
p<O.OI) when normalized to LDT2 (Gl) (Figure7B). In yeast, plant and mouse cells, the
activity of the RnR2 protein is further modified by an S-phase specific translocation from
the nucleus to the cytoplasm where it carries out its actions (Zhang et aI., 2006). In K.

brevis, immunolocalization with the anti-RnR2 antibody showed that this protein was
pr~sent

throughout the cell cycle in the cytoplasm with nuclear staining not evident (data

not shown). This is similar to the exclusive cytoplasmic location of RnR2 in mouse cells
(Engstrom and Rozell, 1988). However, unlike the mammalian RnR2, K. brevis RnR2
presence throughout the cell cycle is similar to what is observed in trypanosomatid, L.

m.amazonensis(Lye et aI., 1999).
Replication Factor C
RFC consists of five subunits that together form the clamp loading protein which
loads the PCNA homotrimeric ring onto replicating DNA. In yeasts the transcription of
RFC subunits does not change during the cell cycle, whereas in humans, transcripts of
RFC2-5 subunits increase during S-phase. In K. brevis, RFC5 transcript levels were
unchanged while its protein expression, although it did not meet the cut-off for statistical
significance, appears to increase in S-phase. An increase in RFC during S-phase would
be expected since the PCNA protein, which RFC binds to and loads onto DNA during
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replication and repair, changes over the K. brevis cell cycle, with highest abundance
during S-phase.

Proliferating Cell Nuclear Antigen
PCNA, the homotrimeric ring that forms the replication fork sliding clamp is
another protein that is regulated differently in various eukaryotic lineages. PCNA is
transcriptionally controlled in budding yeast and humans, but constitutive in fission yeast
over the cell cycle (Jensen et aI., 2006). In K. brevis, the transcript levels were similarly
unchanged. In mammals, PCNA protein expression is widely used as a marker of
actively growing cells because of its S-phase specificity (Elias, 1997). In K. brevis, this
protein was present throughout the cell cycle, although barely visible during mitosis by
Western blot. The most notable change in expression was a shift in band size of
approximately 9 kDa dominating during S-phase. It is possible that the S-phase specific
37kDa form ofPCNA represents the sequential replacement of the 28 kDa PCNA with a
larger isoform. However, there is no precedence for this in other organisms and there
were no such candidates found in the EST library. Alternatively, this shift in molecular
weight may represent post-translational modification of PCNA. Two candidate modifiers
arethe small ubiquitin-like modifier (SUMO; 9 kDa) or ubiquitin (8.5 kDa) since both
modifications to PCNA are known in other eukaryotes. However, total PCNA, both the
28 kDa and 37 kDa forms, are in low abundance by LDT22 which represents mitosis.
The presence of these peptides in K. brevis and their possible roles in PCNA modification
are addressed in Chapter 4.
The immunolocalization data show that the PCNA protein is localized to the
nucleus at all phases of the cell cycle, but its distribution within the nucleus changes.
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Peripheral staining dominated in G 1, while an increase in brightly stained chromatinassociated PCNA was found in S-phase and corresponds with the time at which there is
an observed band size shift of PCN A. As the cells entered G 21M, the proportion of cells
with chromatin-bound PCNA decreased and PCNA at the nuclear periphery increased. It
may be that as the cell finishes DNA replication, PCNA is sequestered to the nuclear
envelope for export and ubiquitination-dependent degradation by the 26S proteosome.
This is consistent with the decreased expression at this time point observed by the
Western blot. The observed nuclear localization throughout the cell cycle is unusual
when compared to other eukaryotes, but has been observed in the promastigote stage of
the trypanosomatid, Leishmania donovani, where PCNA is nuclear throughout the cell
cycle but has distinct nuclear foci in S-phase, which are thought to be active sites of DNA
replication (Kumar et aI, 2009). Like K. brevis, the PCNA protein was not found in the
cytoplasm during any stage of the L. donovani cell cycle. In human cells, PCNA is
absent in G 1, is present in a pool in the nuclear periphery in early S-phase and has a more
nucleoplasmic pool ofPCNA later in S-phase (Essers et aI., 2005). However, it is not
currently known if this change in localization is regulated by its post-translational
modification.

CONCLUSIONS
Although dinoflagellates possess conserved cell cycle proteins present in all
eukaryotes, they have many unusual cell cycle characteristics that suggest some aspects
of their cell cycle regulation may differ from the established eukaryotic models. In
particular, the presence of the spliced leader on K. brevis gene transcripts suggests post93

transcriptional gene regulation. This study demonstrated that S-phase genes classically
regulated at the level of transcription, appear to be under post-transcriptional control in K.
brevis. Among the four S-phase genes studied, there was no evidence for transcriptional
activation during S-phase. Nonetheless, their protein products had maximal expression
levels during S-phase and, in the case of PCNA, a prominent apparent post-translational
modification specific to S-phase.
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Figure I: Multiple Alignments of the amino acid sequences of S-phase proteins. (A)
Proliferating Cell Nuclear Antigen, black bar indicates the location of the peptide used to
develop the anti-PCNA antibody used for immunolocalization and the red bar shows the
peptide used to develop the anti-PCNA antibody used for Western blotting. (B)
Replication Protein A, large subunit. Black bar indicates the location of the peptide used
to develop the anti-RPA antibody used for Western blotting. (C) Replication Factor C,
subunit 3 (D) Replication Factor C, subunit 5. Black bar indicates the location of the
peptide used to develop the anti-RFC5 antibody used for Western blotting. (E)
Ribonucleotide Reductase I and (F) Ribonucleotide Reductase 2, boxed region shows the
highly conserved region in RnR2 to which the peptide antibody used in this study was
developed against in human RnR2.No antibodies were developed for RFC3 or RnRI.
Alignments include the eukaryotes Karenia brevis, Trypanosoma brucei,

Chlamydomonas reinhardtii, Arabidopsis thaliana, Saccharomyces cerevisiae, and Homo
sapIens.
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Figure 2: Phylogenetic (Neighbor-joining) tree of PCNA amino acid sequences with
percent bootstrap support. Inset: dinoflagellates and kinetoplastids.
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Figure 3: Three-dimensional protein models of K. brevis PCNA monomer (top 2 panels).
Top left panel shows where the peptide is located that was used for antibody development
and subsequent immunolocalization studies. Top right model shows the L-A-P-K
binding domain where PCNA binds to RFC. Bottom: trimeric Archaeabacterial (left) and
yeast PCNA (right).
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Figure 4: Spliced leader sequences on S-phase transcripts. Outlined are the spliced leader
sequences on the 5' end of each representative transcript and the start codon (ATG)
downstream from the spliced leader.
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cultures).
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Figure 6: Gene expression results for PCNA, RFC, RP A and RnR2 in K. brevis. The
four S-phase transcripts showed no significant change over the cell cycle. LD time is on
the x -axis and the log2 of the ratio of expression of each gene relative to its expression at
LDT2 is on the y-axis(log2 ratio= C-E, where C is the control cycle threshold and E is the
experimental cycle threshold). Significance was determined using a one-way ANOVA
(PCNA, p=0.943; RFC, p=0.7943; RPA, p=0.8916; and RnR, p=0.8321).
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Figure 7: Western blot analysis of the RP AI , RnR2, RFC5 and PCNA proteins over the
cell cycle. Densitometry of the replicates (n=5) over time is shown in the graph below
each blot. A representative blot is shown for each protein is shown. Changes in band
density over time relative to LDT2 is shown in the graph below each blot (n=5
replicates). RnR2 (B) and PCNA [both the 28 kDa (D) and 37 kDa forms (E)] were
shown to significantly change over the cell cycle (ANOVA, p<0.05). RP Al (A) and
RFC5 (C) did not meet statistical cutoffs, but did appear to increase in S-phase when
observed visually. (F) Total combined PCNA protein did not significantly change over
the cell cycle.
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28kDa and the 37kDa band are specific to the anti-K. brevis PCNA antibody. Protein
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Figure 9: Immunolocalization ofPCNA (A) Representative labeling patterns observed in
Gl, S, and G2/M cells probed with anti-PCNA and a FITC-Iabeled secondary antibody
(green) (i-iii); overlay of FITC with DAPI stained nuclei (blue), where bright blue nuclei
are negative for PCNA (v-vii). Negative controls probed with peptide blocked anti-PCNA
and FITC-Iabeled secondary antibody (iv, viii). Numbers in parenthesis represent the %
of PCNA positive cells counted in triplicate fields of a minimum of 100 cells each. n =
nucleus, c = cytoplasm and p = periphery of the nucleus. (B) Flow cytometric cell cycle
distribution of cells observed in A. (C) Enlarged image of an S-phase cell showing
punctuate staining suggesting chromatin association of PCNA; inset DAPI overlay of the
same cell.
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Table 1: Primers used for qPCR and SL - gene specific peR for identification of the
presence of the 5' spliced leader sequence.
Gene
PCNA
RPAl
RFC
RnRl
RnR2
~Iiced

Forward primer 5 -3

~AGGAAACAAGGACCGGGCAGT

Reverse primer 5 -3
GCAAGCCCTTCTCACTACAA
GGTGCTGTGAAGCTGGTGATGA
CGCCAGCATCCTCAATGACAAC

~AGGCAACAGTATTCTTGT

~CAGATGTACGTGGTCAAA

~CAAGAGGCGGTCAGCTACAAACT

~GTGGATGTGGAGCGGAAGTTCAT

1

1

~CTTGAGGCTCACCTGCAAC

~GCCAGCATTGACGCCATA

Leader

1

~CCGTAGCCATTTTGGCTC
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1

Top hit GenBank Accession number
EU078559(K.brev~)

XP_002786176
EEY69117
XP_002785979
XP 002773236

Table 2: Peptides used for antibody development. The ribonucleotide reductase 2 (RnR2)
antibody is a commercially available peptide antibody developed against the human
RnR2 amino acid sequence.

Protein

Peptide

PCNA (Westen blot)

NVM LKPRESEKPEEKVTLT

PCNA (lmmunolocalization)

DRIADFDLKLMQIESEH

RFC

GRAVYQSTGVPQPEDID

RPA

NLLKKPSEYSNGG RRAALH R

RnR2

QIAMENIHSE
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Table 3: Prevalence and diversity of selected S-phase specific genes represented in the K.
brevis library.

Unique Unique
ESTs
PCNA

Contigs Proteins

GenBank

GenBank

Non-alveolate

Organism Top Hit

Top E-value

Organism Top Hit

E-value
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16

9

Karenia mikimotoi

1. 13E-141

Daucus carota

3.00E-64

replication factor C I subunit3

1

1

1

Xenopus laevis

4.00E-76

Xenopus laevis

4.00E-76

replication factor c, subunit 5

7

2

1 Phytophthora infestans

3.00E-87 Thalassiosira pseudonana

1.00E-80

replication protein A, large subunit

30

3

2

Perkensis marinus

8.00E-71

Arabidapsis thaliana

9.00E-58

ribonucleotide reductase, large subunit

54

12

3

Perkensis marinus

1. 17E-165

Ectocarpus silicolosus

1.00E-161

ribonucleotide reductase, small subunit

2

1

1

Perkensis marinus

1.20E-129

Trypanosoma brucei

3.00E-128
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Chapter 4: S-phase Expression of PCNA: Possible Post-translational Modifications,
CDK Dependence, and its Potential Utility as a Biomarker of Growth Status in
Karenia brevisRed Tides
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INTRODUCTION

Proliferating cell nuclear antigen (PCNA) is involved in many essential cellular
processes. These include DNA replication, DNA damage repair, chromatin structure
maintenance, chromosome segregation and cell-cycle progression (Stoimenov and
Helleday, 2009). PCNA was originally detected as an antigen for autoimmune disease in
systemic lupus erythematosus patients, detected only in the proliferating cell populations
(Miyachi et aI., 1978). Since then it has also been used as a biomarker for actively
dividing cancer cell populations. The crucial involvement ofPCNA in cellular
proliferation and its tight association with cancer transformation has resulted in the
frequent use ofPCNA not only as a diagnostic marker butas a prognostic cell cycle
marker (Elias, 1997). Due to its usefulness as a biomarker for proliferation in
mammalian systems, PCNA has received wide attention in other biological systems. In
the causative malaria parasite Plasmodiumfalciparum, an organism that has 5
developmental stages, PCNA expression is tightly regulated during the intraerythrocytic
development; early, uninucleate ring stages (G 1 phase) contain little PCNA mRNA or
protein and PCNA induction is first detected in the late ring stage and is maximally
expressed in trophozoites (Kilbey et aI., 1993). This progression correlates with the onset
of parasite DNA replication in the intraerythrocytic cycle. Following this logic, PCNA
proteins have been identified in phytoplankton with the interest in their potential as in situ
growth rate markers, including green algae (Dunelliela salina) and bloom forming
dinoflagellates, including Crypthecodinium conhii, Amphidinium carterae and
119

Gymnodinium catenatum (Leveson and Wong, 1999) as well as in Prorocentrum
donghaiense (Liu et aI., 2005) and P. piscicida (Zhang et aI., 2006). When PCNA
expression was investigated over the growth curve in P. donghaiense, it remained at a
comparatively high level during exponential growth and decreased during late stationary
phase (Liu et aI., 2005). Similarly, in the green alga D. salina, PCNA protein abundance
was low at the beginning of growth in lab cultures and peaked during exponential growth
and was hardly detected in late stationary phase. However, in P. piscicida, the abundance
ofPCNA changed only about two-fold between log and stationary phase, making it of
little value as a quantitative marker of growth (Zhang et aI, 2006). An ideal biomarker for
growth status of a cell population is absent in non-growing conditions but abundant in
actively growing cells. In Chapter 3 we found a significant increase in the size ofPCNA
from 28 to 37 kDa and abundant expression of the 37 kDa form only during S-phase in K.

brevis. Theseproperties suggest it may be a useful biomarker for bloom growth.
However, Chapter 3 also identified some unusual phenomena that warrant further
investigation to better understand the regulation of PCNA in the dinoflagellate. First, we
found PCNA transcript levels unchanged over the cell cycle, despite an S-phase specific
increase in protein expression. Since PCNA expression is typically activated by CDKdependent transcription factors, this suggests an unusual regulation of the G I/S
checkpoint. Second, the identity of the ~37 kDa protein remains in question. With no
precedent for a larger form ofPCNA dominating during S-phase in any species studied to
date and no evidence for a longer PCNA sequence in the K. brevis EST library, we
hypothesized that this shift represents a post-translational modification. However, no
post-translational modifications have been described in dinoflagellates to date. The
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studies in Chapter 4 therefore address three questions that further our understanding of
the S-phase specific expression ofPCNA in the dinoflagellate:
(1) Does the S-phase specific change in PCNA molecular weight result from posttranslational modification, and if so, what is the post-translational modification of
PCNA during S-phase?
(2) What CDKs are present in K. brevis and what is the dependence ofPCNA
protein abundance on CDK activity at the G l/S transition?
(3) Does the S-phase specific form ofPCNA have utility as a biomarker for
growth rate in K. brevis?
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METHODS
Analysis of Post-Translational Modification Proteins and eyelin-Dependent Kinases
Sequences with significant homology (BLASTx E-value < 10-04 ) to genes
involved in post-translational modifications, specifically ubiquitination and sumoylation,
and cyclin-dependent kinases (CDKs) were identified from theK. brevis expressed
sequence tag (EST) database housed at NOAA CCEHBR. Annotation of contigs and
gene ontology analysis were performed in Blast2Go.
In silico translationsof the full open reading frames of K. brevis SUMO, ubiquitin

and CDKs were performed using BioEdit software. To obtain the predicted theoretical
molecular weight of SUMO and ubiquitin, the amino acid sequences were analyzed using
the Compute pIlMw tool on the ExP ASy Proteomics server
(http://expasy.org/tools/pi tool.html). For multiple alignments of each protein sequence,
the amino acid sequences from other eukaryotes were obtained from GenBank. Species
used for the analysis of SUMO included: Pfiesteria piscicida, Phaeodactylum
tricornutum, Homo sapiens, Schizosaccharomyces pombe, Arabidopsis thaliana,
Chlamydomonas reinhardtii, andSaccharomyces cerevisiae; and for Ubiquitin included:
Plasmodium jalciparum,Homo sapiens, Schizosaccharomyces pombe,Arabidops is
thaliana, and Chlamydomonas reinhardtii, to include representatives across multiple

phyla. Sequences used for CDKs includedPlasmodiumfalciparum CDK7,
Arabidopsisthaliana CDK C, and Chlamydomonasreinhardtii CDK. Once imported into

BioEdit software, multiple alignments of the species were done using the ClustalW
Multiple Alignment application.
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To determine sites of lysine modification by SUMO and ubiquitin on the K. brevis
PCNA, a bioinformatic approach was used. The full length K. brevis PCNA amino acid
sequence was uploaded into the SUMOsp 2.0 sumoylation site prediction program
(http://sumosp.biocuckoo.org/prediction.php, Ren et aI., 2009). Similarly, the K. brevis
PCNA amino acid sequence was submitted to UbPred, a predictor of protein
ubiquitination sites (http://ubpred.org/ , Radivojac et aI., 2010).

Cultures and Culturing Conditions
K. brevis (Wilson isolate) was grown in 0.22 Jlm filtered seawater (36%0) obtained
from the seawater system at the Florida Institute of Technology field station, Vero Beach,
Florida, enriched withjl2 nutrients (Guillard, 1973), modified with the use of ferric
sequestrene in place ofEDTA' Na2 and FeCb' 6H 20 and the addition of O.OlflM selenous
acid. Cultures were maintained in 1 liter glass bottles at 25°C + 1°C with a 16:8
light:dark cycle, and cool white light at 50-60 flmol photons m-2 sec-I, determined using a
LI-COR LI-250 Light Meter (LI-COR BioSciences, Lincoln, NE). Cell counts for
growth curve analysis and division rate per day calculations were determined on a
Multisizer 3™ Coulter Counter (Beckman Coulter, Inc., Brea, CA).

Cyclin Dependent Kinase Inhibitor Experiments
Flask cultures containing 125mL of K. brevis were grown to mid-log phase (Day
6). On Day 6, cyclin dependent kinase inhibitors and carrier controls (fascaplysin/water,
olomoucine/DMSO) were added just before LDTO (lights-on). Olomoucine was chosen
as an inhibitor for the CDKI studies since this compound has broad CDK specificity and
has been shown to block K. brevis in G 1 as well as mitosis (Van Dolah and Leighfield,
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1999). Fascaplysin was chosen for its specificity to the G liS-phase transition CDK,
CDK4. Carrier controls of the same volume were added to cell cultures for the duration
of experiments (fascaplysin is soluble in water and olomoucine in DMSO). Structures of
these compounds are shown in Figure 1. A series of range finding studies was carried out
for each compound in order to optimize cell viability and the effectiveness of each
compound to block the cell cycle prior to S-phase. Concentrations of fascaplysin that
were tested included 10, 5, 2.5, 1.5, 1, and 0.75 J..lM; and olomoucine concentrations
tested included 100, 50, 25, 12.5, and 6.25 J..lM.
Five independent replicate cultures were sampled for each treatment. To ensure
CDK inhibitor was not just poisoning the cells, viability was assessed at LDT12 (mid-Sphase) using SYTOX (Molecular Probes, Invitrogen) staining after 12 hours of exposure
to inhibitor or carrier control (Figure 2). Fifty J..lL of 5J..lM SYTOX were added to 5mL of
K. brevis culture. Cells were incubated for 15 min. at room temperature followed by
addition of 200J..lL of 50% gluteraldehyde for fixation and incubated for 5 min. Cells
were centrifuged for 3 min. at 600 x g and placed on a microscope slide for enumeration
under an Olympus Fluorescent microscope within 10 minutes. One hundred cells were
counted to a get a percentage of cell viability. Fifteen milliliters of culture were fixed for
flow cytometric analysis and the remaining cell culture

(~100mL)

was centrifuged at 600

x g for 10 min. Protein was then extracted from the cell pellets for western blot analysis
using TriReagent following the manufacturer's protocol.
PCNA Expression Pattern in Flask Cultures over the Cell Cycle
K. brevis cultures in 125mL flasks were grown to mid log phase (Day6). Four
biological replicates were sampled at each time point every 2 hours over the course of S124

phase and LDT2 samples (Gl) were taken to compare with the S-phase samples. S-phase
time points included LDTI0, 12, 14, 16 and 18. Flow cytometry samples were taken
from each culture at each time point for cell cycle analysis. The remaining culture was
centrifuged for 10 min. at 600 x g to pellet the cells for protein extraction using
TriReagent. Proteins were then used for analysis ofPCNA throughout S-phase by
western blotting.
Growth Rate Studies: Log vs. Stationary Phase Experiments
Five replicate 125 mL flask cultures of K. brevis were grown to mid-log phase
(Day 6), late log phase (Day 8 and Day 10), early stationary phase (D12) and stationary
phase (D14) and sampled on the indicated days. Two mL samples were taken on Days 1,
3, 5 and the day of sampling mentioned above (Day 6, 8, 10, 12 and 14) for all cultures in
order to construct a growth curve and to calculate divisions rate. Cells were harvested for
protein extractions at LDT12 (mid-S-phase) on each sampling day and a 15mL aliquot
was taken for flow cytometric analysis. The remaining culture (---100mL) was
centrifuged at 600 x g for 10 min. Protein was then extracted from the cell pellets for
western blot analysis using TriReagent following the manufacturer's protocol.
For analysis ofPCNA expression under different growth rates, 125mL flask
cultures were grown at light intensity of 70 f,lE/m2/s to mid-log phase (Day 6, n=5) or
stationary phase (Day 12, n=5). To obtain log phase cells with lower growth rates,
another set of flasks were wrapped in "neutral density" mesh filters which attenuate the
amount of light the cultures receive to 31 f,lE/m2/s (Day 6, n=4). All cultures were
sampled at LDTI2, which corresponds to mid-S-phase, on the appropriate sampling day.
Cell counts were obtained every other day during the course of the study in order produce
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a growth curve and to calculate growth rate. The equation K'== In (n2/nl)/(t2-tl) was used
to detennine growth rate, where fil and n2 are cell counts at the time points tl and t2.
Divisions per day were then calculated by using the equation K'/ln2. Proteins were
extracted and Western blotting (see below) was carried out with anti-K. brevis PCNA
antibody_ Flow cytometric analysis was performed on 10mL of culture as described
below in order to correlate PCNA band intensity with the percentage of cells in S-phase
at LDT12. A linear correlation analysis in GraphPad Prism 4 software was used to
determine the relationship between growth rate and PCNA abundance.

Cell Cycle Analysis
Ten milliliters of culture were collected from each 1L biological replicate culture
(n==5) at each time point. Cells were fixed in 2% gluteraldehyde by adding 50%
gluteraldehyde directly to culture medium containing cells and stored at 4°C for at least
12 hours. Cells were then centrifuged at 1750 x g to remove fixative and growth
medium. To extract cellular pigments, cells were stored in -20De methanol for a
minimum of 4 hours, centrifuged at 1000 x g and methanol was removed. The cells were
then stained with 10 Jlg/mL propidium iodide (final concentration) in phosphate buffered
saline (PBS) containing 10 mg/mL RNase and 0.5% Tween 20. DNA analysis was
performed on an Epics MXL4 flow cytometer (Beckman Coulter, Miami, FL) using a 5
W argon laser with a 488 nm excitation wavelength and 635 nrn emission wavelength.
Multicycle software (Phoenix Flow Systems, San Diego, CA) was used to obtain the
percentages of cells in each stage of the cell cycle.
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Protein Extraction and Western blotting
Protein was extracted from the experimental samples using TriReagent following
the manufacturer's protocol. A Bradford protein assay (Bradford, 1976) was used to
quantify protein concentration using the Bio-Rad Protein Assay Dye Reagent (Bio-Rad,
Hercules, CA, USA). For western blotting, 10 Jlg of protein extract were loaded on a 412% Bis-Tris gradient gel (Invitrogen Corporation, Carlsbad, CA). For the SUMO
experiments, a human recombinant SUMO 1 protein was used as a positive control. This
recombinant protein was a gift from Dr. Tilman Heise (Dept. of Biochemistry, MUSC).
Proteins were then transferred to a 0.2 Jlm polyvinylidene fluoride (PVDF) membrane
using the Invitrogen iBlot system (Invitrogen Corporation, Carlsbad, CA). The PVDF
membrane was then blocked in 5% non-fat milk in Tris buffered saline (TBS) with 0.1 %
Tween 20 for 1 hour at room temperature. Membranes were then incubated in primary
antibodies overnight at 4°C.The anti-KbPCNA antibody developed against translated K.
brevis was used at 1:5000in TBS with 0.1 % Tween 20 and 5% non-fat milk. Commercial

antibodies were used for the detection of SUMO at 1: 1000 (Rockland Immunochemicals,
Inc., Gilbertsville, P A) and ubiquitin at 1: 1000 (Enzo Life Sciences, Inc., Plymouth
Meeting, PA) in TBS with 0.1 % Tween 20 and 5% non-fat milk. Membranes were
washed 3 x 10 minutes in TBS with 0.1 % Tween 20. Horseradish peroxidase-linked
donkey anti-rabbit Ig was then incubated with the PVDF membrane at 1:2000 for PCNA
and SUMO or 1:5000 for ubiquitin, in TBS with 0.1 % Tween20 for 1 hour at room
temperature. After rinsing membranes in TBS with 0.1 % Tween 20 (2 x 10 minutes) and
TBS (Ix 10 minutes), the Pierce ECL Super Signal West Pico Kit (Pierce, Rockford, IL)
was used for detection. Membranes were exposed to film (Pierce CL-XPosure Film,
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Thermo Scientific, Rockford, IL) and developed for visualization. Densitometry of the
bands of the biological replicates (n=5) was carried out using Alpha Innotech (San
Leandro, CA) FluorChem 8900 software. Significant differences were determined with a
one-way ANOV A using GraphPad Prism 4 software (La Jolla, CA).

Peptide Competition Assay
Ten micrograms of protein extract from stationary phase cells at the time
corresponding to S-phase (Day 12 and 14, LDT 12) were used for the PCNA peptide
competition experiment. The anti-K. brevis PCNA antibody (1 :5000 or 3.6J.lg) was
incubated with 100X peptide (360J.lg of peptide), to which the antibody was developed, in
TBS with 0.1 % Tween 20 and 5% milk for 1 hour at 4°C. The experimental membrane
was incubated overnight at 4 °C with the peptide blocked anti-PCNA. The control blot
was incubated overnight at 4°C in the anti-K. brevisPCNA antibody at 1:5000 in TBS
with 0.1 % Tween20 and 5% non-fat milk. Western blot procedures were followed as
described above.

Immunoprecipitation
Cells were harvested during S-phase (LDT12-14) and proteins were extracted
using TriReagent following the manufacturer's protocol. Protein pellets were solubilized
in 200 J.lL DIGE buffer (7M urea, 2M thiourea, 4% w/v. CHAPS, 30 mM Tris, pH 8.5).
Two micrograms of antibody (anti-PCNA, anti-Ubiquitin or anti-SUMO) were added to
the protein lysate and incubated at 4°C for 1 hour with rotation. Ten microliters of
Protein AlG PLUS-Agarose beads (Santa Cruz Biotechnology, Inc., Santa Cruz, CA)
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were then added to the protein lysate/antibody mixture and incubated at 4°C overnight
with rotation. Immunoprecipitates were collected by centrifugation at 1000 x g for 5 min.
at 4°C. Supernatant was aspirated and discarded. Immunoprecipitates were washed 4
times with PBS repeating the above centrifugation step for 5 min at 4°C. After the final
wash, supernatant was aspirated and discarded and the pellet was resuspended in 40~L of
IX LDS electrophoresis loading buffer (Invitrogen, Carlsbad, CA). Samples were boiled
for 3 min. to remove agarose beads from the immunoprecipitate and centrifuged at 2500
x g for 5 min. at 4°C. Three microliters of reducing agent were then added to

30~L

of the

sample and loaded onto 4-12% acrylimide gels for analysis by western blotting.

Stripping of Western Blots
To reprobe blots with a different antibody than had previously been used, a
stripping protocol was used as follows. Stripping buffer was prepared using 0.93g of
Tris-HCI, 2g of sodium dodecyl sulfate, 20

~L

of J3-mercaptoethanolbrought up to

100mLs and adjusted to pH 6.7. Stripping buffer was warmed to 40°C. The blot to be
reused was then incubated in buffer, rotating at 40°C for 20 min. The blot was then
washed 4 times in phosphate buffered saline for 20 minutes each. The blot was then
washed in 5% non-fat dry milk in Tris buffered saline with 0.1 % Tween-20 two times for
20 minutes each. The new primary antibody for analysis was then added and incubated
following the optimized procedure.
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RESULTS
Possible Post-translational Modifications of PCNA
The presence of multiple forms of the PCNA protein observed in Chapter 3 led to
further investigation of possible post-translational modifications ofPCNA in K. brevis.
PCNA in eukaryotes that have been studied is known to be both sumoylated and
ubiquitinated on lysine residues. Sequences with homology to the sumo and ubiquitin
polypeptides are present in the K. brevis EST library. Multiple alignments of both K.
brevis sequences with other eukaryotes show that they are highly conserved and possess
the G-G motif which binds to the lysine of the modified protein and is present in these
polypeptides across phyla (Figure 1). K. brevis ubiquitin has high homology to known
ubiquitin sequences (BLASTx E value 10-33 ) andthe K. brevis SUMO sequence shows
high conservation as well (BLASTx E value 10-38 ). Amino acid sequence analysis using
the ExPASy compute pI/Mw tool predicts the K. brevis ubiquitin to code for a
polypeptide of8.5kDa and sumo for 9kDa. Sequence analysis of the PCNA amino acid
sequence using the ubiquitin prediction program UbPred, predicted that K184, K190, and
K194 are ubiquitinated with medium confidence (Figure 2)based on the eight known
ubiquitin binding domains that range from 20-150 amino acids in length (French et aI.,
2005). Sequence analysis of K. brevis PCNA using SUMOsp, a sumoylation prediction
program, predicted that K190 is sumoylated with medium stringency (Figure 2). This
was determined to be a Type II non-consensus motif (ESEKPEE). Other organisms with
K190 ofPCNA predicted to be sumoylated include H sapiens and C. reinhardtii. Lysine
238 of K. brevis PCNA was also predicted to be sumoylated with high stringency. This
site (VKYE) was determined to be a Type I consensus site (\f-K-X-E) where \f is A, I, L,
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M, P, F,or V and X is any amino acid residue. Lysine 164 of K. brevis PCNA was not
identified as a possible modification site by ubiquitin and SUMO, which has been shown
in S. cerevisiae to be the site of modification.

Ubiquitin and SUMO are Expressed in K. brevis
The presence of ESTs with homology to ubiquitin and SUMO in the K. brevis
library and their predicted interactions with K. brevis PCNA identify these proteins as
candidates for the post-translational modification of PCNA in S-phase. Numerous ESTs
with homology to members of the ubiquitin pathway have been identified in K. brevis,
including 133 sequences listed in Appendix 2. Commercial antibodies were found to
have specificity to both polypeptides in K. brevis (Figure 3). The anti-ubiquitin antibody
recognizes multiple bands in K. brevis protein lysates at all points in the cell cycle, as
expected if it is used to modify other protein substrates. However, a short exposure of 5
seconds of the western blot to film shows a band at ---6kDa, a band at 14kDa and a
r-.J

higher molecular weight band at ---55 kDa (Figure 3A). The last two lanes of this gel are
samples from LDT16 and 18, respectively. The differential pattern may be different in
these 2 samples due to the fact that the cell population is in the last part of S-phase, or it
might reflect dark-phase specific protein modification, as these time points occur in the
dark. The anti-sumo antibody recognizes the sumo polypeptide in K. brevis, shown to
run at ---I 7kDa. This antibody also recognized the human recombinant proteins used as
positive controls (Figure 3B).

Immunoprecipitation of PCNA
In an effort to identify if the 37 kDa band observed during S-phase represents
ubiquitin or SUMO modification ofPCNA, PCNA was immunoprecipitated from S131

phase cells and Western blot analysis was performed using the same PCNA antibody.
The anti- K. brevis PCNA antibody immunoprecipitated four prominent forms of the
PCNA protein (Figure 4). These included the 28 and ~37 kDa forms that were reported
in Chapter 3 experiments over the K. brevis cell cycle and the growth curve. Additional
bands were detected at ~47 kDa and 62kDa. In order to test whether any of these bands
represented a sumoylated form of PCNA, which would be expected to occur most
prominently during S-phase, once again PCNA was immunoprecipitated from S-phase
cells and subsequently probed with anti-SUMO. This experiment showed that a
sumoylated form ofPCNA at ---47kDa (Figure 5A). In order to determine whether this
band represents sumoylated PCNA, this blot was stripped of the sumo primary antibody
and the HRP-conjugated secondary antibody and reprobed with anti-PCNA. Indeed, this
band was present; however the 28kDa was not present in this immunoprecipitate (Figure
5B), leaving its interpretation open to question.
If the 37 kDa band is a sumoylated form and limited to S-phase, we might expect
its expression to decrease as cells proceed through the growth curve from log to
stationary phase, where growth is diminished. Therefore, cultures of K. brevis (125mL
flasks) were sampled in quadruplicate during mid-S-phase at LDT12 on Day 6, 8, 10, 12
and 14, representing mid-log phase, late log phase, early stationary phase, stationary
phase and late stationary phase, respectively (Figure 6A). Flow cytometry shows that on
Day 6 at LDTI2, 60% of the cell population was in S-phase with 30% in S-phase on Day
8, 11 % on Dayl0, 6% on Day 12 and 0% on Day14 (Figure 6B). On Day 14, only one
culture was still alive and had high cell abundance. However, since the four other
cultures on Day 14 were either dead or had low cell abundance, these samples were not
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used for PCNA western blot analysis. Western blot data shows that the ---37kDa PCNA is
present during S-phase in log phase cultures and decreases repeatably as cells approach
stationary phase (Days 6 through 10) (Figure 7A). In early stationary phase (D 10),
PCNA is barely present. Unexpectedly, a prominent PCNA band at ""-J47kDa appears on
some, but not all, Day 12 cultures. Given that on Day 14 these cultures began to decline,
the presence of this 47 kDa band in some may indicate a tipping point, where some
cultures are beginning to decline and others are not yet there. Densitometry of these
proteins is shown in Figures 7B and C. Although there was no significant difference
using a one-way ANOV A, there is a clear, repeatable trend over the growth curve for
both forms of PCNA. The lack of significance may he due to the high variability with
which K. brevis culture enter stationary phase.
These results prompted a confirmatory study in which we compared the
expression ofPCNA at LDT12 in log phase and stationary phase, 5 replicates each in 125
mL flasks. In the log phase cultures at LDTI2, the ---37kDa PCNA protein is present in
all replicates (Figure 8A). Flow cytometry data shows that 41.1-64.5% of the log phase
cell population was in S-phase at LDT12 when sampling occurred (Figure 8A). In the
stationary phase replicates, the ---37kDa PCNA is barely present in one replicate and
absent from all others replicates (Figure 8B). In 3 of the 5 samples, the ---47 kDa hand
wasprominent. Flow cytometry shows that the stationary phase cultures have only 08.9% of the cell population proceeding through S-phase (Figure 8B).
The presence ofa 47 kDa version ofPCNA was unexpected and warranted
confirmation of its specificity. Therefore, we carried out a peptide competition assay to
confirm that it is in fact PCNA. Figure 8C shows both the 47 kDa band and the 37 kDa
133

form ofPCNA are present. The antibody specificity is blocked with a 100-fold excess of
peptide antigen. Given that it appears only in cultures that appear to be on the cusp of
dying, we hypothesized that this band might represent a ubiquitinated form ofPCNA. To
address this question, immunoprecipitation was carried out using the PCNA antibody and
Western analysis with the anti-ubiquitin antibody. Unfortunately, none of the
immunoprecipitations provided clear evidence of PCNA ubiquitination in K. brevis (data
not shown). However, an intriguing result pointing to the possibility ofPCNA
ubiquitination is shown in Figure 9. A changing pattern of ubi quitination is apparent in
protein lysates from LDT12 in Day 10 (early stationary phase) and Day12 (late stationary
phase) cultures (Figure 9A), when protein degradation might be expected to increase. On
both Day 10 samples and one Day 12 sample, the ubiquitin pathway components and
substrates match. It is in these exact biological replicates that the --47kDa PCNA is not
present (Figure 9B). Additionally, the ubiquitin monomer is abundant in these samples.
In contrast, the Day 12 sample Kb19 shows an entirely different ubiquitination pattern. A
prominent band of ---47 kDa appears, while the pool of monoubi quit in almost disappears
in this sample. It is in this exact biological replicate that the PCNA ---47kDa band is quite
prominent (Figure 9B) and although this data is indirect, it provides evidence of
ubiquitination that is consistent with the appearance of the 47kDa band recognized by the
PCNA antibody.

Candidate Cyelin-Dependent Kinase and eyelin Genes in the K. brevis Library
Sixteen ESTs with homology to cyclin-dependent kinases are present in the K.
brevisEST library as identified by BLAST and gene ontology searches in Genbank by
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BLAST2GO (Table 1). These sixteen ESTs fold into 5 unique contigs. Two have high
homology to CDK7 (e-56) and one has homology to CDK C (e-66). One is the reverse
complement and the last has poor homology to known CDKs. Using PCR with the
spliced leader as forward primer (5' TCCGTAGCCATTTTGGCTCA 3') and a gene
specific as reverse primer (5' GTGCAGGAATGTGTTGCCGTTT 3'), the full length
sequence for the contig with homology to CDK C was obtained (Contig 5041, Marine
Genomics IDI08857, Table 1). This sequence has the 5' spliced leader (Figure 10) and a
cyclin binding motif (PL TAIEK) as shown by alignment with other protist and plant
CDKs (Figurel1). Residues conserved within CDK groups and among species that are
involved in A TP binding have an asterisk (*) above them (Figure 11). Interestingly, the
conserved threonine residue present in the CDK T-Ioop, which is where CDK is
phosphorylated and activated by CDK activating kinase (CAK), is substituted with a
serine in K. brevis. Although divergent, this residue can still be phosphorylated and
activated by a potential CAK, yet to be characterized in K. brevis. This sequence has
highest homology to plant CDKC (Arabidopsis, 3e-57) and a green algae CDK (C.
reinhardtii, 2e-51). CDKC was shown not to interact with either mitotic or G 1 cyclins in

the tomato plant (Joubes et aI., 2001), but rather to bind to RNA polymerase and regulate
transcription. A partial alignment of the K. brevis CDKs shows that these CDKs are more
closely related to plant (Arabidopsis), green algae (Chlamydomonas) and as expected
Apicomplexan (Plasmodium) CDKs (Figure 12).

Concentration Dependence of CDK Inhibitor Activity
Since analysis of CDK sequences in the EST library did not identify a candidate
G 1 specific CDK in K. brevis, we sought to gain insight into which (if any) type of CDK
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might be involved in regulating S-phase proteins, using two CDK inhibitors of differing
specificity (Figure 13). In order to investigate the effects of the CDK inhibitors,
olomoucine and fascaplysin, in K. brevis it was first necessary to identify inhibitor
concentrations that were effective in causing a cell cycle block, but were not toxic to the
cells as determined by SYTOX staining (Figure 14). Fascaplysin concentration was tested
from 0.75 - 5 J.lM (Table 2). From this range, a final concentration of 1.5JlM was selected
for further studies since it allowed only 5% of the cell population to proceed through Sphase, without extensive loss of viability (Table 2). Olomoucine concentration was
tested from 6.25 - 50 JlM (Table 3). From this, a final concentration of 12.5 JlM was
selected for further experiments as determined by viability (96%) and the percent of the
cell population blocked in G 1 93.8% at LDTI2.

PCNA Expression Patterns in Flask Cultures
The growth rates of K. brevis cultures grown in 125 ml flasks were found to be
substantially higher (K'= 0.6) than those in the liter bottles used in Chapter 3, and
therefore flasks were used for the subsequent growth phase studies. However, because
the cells were more synchronous, the pattern ofPCNA expression was first established as
compared to bottle cultures. The flask cultures in this study were highly synchronous
with --60% of the cell population in S-phase by LDT12 (Figure 15A). PCNA protein
abundance was investigated at LDT2, 10,12,14,16, and 18. At LDT2 (G1) the 37 kDa
form ofPCNA was already present and more abundant than the 28 kDa form, which
dominated this time point in the bottle cultures (Figure 15B). However, the abundance of
both forms ofPCNA was low. At all other time points, all of which had >50% of cells in
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S-phase (Figure 15A), only the 37 kDa form was present (Figure 15B). Densitometry
shows a decreasing, but variable, trend in the expression levels in LDT 18 replicates
(Figure 15C). This corresponds to the time when the cell populations are beginning to
exit S-phase and is consistent with our previous observations (Figure 15A).

Effects of CDK Inhibition on PCNA Protein Abundance
Once optimal concentrations of olomoucine and fascaplysin were determined, for
both cellular viability and G 1 block, 5 replicate 125mL flask cultures were treated with
12.5 11M olomoucine or DMSO carrier, 1.511M fascaplysin or water carrier, just prior to
LDTO and sampled at LDT12 (mid-S-phase) for viability, cell cycle analysis and protein
abundance ofPCNA. Sampling occurred 12 hours after CDK inhibitor addition when the
cells would normally be in mid-S-phase as shown by the controls. Table 4 shows the
results from the flow cytometry, SYTOX viability staining, and cell counts per mL. Both
fascaplysin and olomoucine addition resulted in the expected G 1 block with only 0.84%
and 2.54%, respectively, of the cell population proceeding through S-phase.
PCNA protein production was absent at LDT12 when cells were treated with
olomoucine and fascaplysin (Figure 16). Interestingly, expression of both the 28 and ---37
kDa forms ofPCNA were blocked. In the untreated controls at LDT12, only the ---37kDa
band was present, as expected for the peak of S-phase in the flask cultures. For
comparison, a protein lysate showing S-phase bands from a lL bottle culture at the same
time point had both 28 and 37 kDa bands observed previously. Fascaplysin blocked the
production of PCNA more effectively than olomoucine (Figure 16A), however both
inhibitors caused a significant reduction in the production of this protein when
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normalized to untreated controls at the same time point (Figure 16B, p<O.OOOl,
ANOVA). These results suggest both that CDK is involved in regulating the increased
expression ofPCNA in S-phase and a CDK with CDK4-like sensitivity to fascaplysin is
present in K. brevis and active at G l/S.

Growth Phase Specificity of PCNA Expression may Provide a Biomarker for Bloom
Status
Because the 37 kDa form ofPCNA appears only during S-phase, it has the
potential to serve as a marker of actively growing blooms of K. brevis that might find
utility in field monitoring for the growth status of Florida red tides. We therefore
compared the expression level of the 37 kDa band at LTD12 in actively growing
populations (0.30 - 0.60 dive /day), slow growing populations (0.04 - 0.20 dive /day), and
populations in stationary phase (0 diVe /day). Growth curves were produced by taking
cell counts every other day and on the day of sampling in order to calculate divisions/day
in each culture at the time of harvest (Figure 6A). Flow cytometry was used to assess cell
cycle distribution in each culture and the percent of cells in S -phase was determined
(Figure 6B). When the western blot band intensity was plotted vs. the percent of cells in
S-phase for each sample, there was a significant linear relationship between the 37 kDa
form of PCNA protein and the percent of cells entering S-phase (Linear correlation,
r2=O.7812, p<O.OOOl; Figure 17), where the log phase cells show expression ofPCNA
that increases with % of cells in S-phase, whereas stationary phase cultures express little
to no PCNA. These results suggest that the expression of this S-phase specific form of
PCNA may be useful as a marker for actively growing blooms.
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DISCUSSION
Potential Post-translational Modifications ofPCNA by SUMO and Ubiquitin

In higher organisms, PCNA undergoes two different post-translational
modifications that regulate its activity in a cell cycle dependent manner, sumoylation and
ubiquitination (Hoege et aI., 2002). Ubiquitin-dependent proteolysis refers to the
conjugation of the ubiquitin polypeptide to a lysine residue on the target protein for
degradation by the 26S proteosome. Conjugation of ubi quitin to the substrate protein is
through a three-step pathway (Sorkin et aI., 2009): the El Ub-activating enzyme forms a
high-energy intermediate with ubiquitin; then the E2 Ub-conjugating enzyme carries the
activated Ub to ligase E3 which is bound to the substrate (Sorokin et aI., 2009); then,
once the protein is presented to the proteosome, deubiquitination occurs by
deubiquitinating enzymes (DUBs) and ubiquitin can be recycled. Substrates can either be
mono- or polyubiquitinated, which can occur via chains or branches and leads to
proteosome degradation. Monoubiquitination is the attachment of one ubiquitin to a
protein (Hicke and Dunn, 2003), does not lead to degradation and can be involved in
multiple processes. Multiubiquitination (multiple monubiquitination of severallysines on
the substrate) leads to protein destruction by the lysosome (Haglund et aI., 2003). There
is precedence for many proteins to be ubiquitinated at different times over the cell cycle,
including the yeast G 1 cyclins, Cln2 and Clin3, yeast CDK inhibitors, Sicl and Farl, the
mammalian G 1 regulators, cyclins D and E, and the mammalian CDK inhibitor p27

Kip1

,

which all require phosphorylation before ubiquitination (Ciechanover et aI., 2000). There
are many other examples of ubi quitin modified substrates that are specific to each phase
of the cell cycle and can be further characterized by non-proteolytic and proteolytic
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ubiquitination (Wickliffe et aI., 2009). Specifically, there is extensive research that has
investigated the ubiquitination ofPCNA. PCNA can be both mono and
polyubiquitinated. PCNA monoubiquitination has been demonstrated in most
eukaryotes, from budding and fission yeasts to human, chicken and Xenopuslaevis egg
extracts, however polyubiquitination ofPCNA has only been clearly detected in the
yeasts and X laevis egg extracts (Ulrich, 2009). PCNA monoubiquitination promotes
translesion DNA repair and polyubiquitination ofPCNA promotes error-free DNA repair
(Hoege et aI., 2002; Gill, 2004). PCNA is also ubiquitinated during normal cell cycle
progression. In yeast, metazoans and mammalian cells, PCNA is degraded during Sphase after it is used to prevent re-replication thus promoting genomic stability. This
process is mediated through CRL4Cdt2 which is an E3 ubiquitin ligase (Abbas and Dutta,
2011).
Sumo

(~mall

ubiquitin-like modifier) post-translational modifications also have a

wide range of effects within the cell (Johnson, 2004). Sumoylation is involved in cell
cycle regulation, transcription, cellular localization, DNA repair, mitochondrial activity,
plasma membrane ion channels, and chromatin organization (Andreou and Tavemarakis,
2009; Hannoun et aI., 2010). Sumo only shares ~ 18% homology with ubiquitin but has a
similar 3-dimenstional structure (Bayer et aI., 1998). Like ubiquitin, sumo modifies
lysine residues of substrate proteins, is expressed in all eukaryotes, and has a
conjugation-deconjugation system that is reversible (Meulmeester and Melchior, 2008).
The sumo polypeptide is somewhat divergent in eukaryotes with variation in protein size
from proteins ----9 - --11 kDa (Andreou and Tavemarakis, 2009; Hannoun et aI., 2010).
The E1 activating and E2 conjugating enzymes involved in sumoylation are highly
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related to those involved in ubiquitination, however there is only one known E2 enzyme,
Ubc9, involved in sumoylation where there are dozens ofE2 enzymes in the ubiquitin
pathway (Gill, 2004). There is a sumo consensus motif found on many sumo substrates
which consists of the sequence 'P-K-X-E, where 'P is a large hydrophobic amino acid and
K is the site of sumo conjugation (Rodriguez et aI., 2001). PCNA has been found to
posses this motif (Ulrich, 2009) and PCNA sumoylation takes place during S-phase or
after high doses of DNA damage (Hoege et aI., 2002). Sumoylation ofPCNA is thought
to prevent deleterious hyper-recombination during normal replication and lack of
sumoylation causes increased spontaneous sister chromatid recombination during mitotic
growth (Pfander et aI., 2005). PCNA can undergo polysumoylation in yeast, however the
function and importance of this modification is currently unclear (Parker et aI., 2008;
Windecker and Ulrich, 2008).
Sequence analysis shows that one subunit of K. brevis PCNA codes for a protein
of --28kDa. There are no sequences in the cDNA library that appear to code for a protein
with a longer amino acid sequence. Therefore, we hypothesized that the 37 and 47 kDa
forms ofPCNA may be post-translationally modified forms ofPCNA. In eukaryotic
cells, PCNA is ubiquitinated in response to DNA damage, promoting the bypass of
replication-blocking lesions (Hoege et aI., 2002; Stelter and Ulrich, 2003; Kannouche et
aI., 2004). In S. cerevisiae, PCNA becomes sumoylated in a damage-independent
manner during S-phase, preventing unscheduled recombination events (Pfander et la.,
2005). Sumo and ubiquitin can also coexist on a single PCNA subunit in yeast
(Windecker and Ulrich, 2008). In this study, we identified both the ubiquitin and sumo
polypeptides in K. brevis, as well as many genes involved in the ubiquitin and ubiquitin141

like systems, including ubiquitin precursors (polyubiquitins), ubiquitin-conjugating and
ligating enzymes, as well as members of the 26S proteosome and a sumo-activating
enzyme (Appendix 2), providing strong evidence that both of these post-translational
modification systems exist in this dinoflagellate. Based on sequence analysis, the K.
brevis ubiquitin sequence encodes a polypeptide of 8.5kDa, typical to other eukaryotes,

and sumo for 9kDa, somewhat smaller than the typical 10 - 11kDa. By western blot,
ubiquitin was somewhat smaller than expected, --- 6kDa; however this discrepancy in
molecular weight on acrylamide gels is similar to what is observed in other organisms
(Ott et aI., 1998). The sumo polypeptide migrated somewhat larger than expected at '" 17
kDa but again free sumo has been shown to migrate at '" 17kDa in Xenopus (Wang et aI.,
2009) and ~15kDa in Arabidopsis (Colby et aI., 2006), while their sequences predict 10.7
- 11.7kD and 11 - 12 kDa, respectively. This appears to be common in analysis of sumo
proteins by western blotting as all known sumo proteins are ~ 100 amino acids long but
have aberrant sizes when run on gels. For example, in human cancer cells (hep2 cells)
sumo 1 migrates above 16.5 kDa, however the amino acid sequence codes for 11.6 kDa
(Bailey and O'Hare, 2005)._Similarly, the human recombinant sumo 1,2 and 3 run as
standards in the current study all migrate at approximately ---14kDa, somewhat smaller
than the K. brevis sumo, but larger than their predicted sizes from sequence analysis (10.8
- 11.6 kDa).
Once it was determined that the sumo and ubiquitin polypeptides were present
and highly conserved in K. brevis, the PCNA sequence was analyzed using a
bioinformatic approach to investigate whether there were conserved lysine residues or
motifs within PCNA where these modifications could occur. When the K. brevis PCNA
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sequence was analyzed using UbPred, a ubiquitination prediction program (Radivojac et
aI., 2009), three lysines were recognized as possible sites of ubiquitination with medium
confidence (Figure 2). The sites identified included K184, K190 and K194, which do not
correspond with the site ofPCNA ubiquitination (K164) in most eukaryotes (Shaheen et
aI., 2010). A lysine residue is found in the K. brevis PCNA (at K165) and aligns with this
site in all other eukaryotes, but is found within the amino acid context SKEG. The
program used for this analysis was developed and trained on a combined set of 266 nonredundant experimentally verified ubiquitination using experimental proteomic data from
S. cerevisiae (Hitchcock et aI., 2003 and Peng et aI., 2003) and known ubiquitination sites
involved in human disease from GenBank searches. Therefore, this program may not be
the best predictor for dinoflagellate sequences which appear to be divergent in many
respects from model eukaryotes for which large scale datasets are available. Ubiquitin
biding domains are structurally diverseare found in proteins that contain a variety of
structural features and diverse biological functions (Hicke et aI., 2005). SUMOsp (Ren et
aI., 2009) was also used to identify potential sumoylation sites on K. brevis PCNA. The
sites ofPCNA sumoylation are not as well characterized as those of ubi quitin at ion and do
not appear to be as conserved. Two potential sites of sumoylation were identified in K.

brevis PCNA (Figure 2) including K190 (DKPEE) with medium confidence, which is a
non-consensus site and K238 (VKYE) with high confidence, which is within a wellcharacterized sumoylation motif ('P-K-X-E) found in other organisms. Interestingly,
when PCNAs from other organisms were analyzed, SUMOsp also predicted that K190
would be sumoylated in H. sapiens and C. reinhardtii. However, the K238 sumoylation
site appears to be unique to dinoflagellate PCN A, as this residue and its amino acid
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context present in K. brevis is also found in Pyrocystis lunula (Okamoto and Hastings,

2003), Pfiesteria piscicida (Zhang et aI., 2006), Prorocentrum donghaiense (Zhao et aI.,
2009) as well as Alexandrium catenella (Sui et aI., 2008, unpublished from GenBank),

Karenia mikimotoi and Peridiniumfolicaceum (Hou et aI., 2009, unpublished from
GenBank).
Based on sequence analysis of potential PCNA post-translational modification
sites and the dynamics ofPCNA over the cell cycle, it appears likely that K. brevis PCNA
is modified by sumo and ubiquitin. Immunoprecipitation with anti-PCNA was
inconsistent, but revealed both the 28 and 37 kDa forms, as well as bands at 47kDa and
above 62kDa. We had not previously observed the ---62 kDa band. However, since
PCNA can be both polyubiquitinated and polysumoylated (Shaheen et aI., 2010;
Windecker and Ulrich, 2008) this higher band could be due to one of these processes.
When a PCNA immunoprecipitate was probed with anti-SUMO, a band that appeared at
----47kDa. This was higher than expected, based on a 9 kDa SUMO addition; however this
band was also visibly in an S-phase whole cell lysate run in parallel and probed with antiSUMO. When this blot was stripped of the sumo antibody and probed with the antiPCNA antibody, the same band appeared, lending further evidence to that hypothesis that
this represents sumoylated PCNA. Probing PCNA immunoprecipitates with antiubiquitin was uninformative, due to inconsistency in the immunoprecipitation method to
even yield PCNA bands. However, the comparison of ubi quitin patterns with PCNA
patterns over the growth curve in K. brevis identifies a ---47 kDa band that co-migrates
with the 47 kDa band recognized by anti-PCNA. Thisis an interesting result that should
be further investigated to determine how ubiquitination is changing over the cell cycle. It
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is expected as a cell population ages and no longer needs certain proteins for cellular
processes, such as DNA replication, they would be degraded by the ubiquitiniproteosome
system.
The transition from G 1 to S-phase is a critical point when cells activate a division
program, commit to duplicate the genome and proceed to divide (Gutierrez et aI., 2002).
For this transition to occur, cells must pass the restriction point (RP) at some time during
G 1 when growth factors or mitogens are optimal to ensure successful genome

duplication. Passage through the RP, also termed the G 1 checkpoint or START in yeast,
prior to the G l/S transition regulates entry into the cell cycle and subsequent DNA
replication. Cyclin dependent kinase controls the passage through the RP. Although it
appears that the dark to light transition is what entrains cell cycle entry in K. brevis to the
photoperiod, this "zeitgeber" is not precisely equivalent to the RP since cells continue to
cycle in continuous light.In the green alga, Chlamydomonasreinhardtii, a light dependent
commitment point (restriction point) occurs in G 1 (Zachleder and Van Den Ende, 1992).
In contrast to C. reinhardtii, in Euglena, light-dependent commitment points also occur
post-G 1, although their biochemical equivalency to a restriction point is uncertain
(Hagiwara et aI., 2001). The results in Chapter 3 suggest that the restriction point in K.

brevis occurs prior to LDT2, since PCNA positive cells are present by that time.
However, the molecular constituents of the restriction point have yet to be defined in
dinoflagellates. The results presented in this chapter show that there is most likely a
CDK4-like CDK involved in the G liS restriction point in K. brevis since blocking CDK
with fascaplysin in G 1 prevents S-phase entry and PCNA production.
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Cyclin-dependent protein kinases (CDKs) are a large family of serine/threonine
kinases.Certain members of the CDK family regulate the cell cycle while others function
in different cellular processes such as central regulators of transcription (Morgan, 1997;
Liu and Kipreos, 2000). The CDKs involved in cell cycle regulation have cyclin partners
to which they bind and these complexes act as the main drivers of the eukaryotic cell
cycle. The activity of CDK is regulated by multiple mechanisms which include cyclin
association, specific phosphorylations and dephosphorylations and interactions with CDK
inhibitors (CDKls) (Sherr, 1996; Sherr et aI., 1999; Keiichi and Nakayam, 2005).
Throughout the cell cycle, cyclins and CDKIs oscillate due to proteolysis (Murray, 2004)
and it is the ubiquitin-proteosome pathway that mediates the degradation of these
regulatory proteins (Weissman, 2001; Pickart, 2004). In model eukaryotes such as
mammals, when the restriction point is reached, the CDK4/6/cyclin D complex
phosphorylates the retinoblastoma protein (pRb) during early G 1 which leads to the
activation of E2Fs, a family of cell cycle regulatory transcription factors that activate
transcription of S-phase genes (Cam and Dynlacht, 2003). The E2F transcription factor
family is comprised of 8 members (Singh et aI., 2020). E2Fs 1, 2 and 3 interact with pRb
and have a strong transcriptional activation domain (Slansky and Farnham, 1996). E2Fs
4 and 5 have little or no transcriptional activity and E2Fs 6-8 do not bind pRb and are
used to repress transcription by recruitment of transcriptional co-repressors (Frolov and
Dyson, 2004; DeGregori and Johnson, 2006). E2Fl, 2 and 3 can strongly induce S-phase
entry and their activity is necessary for the induction of many genes required for S-phase
progression. pRb inhibits cell cycle progression by repressing the transcriptional activity
ofE2Fs and their target genes (Dimova and Dyson, 2005). E2Fs are absent from
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Apicomlexans and to date, no E2Fs have been identified in dinoflagellates. Therefore,
the activation of cell cycle proteins must be occurring through an alternative method.
The K. brevis CDK sequences appear to be divergent from the well-studied yeast
and mammalian CDKs and cyclins. In yeasts, there is one CDK that drives the cell cycle,
Cdc2 in S. pombe and CDC28 in S. cerevisiae (Simanis et aI., 1987). A plant homolog of
the CDK cdc2 was first identified in Chlamydomonas and wheat (Pisumsativum)
followed by numerous other plant species (Francis, 2007). There are seven classes of
plant CDKs: A-G of which the CDK As, Bs, D and Fs are involved in cell cycle control
(Umeda et aI., 2005; Francis, 2007). Table 1 shows that the K. brevis CDKs appear to be
closely related to plant CDK C (Arabidopsis and Oryza) as well as protist CDK7

(Cryptosporidium). Many examples ofCDKs and cyclins have been found in protists
such Leishmania mexicana (Hassan et aI., 1997), Toxoplasma gondii (Kvaal et aI., 2002;
Khan et aI., 2002), PlasmodiumJalciparum(Le Roch et aI., 2002) and Trypanosoma

brucei (Ellis et aI., 2004). In L. mexicana, one CDK (or CRK, cyclin-dependent related
kinase) has been characterized that is a homolog ofcdc2 which is human CDKI (Gomes
et aI., 2010). This same study purified and expressed 7 putative recombinant CRKs from

L. major. Two putative isoforms of a cdc2-related protein have been identified in T.
gondii (Donald et aI., 2005). InT. brucei, 8 CRKs have been identified that appear to
have different functions over the cell cycle (Gourguechon and Wang, 2009). The CDKs,
cyclins, and a CDK effector protein in P. Jalciparum were identified using homologybased peR and database mining approaches (Doerig et aI., 2008). It was recently found
that a Plasmodium CDK (Pfmrk) binds to an effector protein PfMATl, a putative CDK
activating kinase, which activates Pfmrk and this complex co-localizes to the nucleus and
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regulates DNA synthesis (Jirage et aI., 2010). Phylogenetic analysis ofCDK sequences
from members of the protist groups Giardia, Trypanosoma and several from Plasmodium
showed that these CDKs do not strongly associate with any established CDK family and
it is suggested that although they are orthologs of defined CDK groups, they have
diverged to the point that they are not recognizable using sequence-based phylogenetic
methods (Guo and Stiller, 2004). A cdc2-related kinase in T. brucei was shown to have a
"PQTALRE" motif (Ellis et aI., 2004) and in P. Jalciparum, the CDK-related kinase
PtPK6 possesses a SKCILRE motif (Bracchi-Ricard et aI., 2000). Therefore, protist
CDKs appear to be divergent from metazoan CDKs, although functional conservation
exists throughout eukaryotes.
The divergence of dinoflagellate CDKlcyclins may not be suspiring based on their
unusual cell cycle. The Apicomplexan Plasmodium, possesses 6 CDK-like kinases that
are divergent from the typical eukaryotic CDKs and to date only 3 of these have shown
cyclin-dependent activity in vitro (Doerig et aI, 2002). CDKs have been identified in a
limited number of other marine phytoplankton. In the diatoms Thalassiosira pseudonana
and Phaeodactylum tricornutum, large scale data mining of their recently sequenced
genomes identified multiple key cell cycle regulators such as CDKs, CDK interactors and
cyclins (Huysman et aI., 2010). Five CDKs were identified in P. tricornutum and it
appears that both of these algal species have novel components including diatom-specific
cyclins. Similarly, a dinoflagellate CDK5-like protein has been characterized from in
Lingulodinium polyedrumby protein microsequencing and phylogenetic

analysis(Bertomeu et aI., 2007) and still leaves the question of CDK control of S-phase
entry in dinoflagellates unanswered. CDK5 in metazoans is involved in neuronal
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development (Lalioti et aI., 2010). This dinoflagellate CDK5-like kinase was shown to
react with an anti-PSTAIRE antibody. The PSTAIRE motif is the conserved cyclin
binding motif on CDKs. Thus, this CDK would appear to be involved in the cell cycle.
The K. brevis full length CDK sequence has highest homology to the plant CDKC, not
mammalian CDK5, and has a motif (PLTAIEK) that aligns with the cyclin binding
domain of plants (Arabidopsis), other algae (Chlamydomonas) and other protists
(Plasmodium). However, this CDK sequence has conserved ATP binding residues and

the CDKI studies show that there are G 1 CDK homologs in K. brevis.
The cyclin partners ofCDKs are equally poorly characterized in dinoflagellates.
Cyclins were originally identified because their abundance changed over the cell cycle
(Murray, 2004). Cyclins bind to CDKs through the PSTAIRE motif on CDKs, and these
binding motifs appear to be divergent as CDK sequence and function diverge within and
between organisms. This is shown in this Chapter with the K. brevis eye lin binding
domain diverging from the other motifs (Figures 11 and 12). In kinetoplastids, the CDKrelated kinases show the expected biochemical interactions of CDKs and interact with
cyclins; however, the PSTAIRE motif is degenerate (Ellis et aI., 2004). A mitotic cyclin
homolog was identified in the dinoflagellate L. polyedrum through construction of a
cDNA library, followed by PCR and confinned by functional complementation assays in
yeast to act as a mitotic cyclin (Bertomeu and Morse, 2004). Cyclin B homologs have
been identified in both K. brevis (Barbier et aI., 2003) and Crypthecodinium
cohnii(Barbier et aI., 1998) by immunoreactivity with a yeast cyclin B antibody. The

identification of G I-specific CD Ks and cyclins in dinoflagellates will require additional
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sequencing and in particular, obtaining full length sequences that are currently largely
missing in EST collections.

CDK Inhibition
Since we still lack information on G I-specific CDKs or cyclins in dinoflagellates,
in order to begin to investigate how S-phase genes may be modulated in the absence of
transcriptional control, we investigated if their expression is dependent on CDK activity.
To provide discrimination between CDK classes we employed both the broad inhibitor
olomoucine and the CDK4-specific inhibitor fascaplysin in G 1 to inhibit CDK activity.
Both CDK inhibitors prevented progression into S-phase and expression of the 37 kDa
form ofPCNA when added to cells at the dark to light transition (LDTO). The
olomoucine results show that there is most likely a CDK 1,2, 4 and/or 6 functional
homolog involved in the G I/S transition. The G 1 specific block produced by fascaplysin
points to the involvement of a CDK4-like protein in the G I/S transition. To inhibit
CDK4, fascaplysin binds in the ATP binding pocket ofCDK4 by interacting through a
bidentate (having two atoms from which electrons can be donated) hydrogen bond
donor/acceptor pair, forming one hydrogen bond with the NH backbone ofVa196 via the
carbonyl offascaplysin and Nl of the adenine ring (Soni et aI., 2000). The inhibitory
action of fascaplysin is dependent on CDK4 being bound to its cyclin partner with an
IC so of 0.35 JlM in mammalian cells (Huwe et aI., 2003). The specificity of fascaplysin to
bind to CDK4 as opposed to CDK2 or CDK6 is based on the differences in structure.
CDK4 has an acidic residue (EI44) where CDK2 has a neutral residue (QI31) and a
neutral residue in CDK4 (T 102) is substituted for the positively charged K89 in CDK2,
leading to a two-unit increase in the formal charge of the A TP biding pocket of CDK2
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relative to CDK4 which renders a more favorable electrostatic energy with CDK4
(Mcinnes et aI., 2004). Among mammalian CDKs there is strong sequence homology
between the catalytic domains where A TP binds suggesting similar three-dimensional
structure (Gray et aI., 1999). Interestingly, most of these residues are conserved among
the CDKs within a species, for example in CDKs 1-9 in humans (Gray et aI., 1999), and
many are conserved even in K. brevis, C. rein hardtii, a diatom and two plant species
(Figure 11).
Although, these results do not indicate a direct link between CDK and S-phase
protein expression, they do suggest some CDK dependent pathway responsible for the
translation ofPCNA in absence of transcriptional regulation. In Arabidopsis, CDKA,the
plant cdc2 homolog active in G 1, has been found to interact with elF4a translation factor
which suggests a direct link between the cell cycle and the regulation of translation
(Hutchins et aI., 2004). This interaction is abundant in actively proliferating Arabidopsis
cells and absent from cells that are not dividing. CDKI phosphorylation of the eIF-4E
binding proteins (4 E-BP 1) during mitosis releases elF 4 allowing translation to occur in
HeLa (cervical cancer) cells (Heesom et aI., 2001), which is another example ofCDK
controlled cell cycle progression involving translation control. In K. brevis it may be that
G 1 CDKs are also interacting with the translational machinery to regulate progression of
the cell cycle. Interestingly, no CDKls, such as p2l, p27 or p57, have been identified in
K. brevis, which are responsible for preventing the initiation of DNA replication

(Furstenthal et aI., 2001). CDKls, such as members of the CIP and KIP families, have
also not been identified in other protists including Plasmodium (Doerig et aI., 2002) or
diatoms (Huysman et aI., 2010) and it has been suggested that their sequences may be too
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divergent to allow their identification by homology searches. Clarification of the
mechanisms by which CDK regulate S-phase proteins in dinoflagellates first requires the
identification of the CDKs active at Gl/S. The current study suggests a protein with
CDK4-like activity will be involved.
Growth Rate Specific PCNA

Because of its association with cell proliferation, PCNA has been used for
prognosis of tumor and cancer development (Lee et aI., 1995) and has the potential for
studying growth in phytoplankton. Examination ofPCNA at short increments over Sphase in K. brevis showed that the --37 kDa form is quite abundant throughout DNA
replication during log phase growth (Figure 15). It was expected that the lower band of
28 kDa would be present at LDT2, at which time it was barely visible, and the 37 kDa
band would gradually increase and dissipate over S-phase. However, due to the high
synchronicity of these cultures, if there is a mechanism producing this higher band of
PCNA such as a post-translational modification, most cells may be utilizing this
physiological response. In the dinoflagellate P. do ngha iense, PCNA remained at a high
level during exponential growth and decreased when cultures entered late stationary
phase (Liu et aI., 2005). In another algal protist, the coccolithophore
Pleurochrysiscarterae, a 36 kDa PCNA homolog was shown to have higher abundance

during the exponential growth phase and was diminished in the stationary growth phase
(Lin and Corstjens, 2002).
In the dinoflagellate Pfiesteria piscicida, PCNA was found to be more abundant
in the exponential growth phase compared to stationary phase based on western blot
analysis (Zhang et aI., 2006). Therefore, in this study PCNA protein expression was
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investigated over the growth curve in K. brevisto determine whether PCNA expression
decreases predictably as cells proceed from log into stationary phase. Surprisingly, we
repeatably found a higher molecular weight band of --47 kDa cross-reactive with the
PCNA antibody only in late stationary phase cultures on the cusp of decline. With
further development, we propose that this may lend itself to a marker of terminating
blooms. In order to confirm the results, Day 6 (log phase) S-phase cultures were
compared to Day 12 (stationary phase) S-phase cultures, and it was found that the 37kDa
was prevalent in log phase and absent in the stationary phase cultures (Figure 8). This
suggests that PCNA in stationary phase cultures could be marked for degradation when
the cell no longer needs this protein for proliferation, possibly by ubiquitination.

Potential Utility of PCNA as a Biomarker for Harmful Algal Bloom Monitoring
The comparison of PCNA abundance in log and stationary phase cultures and
cultures with decreased growth rate provided insight into whether PCNA might be useful
as a biomarker for growth. PCNA expression levels were compared in log phase cells at
different growth rates in order to determine if a linear relationship exists between S-phase
progression and PCNA expression levels. We found significant linear correlation
between percent of the cell population in S-phase and expression of the 37 kDa form of
PCNA. The 37kDa band was prominent in cultures sampled during S-phase (LDTI2) on
Day 6, mid-log phase of growth. In stationary phase cultures (Day 12)sampled at the
exact same time (LDTI2), this band is completely absent.The neutral density samples
provide important information in that they have reduced growth rate and when sampled at
the typical log phase time point, there is decreased production of the PCNA protein.
Therefore, this growth pattern along with the differences in PCNA abundance may be
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indicative of the growth state and be informative of the phase of K. brevis bloom
progression. Indeed, the linear correlation analysis did show a significant relationship
between the 37kDa PCNA protein abundance and the percentage of the cell population in
S-phase of the cell cycle (Figure 17). Therefore not only does the 37kDa PCNA have the
potential for use as a biomarker of actively growing blooms; the 47kDa may be useful as
well in identifying bloom termination since this protein only appears in dyeing cultures.
It will be interesting to test the utility of these potential biomarkers and their relationship
to bloom progression in the field. Field populations have been shown to have cell cycle
behavior similar to those of laboratory cultures with all bloom patches tested proceeding
through a circadian regulated G 1, S-phase and G2/Mitosis in a tightly phased and
uniform manner (Van Dolah et aI., 2008). Also similar to laboratory cultures, there is
variation in the percent of the cell population that proceeds through the cell cycle on any
given day. Based on these similarities between field populations and laboratory cultures,
testing ofPCNA protein levels at LDT12-14 could provide predictive information on
growth phase of a bloom. Currently, measurements of in situ growth rates of blooms
require either repeated analysis by flow cytometry to determine the fraction of cells
dividing over the course of a 24 h period, or 24 h 14C uptake measurements as proxies of
growth. The former method requires a research vessel to stay on a bloom patch well into
the night, making it infeasible for routine monitoring. The latter method both requires
radioactivity and artificially manipulates the sample, thereby introducing error in the
measurement. With currents, weather and other physical oceanographic conditions, the
results will most likely be different from that in a controlled laboratory setting.
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Notwithstanding, these studies, for the first time, provide a potential protein biomarker
for growth in K. brevisthat may be sampled during mid-day, when cells are in S-phase.

CONCLUSIONS
The studies presented in this Chapter provide information on how S-phase gene
expression may be regulated in an organism that displays post-transcriptional control of
its cell cycle. Although the analysis of CDK contigs present in the K. brevis library did
not identify a candidate G 1 CDK, the inhibition of S-phase entry by fascaplysin provides
evidence for a CDK4-like kinase in this transition in K. brevis. The PCNA protein
decreased under CDKI treatment. Whether CDK is directly or indirectly interacting with
these DNA replication proteins, in the absence of transcriptional control, begs further
investigation. Additionally, there appears to be post-translational modifications of PCNA
occurring not only over the cell cycle, but over the growth curve as well. Evidence is
provided here for the potential sumoylation and ubiquitination ofPCNA over the cell
cycle (sumoylation) and over the growth curve (ubiquitination). These post-translational
modifications have been shown to be highly conserved across eukaryotes. Sumoylation
is thought to be involved in genomic stability. The prevalence of this form ofPCNA in

K. brevis may reflect the necessity for genome stability due to its unusually large
genome, especially during DNA replication. Post-translational modification may be one
level this unusual eukaryote is regulating cellular processes. These studies provide the
first information on post-translational modifications in dinoflagellates. This level of
protein regulation may be a very important system in K. brevis and other protists. The
results presented in this chapter provide information necessary to determine the level
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(translational or post-translational) at which to develop biomarkers for bloom
progressIon.
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Figure 1: Multiple alignments of (A) the SUMO polypeptide and (B) ubiquitin. Outlined
are the conserved G-G motifs that are involved in lysine conjugation on the substrate
protein.
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Figure 2: K. brevis PCNA amino acid sequence used for analysis (A) DNA polymerase
binding site (B) Conserved Ubiquitin and SUMO binding lysine residue in S. cerevisiae
(C) RFC binding site. Boxed in red are the predicted ubiquitin binding lysine residues by
the UbPred program and in green are the sumoylated lysine residues as predicted by the
SUMOsp program.
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Figure 3: (A) The ubiquitin protein in K. brevis at LDT 2, 10, 12, 14, 16 and 18. (B) The
sumo protein in K. brevis. The first 3 lanes are K. brevis protein extracts from LDT2
(G1), LDT12 (S-phase) and LDT18 (G2/M). Lanes 4,5 and 6 are human recombinant
sumo1, 2 and 3, respectively. Ten micrograms of K. brevis protein extract were loaded in
each well and five micrograms of recombinant SUMO proteins were loaded.
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Figure 4: Immunoprecipitation using the PCNA antibody to obtain all forms ofPCNA.
The blot was probed for Western blotting with the same antibody used for
immunoprecipitation. The left lane is negative control (no protein lysate) which shows a
faint band at 50kDa, representing the heavy chain of the antibody. The right lane shows
immunoprecipitated forms ofPCNA.
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Figure 5: (A) Immunoprecipitation using the PCNA antibody to obtain all forms of
PCNA. The blot was probed for Western blotting with anti-sumo. Lane 1:
Immunoprecipitation of PCNA showing a possible sumoylated form just above 38kDa.
Lane 2: Negative control of no protein lysate showing just the heavy (50kDa) and light
(25kDa) chains form the antibody. Lane 3: Protein lysate from LDT14 showing
components of the sumo pathway/sumo substrates. (B) Blot (A) stripped and probed with
PCNA. The left lane is the immunoprecipitated PCNA that is putatively sumoylated and
right lane is the negative control.
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162

(A)
kDa

06 08 010 012

06 08 010 012

06 08 010 012

06 08 010 012

06 08 010 012

6249382817-

14-

(C)

(8)

E
0;;;
s::

"G)

(I)
G)

o ::J

~(ij

«>

"1U

L-

20

G)

C

0

aG)

6

8

Ii 10

Time (Day)

t'G

40

~>

30

E

20

0>

10

-

30

10

50
(I)
G)

~.2

40

L-

60

Cl

50

0

Cl

>-

0;;;
s::
G)

60

G)

G)

-

-37kDaPCNA

~

:>

«

-47kDa PCNA

70

0

am
6

-8

~
10

12

Time (Day)

12

p=0.1 079, ANOVA

p=0.1886, ANOVA
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Figure 8: PCNA in log and stationary phase cultures. (A) Western blots ofPCNA
in flask cultures showing the ---37kDa band. During log phase at LDTI2.Flow
cytometry data shows that 55.74% of the log phase cell population was
proceeding through S-phase at LDT 12. (B) Western blots data showing a PCNA
of ---45 kDa at LDT 12 in stationary phase cultures. PL=protein lysate from a log
phase culture at LDT 12 showing S-phase bands. (C) Peptide competition assay
showing the specificity of the ---47kDa form ofPCNA. Left panel is western blot
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showing aLDT12 protein lysate from Day 14 (late stationary) and log phase
cultures. Right panel is western blot with antibody incubated in the presence of
the peptide antigen to block specificity. PL=protein lysate from a log phase flask
culture at LDT12 showing absence of S-phase bands.
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Figure 9: Pattern of ubi quitination in K. brevis matches the presence of the hypothesized
ubiquitinated PCNA in biological replicates over the growth curve. (A) Western blot with
anti-ubiquitin antibody showing the putative ubiquitin pathway components and
substrates in Day 10 and 12 samples. (B) Western blot ofPCNA over the growth curve in
two sets of biological replicates. Kb 9, 20, 19 and 7 refer to the same lL biological
replicate cultures. Highlighted in red is the culture (one biological replicate) which is
beyond stationary phase and according to cell counts has cell death occurring.
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Figure 10: Full length sequence of a cyclin-dependent kinase in K. brevis. The presence
of the spliced leader at the 5' end of the sequence is shown in the box, as well as the ATG
start codon and the poly A tail at the 3' end.
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Figure 11: Amino acid sequence of K. brevis CDK. This sequence has highest homology
to the plant CDKCs found in O. sativa, S. lycopersicum, as well as the diatom CDK from

T. psuedonana and the green alga, C. reinhardtii. Shown in the black box is the cyclin
binding domain present in CDKs. The red box highlights the residue that is
phosphorylated, in the T -loop of CDKs, which in tum activates the CDK. The asterisks
(*) represent the residues that are involved in ATP binding and that are conserved in this

K. brevis CDK.
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Figure 12: Partial alignment of K. brevis cyclin dependent kinases (CDKs) and CDK 7
from Plasmodiumfalciparum, CDK C from Arabidopsis thaliana, and a CDK from

Chalmydomonas reinhardtii. Boxed region shows the conserved cyclin binding motif that
characterizes CDKs.
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Figure 13: Cyclin-dependent kinase inhibitors used for the CDKI studies. (A)
Olomoucine, shown to inhibit CDKs 1,2 and 5, (B) Fascaplysin, a CDK4-specific
inhibitor.
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(B)
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Figure 14: SYTOX staining of K. brevis showing (A) live cells with no nuclear staining
and (B) a dead cell with decreased chloroplast autofluorescence and stained nuclei.
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Figure 15: PCNA abundance throughout S-phase. (A) Flow cytometry data showing
---60% of the cell population proceeding through S-phase between LDT12 and 14. (B)
Western blot analysis of PCNA throughout S-phase where the 28kDa PCNA is only
present in a small amount at LDT2. A long exposure was necessary for this band to
appear. (C) Densitometry of the ---37kDa band shows a higher significant difference
between LDT2 and all other S-phase time points.
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Figure 16: PCNA protein abundance at LDT12 after inhibition with CDKls. "S-phase
bands" refers to the positive control for both forms of PCNA from a 1 liter culture. (A)
Western blot analysis. (B) Densitometry of the 5 replicates when normalized to the
control.
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Table 1: Sequences from K. brevis with homology to cyclin dependent kinases. Shown
are the top hit organisms and the e-values.
Marine Genomics 10

Protein

108857
2031566
105637
2033180

cyclin dependent kinase C
cell cycle-related kinase
cyclin-dependent kinase-related kinase
cycl i n-dependent ki nase-rel ated ki nase

2031949

cyclin-dependent kinase 1; p34cdc2

107238

cyclin G associated kinase

2079904

cdc2
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Species

EValue

Arabidopsis Iyrata
Esoxlucius
Cryptosporidium hominis
C. hominis

3.00E-57
5.00E-22
1E-53
6.16E-66

Dunaliella tertio/ecta
80s taurus

3.00E-09

DrosoDhiia me/anoaaster

3.00E-08

4E-29

Table 2: Fascaplysin range finder study results. The concentration determined to induce
the highest percent G 1 block with the highest viability and best reproducibility was
1.5JlM.

%G2/M %Viability

%Gl

%S

Control

39.40

60.60

0.00

95.5

H,O

40.30

59.53

0.17

98

Fascaplysin SIlM

90.40

0.27

9.37

84.5

Fascaplysin 2.SIlM

95.50

1.00

3.53

37

Fascaplysin 1.SIlM

92.17

5.00

2.83

80.4

Fascaplysin 0.7SIlM

75.73

21.83

2.40

68
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Table 3: Olomoucine range finder study results. The concentration determined to induce
the highest percent G 1 block with highest viability and the best reproducibility was

12.5I1M.

%Gl

%S

%G2/M

%Viability

51

48.85

0.15

100

Olomoucine 50J.l,M

97.8

0

2.2

86

DMSO (37.25 J.l,L)

79.6

16.1

4.35

95

Olomoucine 25J.1,M

98.5

0

1.5

92

Olomoucine 12.5J1M

93.8

0.47

5.73

96

DMSO (9.3125 J.l,L)

26.5

68.05

5.5

96

Olomoucine 6.25J.1,M

83.97

13.5

2.5

93.5

DMSO (4.656 ~LJ

44.35

55.3

0.35

92

Control

177

Table 4: Flow cytometry of K. brevis cell populations at LDT12 after inhibition with the
CDKIs, olomoucine or fascaplysin,for 12 hours. Percent viability refers to percent of the
cell population viable after a 12 hour exposure to the CDKIs as determined by SYTOX
staining. Samples from this study were used for protein abundance analysis.

Control

H,O
Fascaplysin 1.51lM

DMSO
Olomoucine 12.51lM

%Gl
39.6
41.94
95.84
58.78
94.84

%S
%G2/M %Viability Cell Counts (Ave. celis/mLl
55.54
4.86
96.8
15,206
54.34
3.76
15,675
98.6
0.84
3.32
15,917
80
1.62
39.58
15,354
98.6
2.54
2.64
13,369
99

178

Chapter 5: Conclusions, Significance and Future Directions
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The studies presented in this dissertation were undertaken to gain better
understanding of processes that regulate the cell division cycle in the dinoflagellate K.

brevis. K. brevis is responsible for toxic red tides that occur almost annually in the Gulf
of Mexico that cause marine animal mortalities, human illness and economic loss by
impacting fisheries and tourism. The study of growth in this organism will lead to better
understanding of processes driving bloom formation and the development of field
biomarkers for assessing bloom status that will improve modeling and mitigation efforts.
Since growth in blooms results primarily from vegetative cell division, processes
regulating the cell cycle are central to bloom growth. The cell cycle of dinoflagellates has
been studied for many decades (Sweeney and Hastings, 1958; Olsen and Chisholm, 1986;
Homma and Hastings, 1989; Roenneberg, 1996; Taroncher-Oldenburg, 1997; Van Dolah
and Leighfield, 1999; Leighfield and Van Dolah, 2001, Litaker et aI., 2002; DagenaisBellefuielle et aI., 2008). However this has mostly been investigated in terms of cellular
physiology and only in the past decade with the development of genomics tools has the
molecular biology of these organisms begun to be elucidated.
Dinoflagellates are a unique group of organisms in which to study cell cycle
based on their position in the tree of life and many novel adaptations found only in this
group of primitive, unicellular eukaryotes. The diversity of cellular and molecular
systems in microbial eukaryotes is staggering, and some emerging patterns are indicative
of convergent evolution which appears to have played a major role in shaping the overall
organization of eukaryotic cells at all levels (Lukes et aI., 2009). Dinoflagellates have
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acquired photosynthesis through secondary (and in the case of K. brevis, tertiary)
endosymbiotic events and through these evolutionary events, have obtained 3 genomes
(nuclear, chloroplastic and mitochondrial (Keeling, 2009). Dinoflagellates deviate from
the canonical view of gene expression, and the central dogma, in that they use transsplicing and have polycistronic messages which are unlike prokaryotic polycistronic
messages in that they seem to contain tandemly repeated copies of the same gene (Zhang
et aI., 2007, Lidie and Van Dolah, 2007, Bachvaroffand Place, 2008; reviewed in Lukes
et aI., 2009). These characteristics are missing from their nearest neighbors, the
apicomplexans and ciliates, and thus appear to be a secondarily evolved state.
Kinetoplastids, such as the parasitic Trypansoma, also possess these unusual molecular
biological characteristics, which are absent from their evolutionary neighbors the
Euglenids, although they are separated from dinoflagellates by more than 900 million
years. As parasites, trypanosomes have to deal with stressful transitions between
environments found in different host species in which these organisms have different life
stages. It is unclear what conditions have driven their convergent evolution, but both
trans-splicing and polycistronic messages appear to confer adaptive advantage to
dinoflagellates and kinetoplastids despite their different life styles.
The overarching objective of this project was to determine how K. brevis
regulates its cell cycle in the absence of transcriptional control of gene expression. As
the cell cycle is one of many processes tightly coupled to the photoperiod, this project
first investigated diel patterns of protein expression in K. brevis. Unlike the dinoflagellate

L. polyedrum,which has been shown to have a circadian rhythm of translation where
translation takes place only during the night, we determined that in K. brevis there does
181

not appear to be circadian regulation of global protein synthesis, and therefore we might
expect to see cell cycle proteins synthesized at times corresponding to the cell cycle
phases in which they are needed. Proteomic analysis using DIGE found only 4% of the
--500 proteins resolved from total cellular protein to be changing in expression over the
diel cycle, and these changes followed varying patterns that would appear to correspond
with their needs, rather than a bulk turnover during the dark as suggested by the studies in

L. polyedrum. Because whole cell protein extracts resolved only the highest expressed
proteins in the cell, subcellular fractionation followed by two dimensional gel proteomic
methods were developed that succeeded in identifying nuclear proteins for which there no
previously published data in dinoflagellates. We found that nuclear isolation in
combination with LTQ MS/MS was essential to obtain successful protein identifications
because we currently lack genomic sequence data from which to derive adequate mass
peptide fingerprints for K. brevis proteins. The identification of nuclear proteins clearly
shows that this method can be used successfully to study K. brevis. Additionally, once
mass spectra are obtained, such as those from the studies presented in Chapter 2, the
spectra can later be searched against newly acquired sequence information with the hopes
of identifying more proteins from previous experiments. Nuclear proteomics should
provide a wealth of information on dinoflagellate biology since this organism has an
unusual nucleus. Nuclear proteomics has recently proved to be a useful tool in studying
plant biology, since the plant nucleus also possesses some significant differences in
appearance and composition from other eukaryotes, which indicates specific molecular
pathways (Erhardt et aI., 2010). The nucleus is a dynamic organelle and proteins are
constantly moving into and out this compartment (Gonzalez-Melendi et aI., 2000).
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Therefore, an interesting experiment would be to investigate the nuclear proteome of K.

brevis over the cell cycle since this organism displays post-transcriptional control,
appears to use translational control and possibly post-translational modifications to
regulate cellular processes and nuclear proteins are now able to be successfully identified.
We had hoped to identify DNA replication proteins in K. brevis nuclei as has been done
in the chickpea C. arietinum. Proteins identified in this plant found a variety of protein
classes including those involved in signaling, gene regulation, DNA replication and
transcription (Panday et aI., 2006). U sing a large amount of K. brevis nuclear protein
may overcome the problem of identifying proteins of specific interest since nuclear
protein samples have low protein quantity and concentration (Erhardt et aI., 2010).
Genomic studies in K. brevis have provided a wealth of information that, without EST
sequencing and development of a microarray, would have been impossible. However,
there are limitations with genomic analysis in that it cannot provide complete information
of cellular and subcellular functions, in which proteins, not genes, govern the functions
(Klein and Thongboonkerd, 2004). Proteins are dynamic and many functions are
regulated by post-translational modifications, which are unable to be investigated using a
genomics approach. This becomes especially important in an organism such as K. brevis
that uses post-transcriptional control of gene expression. As additional information on
the genome of K. brevis becomes available through deep transcriptome sequencing via
second generation sequencing technologies, the use ofproteomics will become easier and
more fruitful.
While this project was underway, a 5' trans-spliced leader sequence was
identified on diverse mRNAs in dinoflagellates, including K. brevis (Lidie and Van
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Dolah, 2007; Zhang et aI., 2007). The presence of the spliced leader sequence and
polycistronic messages in dinoflagellates suggests a constitutive transcription program
similar to the Trypanosomatids, and much of our current insight into dinoflagellates
comes from studies on their well characterized system of post-transcriptional regulation.
In Chapter 3 we reported the presence of the spliced leader sequence on the 5' end ofSphase genes, suggesting that S-phase might be regulated by post-transcriptional
mechanisms, and consistent with this we saw no changes in their transcript abundance
over the cell cycle. Turning to the trypanosome cell cycle for a model, we found the
trypanosomatid,CrithidiaJasciculata possesses polyA binding proteins that stabilize the

mRNAs of DNA metabolism proteins such as RPA1 specifically during S-phase (Pasion
et aI., 1994). These polyA binding proteins bind to an octomer sequence present in
transcripts required for the cell cycle-dependent regulation of the mRNA levels that cycle
and it is thought that the binding of these proteins varies during the cell cycle in parallel
with the levels of putative target mRNAs (Mittra and Ray, 2004). However, we have not
identified a similar octomeric motif, or any other conserved motif, in the 5' or 3' UTR of
K. brevis S-phase genes. Therefore, it would seem that dinoflagellates have a different

solution to the problem of cell cycle phase-specific protein expression. It might be
informative to do a comparative study of this process in dinoflagellates and
apicomplexans, the nearest relatives to dinoflagellates. Apicomplexans lack the spliced
leader mechanism and transcription in the apicomplexan, Plasmodium Jalciparum, is
monocistronic; however, the genome contains a dearth of genes encoding transcription
factors compared with other eukaryotic genomes and comparative genomic analysis
shows a disproportionately high number of proteins involved in mRNA stability and
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deadenylase activity in the genome, suggesting post-transcriptional control of gene
expression to some extent (Coulson et aI., 2004; Le Roch et aI., 2004). It is thought that
these mechanisms may confer advantages for the Plasmodium parasites to quickly adapt
to environmental changes and could explain the common usage of these mechanisms
throughout Apicomplexa (Le Roch et aI., 2004). Since dinoflagellates evolved from a
common ancestor to the apicomplexans, it may be that dinoflagellates are using a similar
approach to life, with enhancement of the spliced-leader to mediate mRNA processing.
At the start of this project ESTs for a number of cell cycle genes had been
identified in K. brevis but they had not been fully characterized. The studies in Chapter 3
found some unusual phenomena in K. brevis cell cycle proteins. The first is the high
copy number of PCNA genes, as evidenced by 11 unique contigs that encode 9 different
amino acid sequences that vary only at 20 conserved polymorphic sites. PCNA is also
highly amplified in other dinoflagellates species. The alveolate Perkinsusmarinus, which
is the closest relative to dinoflagellates, seems to represent an intermediate state between
the true dinoflagellates and the true apicomplexans. Perkensis has over 10 copies of the
PCNA gene, with identical gene structures, similar nucleotide sequences (88-99%) and
almost identical amino acid sequences (Zhang et aI., 2010). A spliced leader sequence
was also found at the 5' end of P. marinus PCNA. It may be that this highly important
gene has not only been conserved throughout evolution but in these unusual protists
which have high copy number of certain genes such as PCNA, the duplication events
have also been retained. Another gene also highly amplified was RnRI. However, its
partner RnR2, as well as RFC and RP A seem to be in low copy number based on EST
diversity. If this is the case it must be that correct protein stoichiometry is achieved at the
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level of translation. In Chapter 3 we observed S-phase specific increases in protein levels
of these proteins, in the absence of increases in their transcript levels. In Trypanosoma

cruzi, PCNA mRNA and protein are detected throughout the cell cycle similar to K.
brevis; however in T. cruzi, there is an increase in both mRNA and protein during S\

phase (Calderano et aI., 2007). The PCNA protein is always present in the nuclear space
but varies over the cell cycle with· replication sites at the nuclear periphery indicating that
there are storage pools of PCNA in T. cruzi (Calderano et aI., 2007). In contrast, in K.

brevis anti-PCNA strongly labeled replication sites distributed throughout the nucleus
during S-phase. In this case, peripheral pools were apparent in Gland G2. This
indicates that replication forks in K . brevis, which have not been previously
characteriz~d,

are distributed throughout the chromatin during S-phase.

The investigation of dinoflagellate CDK and cyclin sequences in Chapter 4
revealed that they had limited sequence siniilarity to the well-characterized CDKs, being
more similar CDKC in plants (Barroco et aI., 2003) and CDK 7 in other alveolates such
as P. Jalciparum (Srinivasan and Krupa, 2005). The K. brevis CDKe-like protein has
conserved ATP binding sites but a divergent cyclin binding motif. We have likely not
identified all of the CDKs in K. brevis in the existing EST library. CDK i$ibitor studies

in Chapter 4 using fascaplysin, which is highly selective for CDK4, points to the presence
of a CDK4-like protein, as this inhibitor blocked DNA replication as well as PCNA
protein production. The timing of the restriction point in K. brevis is currently unknown
and the block in S-phase progression by fascaplysin addition at LDTO (Gl by flow
cytometry analysis) may be indicative of the restriction point occurring sometime around
the dark to light transition. This is suggested by the fact that PCNA is present at LDT2,
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suggesting a subpopulation of cells that have already passed through the restriction point
and are primed to proceed into S-phase. By flow cytometry, S-phase does not begin until
--LDT6; however, by the time flow cytometry can identify a cell as being in S-phase
based on fluorescent DNA staining, it has already carried out significant DNA
replication. Together, these results lead to the possibility that there is/are functional
homolog(s) ofGl CDKs in K. brevis that control cell cycle progression. A question that
is raised from the sequence analysis and cell physiology studies involving CDK is how
many CDKs might be involved in cell cycle progression in K. brevis. A phylogenetic
study ofCDKs across phyla identified 14 CDK members in C. elegans, 13 in D.
melanogaster, 8 inS. pombe, 7 in S. cerevisiae and 21 in H. sapiens (Liu and Kipreos,
2000) and 6 have been identified in P. Jalciparum (Jirage et aI., 2010). It will be
interesting to determine the number of cell cycle CDKs in dinoflagellates and how they
drive the K. brevis cell cycle, given the apparent absence ofCDK-dependent
transcription.
The presence of multiple forms ofPCNA protein in Chapter 3 led to the
investigation in Chapter 4 of possible post-translational modification mechanisms in K.
brevis, specifically sumoylation and ubiquitination. This level of regulation may be
essential in dinoflagellate cell cycle control and it has been neglected in dinoflagellate
research. In general, eukaryotes use a multitude of post-translational modifications to
regulate the cell cycle including but not limited to phosphorylation by cyclin dependent
kinases and other kinases, acetylation of histones by histone acetyltransferases (HATs),
ubiquitination by the anaphase promoting complex and other by other ubiquitin pathway
components, and by the more recently discovered sumoylation of transcription factors
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and PCNA. The fact that K. brevis and other dinoflagellates use mostly posttranscriptional regulation of gene expression leads to the hypothesis that not only
translational control but post-translational modifications may play an even larger role in
cellular processes than in other eukaryotes. For example, PCNA can be ubiquitinated,
sumoylated, and acetylated and in yeast PCNA it appears that ubiquitin and sumo can
coexist in a single PCNA subunit. Therefore, this protein has multiple levels of
regulation and these PTMs could be occurring in the dinoflagellate since they are
reversible and provide flexibility for the cell.
Chapter 4 provides the first evidence of sumoylation in a dinoflagellate which
warrants further study. In the yeast S. cerevisiae, a recent study found that in
exponentially growing cultures that PCNA modification by SUMO is more extensive
than previously reported and includes oligomeric chains on 2 different lysine residues,
K164 and K127 (Windecker and Ulrich, 2008). Changes in molecular weight of K.
brevis PCNA during S-phase are consistent sumoylation during S-phase in exponentially

growing cultures. A single homolog for SUMO was identified in the K. brevis EST
library. Single SUMO homo logs are also found in a variety of protists including
Trypanosoma brucei, T. cruzi, Leishmania major, P.Jalciparum, Theileria annulata,
Entomaeba histolytica, Cryptosporirium parvum and C. hominis (Ponder and Bogyo,

2007), as well as yeast. Immunoprecipitation studies in P. Jalciparum showed that the
nuclear protein Sir2 is sumoylated in this protist and it is suggested that this PTM may
play an important role in this parasite (Issar et aI., 2008). Preliminary data generated here
suggesting that PCNA is sumoylated should be confinned. An infonnative experiment to
further detennine PCNA sumoylation in K. brevis would be to produce a recombinant
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PCNA and either Western blot with an anti-SUMO antibody (which has not proved
trivial) or perform an in vitro sumoylation assay to verify whether PCNA can be
sumoylated. Alternatively, a mass spectrometry approach could be used to obtain
information on sumoylated PCNA. There are signatures that could be indentified such as
the lysine on PCNA to which the sumo G-G motif binds. In the SUMO sequence, there
is a conserved threonine residue on the amino side of the motif that is unique to this
ubiquitin-like modifier which would aid in its identification. This method may prove
difficult due to the fact that sumo can form chains similar to ubiquitin. Additionally,
although the ubiquitin studies were not conclusive, an interesting study would be to
inhibit the ubiquitin pathway, for example using MG 132, and determine if PCNA is
modified. Investigation of post-translational control, specifically of growth related
proteins, in dinoflagellates will ultimately be necessary in order to gain in depth
information on important cellular processes and how they are controlled.
The last objective of this project included an effort to determine whether PCNA
might provide a useful biomarker for growth in Florida red tides. In order to develop
successful biomarkers for growth in dinoflagellates, there is a need for understanding the
basic biology of this organism. K. brevis HAB forecasting is currently done using
satellite derived image products, wind predictions and models derived from previous
observations and research (Stumpf et aI., 2009) which involve integrating physical and
biological oceanographic measurements. There is limited data on the physiological
processes of K. brevis that are critical to growth of cells and populations in different
environments (Sinclair et aI., 2009). Therefore it would be valuable to implement
biomarkers that can fine-tune forecasting models by determining bloom trajectory (i.e.,
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growing or declining) on a cellular scale. The results of this study suggested PCNA at
the protein level could prove useful since this dinoflagellate is regulating its cell cycle at
the post-transcriptional level, such that PCR-based methods would not be infonnative.
The analyses in Chapter 4 show that there is a significant linear correlation between the
expression of S-phase specific 37kDa PCNA and the growth rate of the population. This
protein is virtually absent from stationary phase making this protein a particularly
promising tool for biomarker development. An unexpected result of Chapter 4 was the
identification of a 47 kDa form ofPCNA only in cultures beginning to decline. If the
hypothesis of PCNA ubiquitination during stationary phase presented in Chapter four
proves correct, there is potential for this protein to be developed into a bloom termination
biomarker.
In summary, the studies presented in this body of research provide a new level of
insight into the regulation of protein expression in K. brevis, and in particular the
expression S-phase proteins that are regulated in a cell cycle dependent manner. The new
information gained has both theoretical and applied value. As K. brevis uses posttranscriptional control of the cell cycle unlike most eukaryotes, the insight gained from
these studies will contribute to our understanding of cell cycle regulation from an
evolutionary standpoint. This research has laid the groundwork for further investigations
on cell cycle regulation at the translational or post-translational level in this organism.
Additionally, this work identified an applied endpoint with the potential ofPCNA to be
used as a biomarker for K. brevis bloom progression.
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Appendix 1: Cell cycle genes present in K. brevis. Contigs with homology to S-phase
genes are shaded. Contigs in bold are S-phase genes investigated in this study. Marine
genomics ID is shown and sequences can be found at www.marinegenomics.org.
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Sequence Description

Sequence
Length

#Hits

Minimum Mean
#GOs
e-value Similarity

Gene Ontologies
P:mitosis; C:spindle; C:centrosome; F:ATP binding; F:microtubule-

MGI D1986592 aaa atpase

737

10

1.63E-62

71.90%

7 severing ATPase activity; P:cell division; C:microtubule
C:cytoplasm; C:dynein complex; F:protein binding; P:mitosis;
P:nervous system development; F:motor activity; C:spindle pole;

MGID103202

aaa atpase

571

10 3.39E-17

54.50010

8 C:microtubule
F:DNA ligase (ATP) activity; P:cell cycle; P:DNA repair; F:ATP binding;
F:DNA binding; P:cell division; P:DNA replication; P:DNA

MGID2059523 atp-dependent dna ligase

1700

10

2.27E-05

45.90%

8 recombination
P:apoptosis; F:protein serine/threonine kinase activity; P:cell division;
F:ATP bi nding; P:mitosis; C:outer kinetochore of condensed
chromosome; P:negative regulation of cell cycle; C:cytoplasm;
C:nucleus; P:protein amino acid phosphorylation; P:serine family

MGID2033955 budding uninhibited by benzimidazoles 1 beta

969

MGIDl961650 budding uninhibited by benzimidazoles 3 homolog

752

l.28E-16

53.60'10

3 1. 88E-05

46.67%

0

10

11 amino acid metabolic process
P:ciliary orflagellar motility; P:mitosis; F:calcium ion binding;

MGI D2079501 caltractin ame: full=centrin

1295

10

l.37E-09

63.10010

6 C:centrosome; C:bacterial-type flagellum; P:cell division

MGIDl944632 caltractin ame: full=centrin

438

10

2.59E-31

79.30010

5 F:calcium ion binding; P:cell division

MGID1950142 caltractin ame : full=centrin

381

10

6.95E-16

62.00%

5 F:calcium ion binding; P:cell division

P:ciliary orflagellar motility; P:mitosis; C:bacterial-type flagellum;
P:ciliary or flagellar motility; P:mitosis; C:bacterial-type flagellum;
c:cytosol; F:bindi ng; P:negative regulation of ubiquitin-protein ligase
activity duri ng mitotic cell cycle; P:mitotic metaphase plate
congression; P:cell division; P:anaphase-promoting complexdependent proteasomal ubiquitin-dependent protein catabolic
process; P:G1 phase of mitotic cell cycle; P:positive regulation of
ubiquitin-protein Iigase activity during mitotic cell cycle; P:regulation
of exit from mitosis; P:regulation of mitotic metaphase/anaphase
transition; C:nucleoplasm; C:anaphase-promoti ng complex
MGID1986476 cdc23 (cell division cycle homolog)
MGI D2025806 cdc27 nuc2-like protein

696

10

1.72E-15

1010

10

7.28E-18

53.80010
52.60'10

12
1 F:binding
P:protein amino acid phosphorylation; F:ATP binding; F:protein
serine/threonine kinase activity; P:serine family amino acid metabolic

MGI D2063280 cdc2-like protein

460

10 3.62E-41

71.10010

4 process
P:peptidyl-tyrosine phosphorylation; F:ATP binding; F:protein tyrosine
kinase activity; C:nucleus; P:protein amino acid autophosphorylation;
F:protein serine/threonine kinase activity; P:serine family amino acid

MGID1984286 cdc-like kinase 2

769

8 l.23E-15

55.25%

7 metabolic process
P:protein amino acid phosphorylation; P:cell cycle; F:ATP binding;
C:nucleus; F:cyclin-dependent protein kinase activity; P:cell division; ;

1453

10

l.75E-56

908

10

1. 11E-27

53.90010
55.70010

8 P:serine family amino acid metabolic process

MGI D2079185 cell division
MGID1950185 cell division control protei n

696

4 8.03E-05

43.25%

5 processing; C:nucleus

MGI D2031566 cell cycle related kinase

2 P:cell cycle; F:binding
C:cytoplasm; F:exonuclease activity; F:nucleic acid binding; P:rRNA
F:RNA polymerase II carboxy-terminal domain kinase activity;
C:midbody; C:spindle microtubule; P:mitotic cell cycle G2/M transition
DNA damage checkpoint; P:cell division; P:anti-apoptosis; F:ATP
binding; P:mitosis; F:cyclin-dependent protein kinase activity;
C:nucleus; P:protein amino acid phosphorylation; F:Hsp70 protein
binding; P:serine family amino acid metabolic process;

MGIDl944473 cell division control protein 2

512

10

2.D4E-32

73.40010

MGID2062699 cell division cycle protein 23

747

10

2.27E-27

59.50010

14
P:regulation of mitotic metaphase/anaphase transition; F:binding;
3 C:anaphase-promoting complex
F:nucleoside-triphosphatase activity; F:ATP-dependent peptidase
activity; F:ATP binding; P:proteolysis; F:serine-type endopeptidase
activity; P:cell division; P:ATP-dependent proteolysis

MGID106856

cell division cycle protein 48

594

10

1. 13E-64

211

70.70010

7

MGI D2053020 cell division protein

758

7 2.5OE-05

47.29%

0
F:identical protein binding; F:serine-type endopeptidase activity;
P:response to cadmium ion; C:plasma membrane; C:cell wall; F:ATP
binding; F:nucleoside-triphosphatase activity; P:proteolysis; F:ATPdependent peptidase activity; P:cell division; P:ATP-dependent

MGID2075292 cell division protein

10 3.40E-I13
10 7.53E-ll

81.40%

MGIDI988475 cell division transporter substrate-bi nding protein

880
796

11 proteolysis

44.100A.

2 P:biological_process; C:cellular component

MGIDI942943 centri n

304

10 8.53E-13

79.10%

P:ciliary or flagellar motility; C:bacterial-type flagellum; F:calcium ion
3 binding
F:ATP-dependent helicase activity; F:nucleic acid binding; P:mitosis;
F:calcium ion binding; C:centrosome; F:ATP binding; P:cell division

MGID1952319 centrin

500

10 6. 84E-14

91.80%

7

MGIDI950294 centrin

647

10 1.28E-51

80.00%

5 F:calcium ion binding; P:cell division

P:ciliary or flagellar motility; P:mitosis; C:bacterial-type flagellum;
F:ATP-dependent helicase activity; F:nucleic acid bindi ng; P:mitosis;
F:calcium ion binding; C:centrosome; F:ATP binding; P:cell division
MGID1939358 centrin

410

10 1. 14E-10

80.20%

7
F:ATP-dependent helicase activity; P:ciliary orflagellar motility;
F:nucleic acid binding; F:calcium ion binding; F:ATP binding; C:bacterial

MGID2035389 centrin

1074

10 5. 13E-57

82.90%

6 type flagellum
P:ciliary or flagellar motility; P:mitosis; C:bacterial-type flagellum;

MGID2035650 centrin

769

10 1.39E-75

87.60%

5 F:calcium ion binding; P:cell division
P:ciliary or flagellar motility; P:mitosis; C:bacterial-type flagellum;

MGID2035920 centrin

672

10 1.C6E-75

87.60%

5 F:calcium ion binding; P:cell division

MGID2039572 centrin

764

10 1.37E-75

87.60%

P:ciliary or flagellar motility; P:mitosis; C:bacterial-type flagellum;
5 F:calcium ion binding; P:cell division

MGID2039826 centrin

826

10 1. 59E-75

87.60%

5 F:calcium ion binding; P:cell division

MGI D2040229 centrin

774

10 2.85E-76

88.20%

5 F:calcium ion binding; P:cell division

MGID2021179 centrin

815

10 1. 54E-75

87.60%

5 F:calcium ion binding; P:cell division

MGID2043662 centrin

768

10 1.39E·75

87.60%

5 F:calcium ion binding; P:cell division

MGID2045393 centrin

794

10 1. 48E·75

87.60%

5 F:calcium ion binding; P:cell division

MGID2046404 centrin

770

10 6. 24E-76

88.200A.

P:cil iary or flagellar motil ity; P:mitosis; C:bacterial-type flagellum;
5 F:calcium ion binding; P:cell division

MG1D2047451 centrin

792

10 1.48E-75

87.60%

5 F:calcium ion binding; P:cell division

P:ciliary or flagellar motility; P:mitosis; C:bacterial-type flagellum;
P:ciliary orflagellar motility; P:mitosis; C:bacterial-type flagellum;
P:ciliary or flagellar motility; P:mitosis; C:bacterial-type flagellum;
P:ciliary or flagellar motility; P:mitosis; C:bacterial-type flagellum;
P:ciliary or flagellar motility; P:mitosis; C:bacterial-type flagellum;

P:ciliary orflagellar motility; P:mitosis; C:bacterial-type flagellum;
F:ATP-dependent he Iicase activity; F:nucleic acid bindi ng; P:mitosis;
F:calcium ion binding; C:centrosome; F:ATP binding; P:cell division
MGID2053478 centrin

602

10 2. 11E-31

81.200Ai

7

MGID2055568 centrin

817

10 1.56E-75

87.60%

5 F:calcium ion binding; P:cell division
P:ciliary orflagellar motility; P:mitosis; C:bacterial-type flagellum;

MGID2057811 centrin

787

10 2.94E-76

88.20%

5 F:calcium ion binding; P:cell division
P:ciliary or flagellar motility; P:mitosis; C:bacterial-type flagellum;

789

10 1.47E-75
10 7.88E-19

87.600Ai
44.90%

5 F:calcium ion binding; P:cell division
3 C:chromosome, centromeric region; P:mitosis; C:nucleus

P:ciliary orflagellar motility; P:mitosis; C:bacterial-type flagellum;

MGID2072941 centrin
MGID2033952 centromere protein zwl0

1370

MGIDI06806 centrosomal protein

860

1 5.44E-05

46.00%

0

MGID2036S40 centrosomal protein 110
MGID1991453 centrosomal protein 164kda isoform 4

847
890

10 5.65E-07
4 3.70E-04

50.90%
48.00%

0

MGIDI985334 centrosomal protein 2isoform 1isoform 2

739

MG1D198649O centrosomal protein 250
MGID2020556 centrosomal protein 290kda

642

10 1.27E-06
10 5. 21E-OS

44.90%
43.10%

2 C:cilium; P:cell cycle
2 C:cilium; P:cell cycle

1075

1 5.04E-04

48.oooA.

0

212

3 C:centrosome; F:protein binding; P:cell division

P:vesicle-mediated transport; C:cytosol ; P:cell projection organization;
F:microtubule minus-end binding; P:eye photoreceptor cell
development; C:cell surface; C:centrosome; P:hindbrain development;
F:transcription activator activity; C:photoreceptor connecting cilium;
P:otic vesicle formation; C:gamma-tubulin complex; P:pronephros
development; P:protein transport; C:membrane; C:nucleus; C:tubulin
complex; P:positive regulation of transcription
MGID2042570 centrosomal protein 290kda

1247

10

8.70E-06

43.00010

18
C:chromosome, centromeric region; F:zinc ion binding; P:cell cycle;
P:regulation of transcription, DNA-dependent; P:chromatin assembly
or disassembly; F:histone methyltransferase activity (H3-K9 specific) ;
P:histone H3-K9 methylation; C:nuclear heterochromatin; P:cell
differentiation; F:chromatin binding; P:chromatin remodeling

MGID1952149 chromodomain protein (hp1-like)

432

10

l.00E-06

65.90%

11
F:kinesin binding; P:centrosome organization; P:cell cycle; C:ci liary
rootlet; P:cell projection organization; C:centriole; F:structural

MGID1965108 ciliary rootlet coiled- rootletin

815

10

2.35E-07

40.90%

8 molecule activity; C:kinesin complex
P:protein amino acid phosphorylation; P:positive regulation of cell
proliferation; P:multicellular organismal development; P:regulation of
mitosis; F:ATP binding; F:cyclin -dependent protei n kinase activity;
P:cell division; ; P:serine family amino acid metabolic process

MG ID 108857

cyclin dependent kinase

804

10

1.52E-51

62.10%

9
0

MGID1990865 cyclin domain protein f-box protein

717

6

4.26E-08

54.50%

MGID2032522 cyclin domain protein f-box protein

1507

10

5.08E-14

47.70%

2 F:protein binding; F:calcium ion binding

430

3

1.00E-12

58.00010

1 C:nucleus

MGID2022329 cyclin fold protein 1 isoform 2

P:protein amino acid phosphorylation; F:ATP binding; F:protein
serine/threonine kinase activity; P:serine family amino acid metabolic
MGID2031949 cyclin -dependent kinase 1 p34cdc2

1332

10

1.87E-09

45.70%

4 process
P:protein amino acid phosphorylation; F:ATP binding; F:protein
serine/threonine kinase activity; F:protein tyrosine kinase activity;

MGID2033180 cyclin-dependent kinase-related kinase

1309

10

6.16E-66

61.00010

5 P:serine family amino acid metabolic process

MGID2021802 dna repair helicase rad25 family protein

1249

10

2.39E-96

68.80%

6 P:nucleotide-excision repair; C:nucleus; C:replication fork

MGID2045460 dna ligase

1198

10

6.88E-61

56.10%

6 (ATP) activity; P:DNA recombination; P:DNA repair

F:DNA binding; F:ATP-dependent DNA helicase activity; F:ATP binding;
P:DNA replication; F:ATP binding; F:zinc ion binding; F:DNA ligase
F:protein tyrosine phosphatase activity; P:DNA replication; P:protein
amino acid dephosphorylation; F:ATP binding; F:nucleosidetriphosphatase activity; F:DNA ligase (ATP) activity; P:DNA
MGID2021309 dna ligase iii -like protein

956

10

6.38E-37

54.40%

9 recombination; P:DNA repair; P:tyrosine metabolic process
C:focal adhesion; P:positive regulation of neurogenesis; P:response to
X-ray; P:response to gamma radiation; F:protein C-terminus binding;
P:central nervous system development; P:single strand break repair;
P:chromosome organization; P:immunoglobulin V(D)J recombination;
P:double-strand break repair via nonhomologous end joining;
P:nucleotide-excision repair, DNA gap filling; P:cell division;
C:cytoplasm; P:somatic stem cell maintenance; P:negative regulation
of neuron apoptosis; C:DNA-dependent protein kinase -DNA ligase 4
complex; P:DNA ligation involved in DNA repair; F:DNA binding;
C:condensed chromosome; P:T cell differentiation in the thymus;
P:provirus integration; P:DNA ligation involved in DNA recombination ;
P:Tcell receptor V(D)J recombination; P:positive regulation of
fibroblast proliferation; P:pro-B cell differentiation; F:DNA ligase
(ATP) activity; C:DNA ligase IV complex; P:initiation of viral infection;
F:ATP binding; P:in utero embryonic development; P:DNA replication;
P:cell cycle; P:isotype switching

MGID1960453 DNA ligase IV

809

10

1.76E-23

56.90%

MGID2073646 DNA ligase-like

655

6

1.00E-17

48%

213

33
3 F:ligase activty; F:methyltransferase activity; C:plastid

F:DNA-directed DNA polymerase activity; P:DNA replication;
F:exonuclease activity; F:DNA bi nding; F:two-component sensor
activity; C:membrane; C:DNA polymerase complex; P:two-component
signal transduction system (phosphorelay); C:protein histidine kinase
MGID107892

dna polymerase epsilon subunit

803

10

8.10E-13

45.80%

10 complex; P:phosphorylation
F:DNA-directed DNA polymerase activity; P:DNA replication; F:DNA
binding; C:DNA polymerase III complex; F:ATP binding; F:nucleoside-

MGID1970469 dna polymerase iii (subunit gamma tau)

744

1

2.05E-04

40.00%

7 triphosphatase activity; C:nucleus

MGID1971927 dna polymerase kappa

793

10

5.89E-32

59.20%

1 P:DNA repair
F:N-acetyltransferase activity; F:DNA binding; C:intracellular;
F:aspartic-type endopeptidase activity; F:zinc ion binding; P:DNA

MGID1993226 dna polymerase lambda (pol lambda)

828

5

3.50E-06

49.60"10

7 integration; P:acyl -carrier-protein biosynthetic process

MGID2053352 dna replication complex gins protein psfl

850

10

9.65E-23

54.70%

1 C:integral to membrane

MGID1984213 dna replication licenSing factor mcm6

852

10

1.18E-44

57.40%

4

F:ATP binding; C:nucleus; F:DNA binding; P:DNA replication initiation
P:regulation of DNA replication initiation; P:cytokinesis; F:zinc ion
binding; P:embryonic development ending in birth or egg hatching;
P:cell cycle; P:regulation of transcription, DNA-dependent; P:ONA
unwinding involved in replication; C:MCM complex; P:reproduction;
F:DNA binding; F:ATP binding; C:chromatin; F:ATPase activity;
MGID2054360 dna replication licensing factor mcm6

1816

10

4.97E-98

60.60%

MGID2060973 dna replication licensing factor mcm7

578

10

1.63E-06

57.00%

14 F:chromatin binding
P:DNA replication initiation; F:DNA binding; F:ATP binding;
5 F:nucleoside-triphosphatase activity; C:nucleus
F:nucleoside-triphosphatase activity; P:cell cycle; C:integral to
membrane ; F:ATP binding; F:DNA binding; P:cell division;

MGIDl948832 dna segregation atpase related protein

459

3

4.17E-05

50.33%

7 P:chromosome segregation
F:nucleoside-triphosphatase activity; P:cell cycle; C:integral to
membrane ; F:ATP binding; F:DNA binding; P:cell division;

MGID2067895 dna segregation atpase related protein

480

4

4.18E-05

51.50%

7 P:chromosome segregation

MGID1960293 dph1 homolog

786

10

2.59E-48

69.70%

5 binding; P:cell proliferation

C:cytoplasm; P:negative regulation of cell cycle; C:nucleus; F:protein
P:ciliary or flagellar motility; F:ATP -dependent helicase activity;
F:nucleicacid binding; P:mitosis; F:calcium ion binding; C:centrosome;
F:ATP binding; C:bacterial -type flagellum; P:cell division
MGID1964053 ef-hand 1

613

10

1.31E-31

80.80%

9
C:cytoplasm; P:microtubule-based movement; C:microtubule
associated complex; P:mitosis; F:ATP binding; P:cell division;

MGID2059101 kinesin -related motor protein eg5 1

1523

10

2.85E-47

54.30%

8 F:microtubule motor activity; C:microtubule
F:sequence-specific DNA binding; C:nucleus; F:flap endonudease
activity; F:5'-3' exonuclease activity; P:DNA repair; P:DNA catabolic

MGID1947619 flap endonuclease 1

541

10

2.47E-08

60.70%

6 process

MGID1947939 gtp-binding prote in

358

10

1.03E-19

57.40%

4

P:cell cycle; C:intracellular; P:barrier septum formation; F:GTP binding
F:protein transporter activity; F:protein binding, bridging;
P:chromosome condensation; C:nuclear pore ; P:M phase of mitotic cell
cycle ; P:NLS-bearing substrate import into nucleus; C:cytoplasm;
P:response to stress; F:GTP binding; P:regulation of mitotic cell cycle
MGI02073891 importin alpha
MGI02032753 katanin p80 (wd repeat containing) subun it b 1

1766

10

1.62E-38

46.80%

813

10

4.40E-22

54.90%

10
5 P:mitosis; C:spindle ; C:centrosome ; C:microtubule ; P:cell division
P:negative regulation of microtubule depolymerization ; P:positive
regulation of microtubule depolymerization ; C:axon; c:microtubule;
C:spindle pole; C:centrosome; P:cell division ; F:microtubule-severing
ATPase activity; F:dynein binding; P:mitosis; F:prote in
heterodimerization activity; C:dynein complex

MGID2032756 katan in p80 subunit

785

10

5.06E-12

49.50%

12
P:microtubule-based movement; P:cell proliferation; F:DNA binding;
P:mitosis; C:spindle ; C:plus-end kinesin complex; C:centrosome; F:ATP
binding; F:microtubule motor activity; C:microtubule

MG101974388 kinesin family member 15

764

10

7.87E-15

57.90%

MGID2021441 med iator of dna damage checkpoint 1

840

10

3.6OE-14

54.20%

10
C:cytoskeleton; C:nudeoplasm; F:protein binding; C:focal adheSion;

214

6 P:cell cycle ; P:DNA repair

MGID2031034 minichromosome maintenance complex component 10

833

10

1.22E-06

43.50"10

3 C:nucieus; F:zinc ion bindi ng; P:DNA replication
F:DNA helicase activity; F:nucieoside-triphosphatase activity;
C:nucieolus; P:regulation of transcription, DNA-dependent; P:DNA
unwindi ng i nvolved in replication; F:ATP binding; F:protein binding;
P:DNA replication initiation; F:si ngle-stranded DNA bind ing;

MGID2036751 minichromosome maintenance complex component 4

1312

10

5.63E-43

57.20%

11 C:nucieoplasm; C:replication fork
F:DNA helicase activity; F:nucieoside-triphosphatase activity;
C:nucieolus; P:regulation of transcription, DNA-dependent; P:DNA
unwinding involved i n replication; F:ATP binding; F:protein binding;
P:DNA replication initiation; F:single-stranded DNA bind ing;

MGID2036754 minichromosome maintenance complex component 4

823

10

3.44E-30

57.90%

11 C:nucieoplasm; C:repl ication fork

MGID2058230 minichromosome maintenance prote in 3

597

MGID1973770 mitotic checkp oint protein

751

10

5.99E-44

67.00%

1 F:protein binding

MGIDl944670 mitotic checkpoint prote in bub3

449

10

3.35E-18

57.90%

2 P:bio logica l process; C:CUL4 RING ubiquitin ligase complex

3.ooE-07

0

F:DNA polymerase processivity factor activity; F:DNA binding;
P:regulation of DNA replication; C:PCNA complex; C:nucleus; C:DNA
MG I 0107271

proliferating cell nuclear antigen

936

10 1.11E-134

94.50%

6 polymerase complex
F:DNA polymerase processivity factor activity; F:DNA binding;
P:regulation of DNA replication; C:PCNA complex; C:nucleus; C:DNA

MG I 01938210 proliferating cell nuclear antigen

702

10 2.S4E-123

95.10%

6 polymerase complex
F:DNA polymerase processivity factor activity; F:DNA binding;
P:regulation of DNA replication; C:PCNA complex; C:nucleus; C:DNA

MG I 01942569 proliferating cell nuclear antigen

834

10

6.37E-21

89.70%

6 polymerase complex
F:DNA polymerase processivity factor activity; F:DNA binding;
P:regulation of DNA replication; C:PCNA complex; C:nucleus; C:DNA

MGIOl942792 proliferating cell nuclear antigen

779

10

1.44E-43

85.20%

6 polymerase complex
F:DNA polymerase processivity factor activity; F:DNA binding;
P:regulation of DNA replication; C:PCNA complex; C:nucleus; C:DNA

MGI019S0082 proliferating cell nuclear antigen

660

10

3.20E-S2

76.30%

6 polymerase complex
F:DNA polymerase processivity factor activity; F:ONA binding;
P:regulation of DNA replication; C:PCNA complex; C:nucleus; C:DNA

MGIOl9S0735 proliferating cell nuclear antigen

731

10

1.94E-l0

54.40%

6 polymerase complex
F:DNA polymerase processivity factor activity; F:DNA binding;
P:regulation of DNA replication; C:PCNA complex; C:nucleus; C:DNA

MG I01959915 proliferating cell nuclear antigen

596

10

1.66E-73

83.00%

6 polymerase complex
F:DNA polymerase processivity factor activity; F:DNA binding;
P:regulation of DNA replication; C:PCNA complex; C:nucleus; C:DNA

MG I01964521 proliferating cell nuclear antigen

793

10 5.14E-137

95.50%

6 polymerase complex
F:DNA polymerase processivity factor activity; F:DNA binding;
P:regulation of DNA replication; C:PCNA complex; C:nucleus; C:DNA

MGIOl964522 proliferating cell nuclear antigen

827

10 2.18E-117

94.20%

6 polymerase complex
F:DNA polymerase processivity factor activity; F:DNA binding;
P:regulation of DNA replication; C:PCNA complex; C:nucleus; C:ONA

MGIOl994890 proliferating cell nuclear antigen

789

10 9.39E-115

94.50%

6 polymerase complex
F:DNA polymerase processivity factor activity; F:DNA binding;
P:regulation of DNA replication; C:PCNA complex; C:nucleus; C:DNA

MGI02019375 proliferating cell nuclear antigen

78>

10 5.38E-131

94.70%

6 polymerase complex
F:DNA polymerase processivity factor activity; F:DNA binding;
P:regulation of DNA replication; C:PCNA complex; C:nucleus; C:DNA

MGI02027046 proliferating cell nuclear antigen

994

10 2.28E-141

94.90%

6 polymerase complex
F:DNA polymerase processivity factor activity; F:DNA binding;
P:regulation of DNA replication; C:PCNA complex; C:nucleus; C:DNA

MG I 02047621 proliferating cell nuclear antigen

992

10 5.OSE-141

95.50%

6 polymerase complex
F:DNA polymerase processivity factor activity; F:DNA binding;
P:regulation of DNA replication; C:PCNA complex; C:nucleus; C:DNA

MGI02OS2699 proliferating cell nuclear antigen

901

10 1.22E-135

95.40%

6 polymerase complex
F:DNA polymerase processivity factor activity; F:DNA binding;
P:regulation of DNA replication; C:PCNA complex; C:nucleus; C:DNA

MGI02OS7215 proliferating cell nuclear antigen

945

10 9.41E-142

215

95.10%

6 polymerase complex

F:DNA polymerase processivity factor activity; F:DNA binding;
P:regulation of DNA replication; C:PCNA complex; C:nucleus; C:DNA
MGID2060175 proliferating cell nuclear antigen

440

10

1. 16E-47

94.30%

6 polymerase complex
F:DNA polymerase processivity factor activity; F:DNA binding;
P:regulation of DNA replication; C:PCNA complex; C:nucleus; C:DNA

MGID2063631 proliferating cell nuclear antigen

669

10 6.10£-116

95.00%

6 polymerase complex
F:DNA polymerase processivity factor activity; F:DNA binding;
P:regulation of DNA replication; C:PCNA complex; C:nucleus; C:DNA

MGID2063966 proliferating cell nuclear antigen

1921

10 1.13E-141

95.10%

6 polymerase complex
F:DNA polymerase processivity factor activity; F:DNA binding;
P:regulation of DNA replication; C:PCNA complex; C:nucleus; C:DNA

MGID2069044 proliferating cell nuclear antigen

626

10

1.65E-45

92.30%

6 polymerase complex
F:DNA polymerase processivity factor activity; F:DNA binding;
P:regulation of DNA replication; C:PCNA complex; C:nucleus; C:DNA

MGID2077091 proliferating cell nuclear antigen

1008

10 2.43E-13O

90.50%

6 polymerase complex
F:manganese ion binding; P:regulation of DNA replication; F:protein Cterm i nus binding; P:ceramide metabolic process; C:protein
phosphatase type 2A complex; P:response to organic substance;
C:microtubule cytoskeleton; P:negative regulation of tyrosine
phosphorylation of Stat3 prote i n; P:regulation of cell adhesion;
P:mesoderm development; C:cytosol ; F:protein heterod i merization
activity; P:regulation of Wnt receptor signaling pathway; P:RNA
splicing; P:regulation of cell cycle; F:iron ion bind i ng; P:i nduction of
apoptosis; P:negative regulation of cell growth; P:i nactivation of MAPK
activity; P:regulation of cell differentiation; P:prote in ami no acid
dephosphorylation ; P:regulation of transcri ption; P:second-messenger
mediated signaling; C:plasma membrane; C:soluble fraction;
C:nucleus; F:prote i n serine/threonine phosphatase activity;

MGID207S819 prote i n phosphatase 2 catalytic alpha isoform

1392

10 8.S8E-138

84.70%

MGID20811S7 rad17 homolog

1067

10

3. llE-14

42.30"10

28 C:mitochondrion
P:cell cycle; F:ATP binding; F:nucleoside-triphosphatase activity;
S C:nucleus; P:DNA repair
P:DNA replication; P:nucleotide-excision repair, DNA gap filling;
C:nucleoplasm; F:DNA clamp loader activity; C:DNA replication factor C
complex; F:ATP binding; F:enzyme binding; C:DNA polymerase

MGID20S6083 replication factor c (activator 1)

1298

10

8.76E-81

66.30%

8 complex
P:DNA replication; F:ATPase activity; F:DNA binding; C:DNA replication
factor C complex; F:protein binding; F:ATP binding; C:nucleus

MGID106618

replication factor c (activator 1) 38kda

864

10

7.34E-5O

64.20%

7
P:DNA replication; F:DNA clamp loader activity; C:DNA replication
factor C complex; F:ATP binding; C:nucleus; C:DNA polymerase

MGID1942001 replication factor c 36 kda subunit

498

10

1. 16E-21

61.70%

6 complex
P:nucleotide-excision repair, DNA damage removal; P:DNA
recombination; P:meiosis; F:zinc ion binding; C:cytoskeleton; P:DNAdependent DNA replication; P:nucleotide-exdsion repair, DNA gap
filling; C:PML body; F:protein binding; C:condensed chromosome;
F:single-stranded DNA binding; C:cytoplasm; F:chromatin binding;
C:DNA replication factor A complex; C:chromatin

MGID2026854 replication protein 70kda

1690

10

2.8OE-48

50.30%

44G

10

G.81E-OS

49.70%

15
P:DNA replication; P:chromatin modif ication; P:cell cycle; C:nucleus;

MGID19S7189 retinoblastoma binding protein 4

S P:regulation of transcription, DNA-dependent
C:cytosol; P:purine nucleoside metabolic process; P:S phase of mitotic
cell cycle; F:ribonucleoside-diphosphate reductase activity;
P:oxidation reduction; F:ATP binding; P:purine deoxyribonucleoside
triphosphate biosynthetic process; F:protein binding; P:pyrimidine
deoxyribonucleoside triphosphate biosynthetic process;
C:ribonucleoside-diphosphate reductase complex; P:regulation of
DNA replication; P:purine base metabolic process; P:pyrimidlne base
metabolic process; P:deoxyribonucleoside diphosphate metabolic

MGID1964781 ribonucleoside-diphosphate alpha subunit

841

10

2.44E-95

216

71.80%

14 process

C:ribonucleoside-diphosphate reductase complex; P:DNA replication;
F:protein binding; P:oxidatlon reduction; F:AlP binding;
F:ribonucleoside-diphosphate reductase activity; P:purine base

MGI02022197 ribonucleoside-diphosphate alpha subunit

1153

MGI02033417 ribonucleoside-diphosphate alpha subunit

10 1.56E-147

82.50%

807

10

1.51E-91

78.80%

MGI02033632 ribonucleoside-diphosphate alpha subunit

821

10

6.99E-92

79.10%

MGI02044150 ribonucleoside-diphosphate alpha subunit

2782

10

0

80.60%

MGI01954849 ribonucleoside-diphosphate large

161

10

9.46E-13

84.80%

MGI02030200 ribonucleoside-diphosphate large

837

10

3.41E-65

85.20%

MGI02046113 ribonucleoside-diphosphate large

892

10 8.44E-65

86.50%

494

10 1.11E-21
10 1.17E-161
10 8.38E-125

83.10%
79.70%
80.90%

MG I02063679 ribonucleoside-diphosphate large
MGI02057891 ribonucleoside-diphosphate reductase large chain
MGI02056546 ribonucleotide-diphosphate small

1n4
1399

MGID105468

similar to Plasmodium falciparum . DNA helicase

861

63.30%

snf2 family dna-dependent atpase

588

10
10

8.39E-30

MGID108507

8.11E-2S

62.00"10

MGID2051432 s-phase kinase -associated

1309

10

7.57E-48

69.60%

MGID2026304 timele ss interacting protein

1486

10

5.34E-08

45.40%

217

metabolic process; P:pyrimidine base metabolic process;
9 P:deoxyribonucleoside diphosphate metabolic process
P:oxidation reduction; C:ribonudeoside-diphosphate reductase
complex; F:protein binding; F:ribonucleoside-diphosphate reductase
activity; P:DNA replication; P:purine base metabolic process;
P:pyrimidine base metabolic process; P:deoxyribonucleoside
8 diphosphate metabolic process
P:oxidation reduction; C:ribonudeoside-diphosphate reductase
complex; F:protein binding; F:ribonucleoside-diphosphate reductase
activity; P:ONA replication; P:purine base metabolic process;
P:pyrimidine base metabolic process; P:deoxyribonucleoside
8 diphosphate metabolic process
C:ribonucleoside-diphosphate reductase complex; P:DNA replication;
F:protein binding; P:oxidation reduction; F:AlP binding;
F:ribonucleoside-diphosphate reductase activity; P:purine base
metabolic process; P:pyrimidine base metabolic process;
9 P:deoxyribonucleoside diphosphate metabolic process
C:ribonucleoside-diphosphate reductase complex; P:ONA replication;
F:protein binding; P:oxidation reduction; F:AlP binding;
F:ribonucleoside-diphosphate reductase activity; P:purine base
metabolic process; P:pyrimidine base metabolic process;
9 P:deoxyribonucleoside diphosphate metabolic process
C:ribonucleoside-diphosphate reductase complex; P:ONA replication;
F:protein binding; P:oxidation reduction; F:AlP binding;
F:ribonucleoside-diphosphate reductase activity; P:purine base
metabolic process; P:pyrimidine base metabolic process;
9 P:deoxyribonucleoside diphosphate metabolic process
C:ribonucleoside-diphosphate reductase complex; P:ONA replication;
F:protein binding; P:oxidation reduction; F:AlP binding;
F:ribonucleoside-diphosphate reductase activity; P:purine base
metabolic process; P:pyrimidine base metabolic process;
9 P:deoxyribonucleoside diphosphate metabolic process
C:ribonucleoside-diphosphate reductase complex; P:ONA replication;
F:protein binding; P:growth or development of symbiont on or near
host; P:oxidation reduction; F:ribonucleoside-diphosphate reductase
activity; P:purine base metabolic process; P:pyrimidine base metabolic
process; P:deoxyribonudeoside diphosphate metabolic process
9
9 C:ribonucleoside-diphosphate reductase complex; P:DNA replication;
8 P:oxidation reduction; F:iron ion binding; F:ribonudeosideP:chromatin modification; F:DNA-dependent ATPase activity;
F:hel icase activity; F:DNA bind ing; F:ATP binding; C:nucleus; F:zinc ion
7 binding
8 P:i nte in-med iated prote in spl ici ng; F:hel icase activity; F:DNA bind ing;
P:ubiquitin-dependent protein catabolic process; F:protein binding
2
P:regulation of DNA repl ication during S phase; C:nuclear chromatin;
P:DNA replication checkpoint; P:cell divisi on ; P:replication fork
protection ; P:intra-S DNA damage checkpoint; F:protein binding;
P:mitosis; P:positive regulation of cell proliferation; C:cytoplasm
10

Appendix 2: Genes involved in post-translational modifications, including the
ubiquitination and sumoylation pathways, present in K. brevis. The contigs with
homology to ubiquitin and SUMO polypeptide genes are shaded. Marine genomics ID is
shown and sequences can be found at www.marinegenomics.org.
Marine Genomics

Sequence Description

ID

Sequence
Length

Minimum
eValue

#Hits

Mean
Similarity

#GOs

Gene Ontologies

MGID2030002

26s protease regulatory subunit 8

1418

10

0

88.10%

C:protein complex; P:protein catabolic process; F:ATP binding;
6 F:nucleoside-triphosphatase activity; C:nucleus; C:cytosol

MG I02034299

26s proteasome regulatory atpase subunit

1407

10

0

90.00%

C:protein complex; P:protein catabolic process; F:ATP binding;
6 F:nucleoside-triphosphatase activity; C:nucleus; c:cytosol

MGID1978797

26s proteasome regulatory particle triple-a atpase su

325

9

1.89E-29

68.22%

C:cytoplasm; F:peptidase activity; F:ATPase activity; P:ubiquitin6 dependent protein catabolic process; F:ATP binding; C:nucleus

MG102021373

ankyrin partial

802

10

9.57E-06

55.70%

MG I02040404

ankyrin unc44

853

8

1.41E-05

54.63%

MGID2026032

ariadne homolog 2

791

10

6.29E-I0

40.70%

MGID2033025

arm repeat-containing protein

774

8

4.06E-06

40.75%

MGID1969538

atlg15100 f911 3

599

10

7.95E-07

56.80%

MGID2034824

btb domain containing 1

1611

10

3.47E-08

38.90%

MGID1975704

calcium ion binding protein

733

7

7,61E-04

56.29%

F:protein binding; P:protein ubiquitination; F:ubiquitin-protein
6 ligase activity; C:nucleus; F:zinc ion binding; C:cytosol
F:ubiquitin-protein ligase activity; C:ubiquitin ligase complex;
4 F:binding; P:protein ubiquitination
C:eytoplasmic membrane-bounded vesicle; P:protein
ubiquitination; F:ubiquitin-protein ligase activity; F:zinc ion
6 binding; C:plastid; C:ubiquitin ligase complex
C:cytoplasm; C:protein complex; P:ubiquitin-dependent protein
4 catabolic process; F:protein binding
P:protein ubiquitination; F:ubiquitin-protein ligase activity; F:zinc
4 ion binding; C:ubiquitin ligase complex
C:cytosol; F:binding; P:negative regulation of ubiquitin-protein
ligase activity during mitotic cell cycle; P:mitotic metaphase plate
congression; P:cell division; P:anaphase-promoting complexdependent proteasomal ubiquitin-dependent protein catabolic
process; P:G1 phase of mitotic cell cycle; P:positive regulation of
ubiquitin-protein ligase activity during mitotic cell cycle;
P:regulation of exit from mitosis; P:regulation of mitotic
metaphase/anaphase transition; C:nucleoplasm; C:anaphase12 promoting complex

2 C:cytoplasm; P:u biquitin-dependent protein catabolic process
F:ubiquitin-protein ligase activity; C:intracellular; P:ubiquitin
4 cycle; P:protein ubiquitination

MGID1986476

edcB (cell division cycle homolog)

696

10

1.72E-15

53,80%

MG1D2047165

chp-rich zinc finger

899

10

1.39E-06

46.40%

; F:ubiquitin-protein ligase activity; C:intracellular; P:ubiquitin
6 cycle; F:zinc ion binding; P:protein ubiquitination
C:cytoplasm; C:nucleolus; F:protein binding; P:ubiquitindependent protein catabolic process; F:ubiquitin thiolesterase
6 activity; P:protein deubiquitination

757

10

1.97E-18

45.90%

deltex 4 homolog

1182

10

6.21E-06

46.90%

dna repair protein

344

10

l.29E-09

56.30%

C:cytoplasm; F:binding; P:mRNA transport; P:ubiquitin cycle;
6 F:ubiquitin-protein ligase activity; P:protein ubiquitination
C:cytoplasm; F:ONA-dependent ATPase activity; F:helicase
activity; F:DNA binding; F:protein binding; P:protein
ubiquitination; F:ATP binding; F:ubiquitin-protein ligase activity;
C:nucleus; F:zinc ion binding; C:ubiquitin ligase complex; P:DNA
12 repair

56.50%

P:protein modification process; P:proteasomal ubiquitindependent protein catabolic process; F:damaged DNA binding;
5 P:nucleotide-excision repair; C:nucleus
P:protein modification process; P:proteasomal ubiquitindependent protein catabolic process; F:damaged DNA binding;
5 P:nucleotide-excision repair; C:nucleus

MGID1982613

clan family ubiquitin hydrolase-like cysteine peptidas

MG102038778

MGID1944780

MG I02028070

dna repair...erotein putatitve

1021

10

1.96E-IO

MGID2057998

dna repair protein rad23

619

10

4.40E-19

56.00%

MGI01958756

f-box and leucine-rich repeatIlrotein 14b

785

10

4.44E-08

46.20%

MGID2041513

f-box and leucine-rich repeat protein 20

831

10

8.11E-19

43.30%

F:ubiquitin-protein ligase activity; C:SCF ubiquitin ligase complex;

218

4 FJlfotein binding; P]>!,otein ubiquitination
C:cytoplasm; P:ubiquitin-dependent protein catabolic process;
3 F:protein binding

P:ubiquitin-dependent protein catabolic process; F:zinc ion
binding; F:peptidyl-arginine C-methyltransferase activity;
F:ubiquitin-protein ligase activity; P:protein ubiquitination;
F:protein binding; F:histone-arginine N-methyltransferase
activity; C:ubiquitin ligase complex; P:sensory perception of
MGID2039744

f-box only protein

MGID2023224

hect domain and ankyrin repeat e3 ubiquitin protein

1923

10

6.40E-75

54.40%

852

10

4.66E-33

52.60%

12 sound; C:cytoplasm; C:nucleus; P:protein amino acid methylation
F:protein binding; P:ubiquitin cycle; F:ubiquitin-protein ligase
5 activity; C:endoplasmic reticulum; P:protein ubiquitination

P:ubiquitin-dependent protein catabolic process; F:zinc ion
binding; C:mitochondrial inner membrane; F:guanyl-nucleotide
exchange factor activity; P:spermatogenesis; F:ubiquitin-protein
ligase activity; F:ATP binding; F:protein binding; F:heme binding;
P:regulation of mitotic metaphase/anaphase transition;
P:intraceUular protein transport; P:protein amino acid
MGID2033139

hect domain and rid 2

744

10

2.04E-12

48.60%

phosphorylation; C:anaphase-promoting complex; P:regulation
15 of GTPase activity; P:protein ubiquitination

MGID2039182

hect domain and rid 2

674

10

2.84E-12

54.10%

P:regulation of mitotic metaphase/anaphase transition; F:protein
binding; F:heme binding; P:ubiquitin cycle; F:ubiquitin-protein
ligase activity; F:zinc ion binding; C:anaphase-promoting
8 complex; P:protein ubiquitination

MGID1992109

hect domain and rid 3

833

10

5.43E-15

44.80%

C:intracellular; P:ubiquitin-dependent protein catabolic process;
4 F:acid-amino acid ligase activity; P:protein modification process

MGID2057691

hect domain and rid partial

MGID2029262

hect domain-containing family protein

MG1D1977338

histone deacetylase 6

1194

10

2.77E-13

56.70%

757

10

2.10E·28

51.00%

739

10

1.77E-16

40.70%

P:regulation of mitotic metaphase/anaphase transition; F:protein
binding; P:protein ubiquitination; F:heme binding; F:ubiquitinprotein ligase activity; F:zinc ion binding; C:anaphase-promoting
7 complex
F:ubiquitin-protein ligase activity; C:intracellular; P:ubiquitin
4 cycle; P:protein ubiquitination

P:negative regulation of microtubule depolymerization;
P:chromatin modification; P:ubiquitin-dependent protein
catabolic process; F:histone deacetylase activity; F:zinc ion
binding; P:protein amino acid deacetylation; P:protein
polyubiquitination; C:microtubule; P:regulation of transcription,
DNA-dependent; F:tubulin deacetylase activity; C:histone
deacetylase complex; F:actin binding; C:cytoplasm; F:histone
deacetylase binding; P:nitrogen compound metabolic process;
16 C:tubulin complex

P:negative regulation of microtubule depolymerization;
P:chromatin modification; P:ubiquitin-dependent protein
catabolic process; F:histone deacetylase activity; F:zinc ion
binding; P:protein amino acid deacetylation; P:protein
polyubiquitination; C:microtubule; P:regulation oftranscription,
DNA-dependent; F:tubulin deacetylase activity; C:histone

MGID2037051

histone deacetylase 6

998

10

3.92E-16

51.20%

deacetylase complex; F:actin binding; c:cytoplasm; F:histone
deacetylase binding; P:nitrogen compound metabolic process;
16 C:tubulin complex

P:negative regulation of microtubule depolymerization;
P:chromatin modification; P:ubiquitin-dependent protein
catabolic process; F:histone deacetylase activity; F:zinc ion
binding; P:protein amino acid deacetylation; P:protein
polyubiquitination; C:microtubule; P:regulation of transcription,

MGID2076755

MGID2040793

histone deacetylase 6

hsp chaperone complex subunit

1607

815

10

10

7.44E-19

3.39E-06

55.90%

50.00%

DNA·dependent; F:tubulin deacetylase activity; C:histone
deacetylase complex; F:actin binding; C:cytoplasm; F:histone
deacetylase binding; P:nitrogen compound metabolic process;
16 C:tubulin complex
P:protein folding; F:binding; P:mycelium development; P:protein
ubiquitination; F:ubiquitin-protein ligase activity; C:nucleus;
8 C:cytosol; C:ubiquitin ligase complex
P:protein folding; F:binding; P:mycelium development; P:protein
ubiquitination; F:ubiquitin-protein ligase activity; C:nucleus;

MGID2075692

hsp chaperone complex subunit

MGID2054805

immediate-early fungal elicitor protein cmpg1

MGID2068259

klh12 xenia ame: full=kelch-like protein 12

MGID1946605

leucine rich repeat family expressed

1607

1.23E-05

48.88%

8 C:cytosol; C:ubiquitin ligase complex

811

10

3.04E-07

51.00%

1129

10

6.12E-40

47.40%

F:binding; P:protein ubiquitination; F:ubiquitin-protein ligase
6 activity; C:plastid; C:mitochondrion; C:ubiquitin ligase complex
P:Wnt receptor signaling pathway; F:protein binding;
P:multicellular organismal development; P:ubiquitin-dependent
5 protein catabolic process; P:ubiquitin cycle

389

10

2.08E-12

51.50%

C:cytoplasm; P:ubiquitin-dependent protein catabolic process;
4 F:protein binding; P:protein modification process
C:neuron projection; P:positive regulation of MAPKKK cascade;
P:activation of MAP KKK activity; P:regulation of exocytosis;
P:exocrine system development; P:neurotransmitter secretion;
P:regulation oftranscription, DNA-dependent; C:intrinsic to
plasma membrane; F:GTP binding; F:calcium ion binding;
P:protein transport; P:small GTPase mediated signal
transduction; F:ubiquitin-protein ligase activity; P:protein
ubiquitination; F:identical protein binding; C:perinuclear region
of cytoplasm; F:GTPase activity; P:regulation of apoptosis;
F:transcription factor binding; F:ATP binding; C:transcription

MGID2054783

member ras oncogene family

1042

10

l.34E-22

219

54.70%

21 factor complex

MGID2079469

mib2 protein

MGID1944670

mitotic checkpoint protein bub3

MGID2054988

MG ID2075908

mynd finger family protein

mynd finger family protein

MGID2027142

nad-dependent histone deacetylase

MGID1985341

nedd4 protein

P:regulation of receptor internalization; P:ubiquitin-dependent
protein catabolic process; P:melanocyte differentiation; F:zinc
ion binding; F:signal transducer activity; P:Notch signaling
pathway; C:cytoplasmic vesicle; P:positive regulation of I-kappaS
kinase/NF-kappaS cascade; C:eariy endosome; F:ubiquitinprotein ligase activity; F:actin binding; P:protein
autoubiquitination; C:ubiquitin ligase complex; C:perinuclear
15 region of cytoplasm; F:protein homodimerization activity

1262

10

1.05E-06

48.60%

449

10

3.35E-18

57 .90%

2 P:biological process; C:CUL4 RING ubiquitin ligase complex

53 .00%

P:ubiquitin-dependent protein catabolic process; F:ubiquitin
thiolesterase activity; F:squalene-hopene cyclase activity; F:zinc
5 ion binding; P:protein deubiquitination

52.70%

P:ubiquitin-dependent protein catabolic process; F:ubiquitin
thiolesterase activity; F:squalene-hopene cyclase activity; F:zinc
5 ion binding; P:protein deubiquitination

F:NAD or NADH binding; F:zinc ion binding; P:protein amino acid
deacetylation; F:histone acetyltransferase binding;
C:microtubule; C:chromatin silencing complex; P:negative
regulation of striated muscle tissue development; F:tubulin
deacetylase activity; F:ubiquitin binding; P:cell division; F:DNA
binding; P:chromatin silencing; F:NAD-dependent histone
deacetylase activity; P:mitosis; F:transcription factor binding;
C:cytoplasm; F:histone deacetylase binding; P:nitrogen
compound metabolic process; C:tubulin complex; C:histone
21 deacetylase complex; C:transcription factor complex

851

1362

10

10

l.27E-06

2.00E-06

1330

10

4.28E-22

53.80%

693

8

3.06E-04

52.75%

F:ubiquitin-protein ligase activity; C:intracellular; P:ubiquitin
5 cycle; F:protein binding; P:protein ubiquitination
P:sodium ion transport; P:ubiquitin-dependent protein catabolic
process; P:response to metal ion; P:cellular sodium ion
homeostasis; P:positive regulation of endocytosis; F:sodium
channel regulator activity; F:ubiquitin-protein ligase activity;
P:excretion; P:protein ubiquitination; F:protein binding;
P:regulation of protein catabolic process; P:interspecies
interaction between organisms; C:cytoplasm; P:water

MGID2055265

nedd4 protein

1633

10

9.01E-12

58.30%

14 homeostasis
P:ubiquitin-dependent protein catabolic process; P:sarcomere
organization; F:zinc ion binding; F:ligase activity; F:protein
binding; C:muscle tendon junction; C:VCS complex
P:immune response; P:ubiquitin-dependent protein catabolic
process; F:cysteine-type peptidase activity
P:ubiquitin-dependent protein catabolic process; F:ubiquitin
thiolesterase activity; P:ubiquitin cycle; P:protein
deubiquitination
C:cytoplasm; P:positive regulation oftranscription;
F:transcription regulator activity; F:protein binding; P:protein
ubiquitination; C:nucleus
C:cytoplasm; C:cell wall; C:nucleus; P:protein modification

594

10

6.41E-09

65 .30%

7

1845

10

2.76E-12

45 .30%

3

peptidase c19 family protein

736

10

1.10E-26

56 .40%

4

MGID107043

plasmodium falciparum polyubiquitin

904

10

8. llE-63

78.80%

6

MGID2042393
MGID1973919
MGID2025451

polyubiquitin 1
polyubiquitin 2
polyubiquitin ubi4

1206
708
824

10
10
10

2.06E-04
2.03E-43
1.77E-18

50.50%
87 .50%
74.60%

5 process; C:plasma membrane
2 F:zinc ion binding; P:protein modification process
2 F:zinc ion binding; P:protein modification process

MGID2048506

neuralized homolog

MGID2036338

otu ubiquitin aldehyde binding 1

MGID1991203

F:RNA binding; P:negative regulation of ubiquitin-protein ligase
activity during mitotic cell cycle; C:mitochondrion; F:threoninetype endopeptidase activity; P:anaphase-promoting complexdependent proteasomal ubiquitin-dependent protein catabolic
process; P:positive regulation of ubiquitin-protein ligase activity
during mitotic cell cycle; F:protein binding; C:proteasome core
MGID2048982

[proteasome ( macropain) alpha 6

967

10

5.84E-70

73 .00%

MGID1947361
MGID1945086

smad ubiquitination regulatory factor 1
small ubiquitin-like modifier

533

10

516

10

2.57E-07
2.88E-37

46.00%
70.90%

MGID2030454

sumo-1 activating enzyme e1 n subunit

1121

10

2.65E -27

51.30%

220

9 complex; C:nucleus
P:negative regulation of SMP signaling pathway; P:negative
regulation of ossification; C:intracellular; F:ubiquitin-protein
ligase activity; P:cell differentiation; F:protein binding;
P:ectoderm development; P:protein ubiquitination during
8 ubiquitin-dependent protein catabolic process
1 P:protein modification process
F:small protein activating enzyme activity; P:ubiquitin cycle;
5 F:binding; C:nucleus; F:ligase activity

P:cell differentiation; F:DNA binding; P:mRNA transport;
F:ubiquitin-protein ligase activity; C:nucleus; P:protein
MGID2030838

uba and wwe domain containing 1

MGID107380

ubc6p like ubiquiting conjugating enzyme possible tr
ubiQuitin

MGID1945979

1119

10

1.86E-26

927
300

10
10

2.17E-50

75.20%

5.29E-32

100.00%

57.70%

MG1D2041303

ubiquitin 40s ribosomal protein s27a fusion

834

10

8.17E-19

85.20%

MGID1984359

ubiquitin carboxyl -terminal

664

10

5.74E-10

40.90%

6 ubiquitination
C:integral to membrane; P:regulation of protein metabolic
process; F:small conjugating protein ligase activity; P:post4 translational protein modification
1 P:protein modification process
C:ribosome; P:protein modification process; F:structural
constituent of ribosome; F:zinc ion binding; P:translation;
6 P:ribosome biogenesis
P:ubiquitin -dependent protein catabolic process; F:calcium ion
binding; F:ubiquitin thiolesterase activity; C:membrane;
5 P:protein deubiquitination

P:RNA splicing; F:protein binding; P:ubiquitin-dependent protein
catabolic process; P:mRNA processing; F:ubiquitin thiolesterase
MGID2052656

ubiquitin carboxyl -terminal

1234

10

9.00E-96

65.00%

8 activity; C:nucleus; F:zinc ion binding; P:protein deubiquitination
C:cytoplasm; P:protein deubiquitination; P:eating behavior;
P:ubiquitin-dependent protein catabolic process; F:ubiquitin

MGID2078878

ubiquitin carboxyl-terminal esterase 13

958

10

2.87E-53

60.90%

MGID2055229
MGID1963697

ubiquitin carboxyl-terminal hydrolase
ubiquitin carboxyl-terminal hydrolase 6

1402
831

10
10

8.96E-10
2.21E-08

37.60%
57.50%

MGID1945063

ubiquitin carboxyl -terminal hydrolase family protein

454

10

1.11E-05

60.40%

MGID2049337

ubiquitin carboxyl-terminal hydrolase family protein

804

10

3.07E-36

56.80%

thiolesterase activity; P:ubiquitin cycle; P:protein
4 deubiquitination

MGID2028135
MGID1987082

ubiquitin carboxyl-terminal hydrolase isozyme 13
ubiquitin conjugating enzyme

1028
791

10
10

3.68E-57
2.16E-10

58.30%
49.40%

C:intracellular; P:ubiquitin-dependent protein catabolic process;
4 F:ubiquitin thiolesterase activity; P:protein deubiquitination
1 P:protein modification process

MGID1984306

ubiquitin conjugating enzyme

806

8

2.26E-55

84.25%

MGID1946804

ubiquitin conjugating enzyme

336

10

2.06E-10

65.70%

MGID2024467

ubiquitin conjugating enzyme

865

10

3.61E-81

79.50%

MGID1976492

ubiquitin conjugating enzyme 1

331

1

4.98E-06

85.00%

P:ubiquitin cycle; P:regulation of protein metabolic
3 F:small conjugating protein ligase activity
P:ubiquitin cycle; P:regulation of protein metabolic
3 F:small conjugating protein ligase activity
P:ubiquitin cycle; P:regulation of protein metabolic
3 F:small conjugating protein ligase activity
P:ubiquitin cycle; P:regulation of protein metabolic
3 F:small conjugating protein ligase activity

MGID1968753

ubiquitin conjugating enzyme 7 interacting protein

865

6

l.31E-06

60.83%

2 F:zinc ion binding; F:protein binding

MGID2022383

ubiquitin conjugating enzyme 7 interacting protein

788

10

6.90E-09

57.50%

3 F:zinc ion binding; F:nucleic acid binding; F:protein binding

6 thiolesterase activity; P:adult walking behavior
P:ubiquitin-dependent protein catabolic process; F:ubiquitin
thiolesterase activity; P:ubiquitin cycle; P:protein
4 deubiquitination
0
P:ubiquitin-dependent protein catabolic process; F:ubiquitin
3 thiolesterase activity; P:protein deubiquitination
P:ubiquitin-dependent protein catabolic process; F:ubiquitin

process;
process;
process;
process;

P:nuclear migration; P:ubiquitin-dependent protein catabolic
process; F:ubiquitin thiolesterase activity; P:germ cell migration;
P:cellularization; P:negative regulation of proteolysis; P:mystery
cell fate differentiation; P:embryonic development;
MGID1957111
MGID2063489
MGID1948161
MGID2032537

ubiquitin domain-containing protein
ubiquitin domain-containing protein
ubiquitin family protein
ubiquitin family protein

MGID2039702

ubiquitin family protein

MGID2020514
MGID2051780
MGID1962857

ubiquitin fusion degradation (yeast ufd homolog) fam
ubiquitin isoform cra a
ubiquitin ligase complex f-box protein

696
620
435
1157

10
10
10
4

9.16E-09
7.79E-08
7.24E-74
1.48E-04

59.60%
48.40%
98.20%
68.25%

11
1
1
1

862

10

6.23E-09

47.80%

3

872
1313
802

10
10
10

3.81E-06
4.65E-13
9.24E-09

55.10%
51.30%
55.70%

9
2
1
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P:endocytosis; P:protein deubiquitination; C:cytoplasm
P:protein modification process
P:protein modification process
P:protein modification process
C:extracellular region; P:intein-mediated protein splicing;
P:pathogenesis
C:cytoplasm; F:ubiquitin protein ligase binding; P:protein
autoubiquitination; F:chaperone binding; P:protein
polyubiquitination; F:ubiquitin-protein ligase activity;
P:embryonic development ending in birth or egg hatching;
C:nucleus; C:ubiquitin ligase complex
C:nucleus; P:protein modification process
F:protein binding

C:cytoplasm; F:ubiquitin-specific protease activity; C:nucleolus;
F:protein binding; P:ubiquitin-dependent protein catabolic
MGID1991202

ubiquitin specific peptidase 15

755

10

6.93E-24

62.40%

6 process; P:protein deubiquitination
P:ubiquitin-dependent protein catabolic process; F:ubiquitin
thiolesterase activity; F:zinc ion binding; P:protein

MGIDI06568

ubiquitin specific peptidase 3

923

10

2.03E-08

40.80%

4 deubiquitination
F:Rab GTPase activator activity; C:lysosome; P:ubiquitindependent protein catabolic process; F:ubiquitin thiolesterase
activity; F:nudeic acid binding; F:ca1cium ion binding; F:cysteine-

MGID2073584

ubiquitin specific peptidase 32

1086

10

2.30E-20

45.20%

type endopeptidase activity; P:regulation of Rab GTPase activity;
10 F:protein binding; P:protein deubiquitination
F:glycylpeptide N-tetradecanoyltransferase activity; P:ubiquitindependent protein catabolic process; P:N-terminal protein
myristoylation; F:ubiquitin thiolesterase activity; C:nucleus;
P:acyl,arrier-protein biosynthetic process; P:protein

MGID2031434

ubiquitin specific peptidase 36

948

10

1.31E-50

59.70%

7 deubiquitination

MGID2031330

ubiquitin specific protease 31

817

10

4.30E-17

46.90%

4 F:ubiquitin thiolesterase activity; P:protein deubiquitination

C:cytoplasm; P:ubiquitin-dependent protein catabolic process;

P:ubiquitin-dependent protein catabolic process; F:ubiquitin
thiolesterase activity; F:transcription initiation factor activity;
F:zinc ion binding; P:transcription initiation; F:DNA binding;
P:ubiquitin cycle; F:queuine tRNA-ribosyltransferase activity;
C:transcription factor TFII 0 complex; P:queuosine biosynthetic
MGID1994290

ubiquitin specific protease 43

709

10

3.98E-23

50.80%

MGID109427

ubiquitin-activating enzyme el

263

10

5.0SE-06

61.90%

5 ubiquitination

MGID1974830

ubiquitin-associated domain,ontaining

770

3

1.46E-24

57.00%

0

MGID1976634

ubiquitin-conjugating enzyme

466

10

2.92E-54

86.30%

3 F:small conjugating protein ligase activity

MGID1976063

ubiquitin-conjugating enzyme

800

10

4.41E-43

73.20%

P:ubiquitin cycle; P:regulation of protein metabolic process;
3 F:small conjugating protein ligase activity

12lprocess; P:protein deubiQuitination; P:regulation of transcription
F:ATP binding; F:ubiquitin-protein ligase activity; F:small protein
activating enzyme activity; P:ubiquitin cycle; P:protein

P:ubiquitin cycle; P:regulation of protein metabolic process;

C:cytosol; P:negative regulation of ubiquitin-protein ligase
activity during mitotic cell cycle; P:protein polyubiquitination;
P:positive regulation of protein ubiquitination; P:BMP signaling
pathway; P:anaphase-promoting complex-dependent
proteasomal ubiquitin-dependent protein catabolic process;
F:ubiquitin-protein ligase activity; P:positive regulation of
ubiquitin-protein ligase activity during mitotic cell cycle;
MGID1976064

ubiquitin-conjugating enzyme

817

10

4.59E-19

74.50%

9 C:nucleoplasm
P:ubiquitin cycle; P:regulation of protein metabolic process;

MGID1975837

ubiquitin-conjugating enzyme

698

10

1.22E-4S

91.00%

3 F:small conjugating protein ligase activity

MGID1965228

ubiquitin-conjugating enzyme

662

10

1.62E-65

90.30%

P:ubiquitin cycle; P:regulation of protein metabolic process;
3 F:small coniugatiOl1. protein ligase activity

MGID1964821

ubiquitin-conjugating enzyme

765

10

1.10E-32

68.30%

P:regulation of protein metabolic process; F:small conjugating
3 protein ligase activity; P:post-translational protein modification

MGID1962935

ubiquitin-conjugating enzyme

614

10

3.81E-23

89.50%

P:ubiquitin cycle; P:regulation of protein metabolic process;
3 F:small conjugating protein ligase activity

MGID1954817

ubiquitin-conjugating enzyme

446

10

2.76E-44

81.30%

P:ubiquitin cycle; P:regulation of protein metabolic process;
3 F:small conjugating protein ligase activity

MGID1944212

ubiquitin-conjugating enzyme

590

10

1.41E-69

87.40%

3 F:small conjugating protein ligase activity

MGID1949460

ubiquitin-conjugating enzyme

529

10

4.55E-41

70.30%

P:ubiquitin cycle; P:regulation of protein metabolic process;
3 F:small conjugating protein ligase activity

MGID1941007

ubiquitin-conjugating enzyme

663

10

5.13E-51

74.40%

3 F:small conjugating protein ligase activity

MGID2036731

ubiquitin-conjugating enzyme

821

10

5.97E-59

88.00%

P:ubiquitin cycle; P:regulation of protein metabolic process;
3 F:small conjugating protein ligase activity

MGID2038699

ubiquitin-conjugating enzyme

1117

10

1.50E-30

62.50%

3 F:small conjugating protein ligase activity
P:ubiquitin cycle; P:regulation of protein metabolic process;

MGID2040596

ubiquitin-conjugating enzyme

614

10

2.43E-70

88.60%

3 F:small conjugating protein ligase activity

MGID2041278

ubiQuitin-conjugating enzyme

644

10

4.05E-66

90.30%

3 F:small conjugating protein ligase activity

MGID2046806

ubiquitin-conjugating enzyme

1050

10

2.70E-71

89.20%

3 F:small conjugating protein ligase activity

MGID2049051

ubiquitin-conjugating enzyme

840

10

2.47E-55

84.00%

P:ubiquitin cycle; P:regulation of protein metabolic process;
3 F:small conjugating protein ligase activity

MGID2056449

ubiquitin-conjugating enzyme

620

10

1.14E-67

88.30%

3 F:small conjugating protein ligase activity

MGID2058457

ubiquitin.conjugating enzyme

626

10

4.03E-68

88.90%

P:ubiquitin cycle; P:regulation of protein metabolic process;
3 F:small conjugating protein ligase activity

MGID2062954

ubiquitin-conjugating enzyme

360

10

3.90E-35

91.30%

3 F:small ConiURatinR protein liRase activity
P:ubiquitin cycle; P:regulation of protein metabolic process;

MGID2066195

ubiquitin-conjugating enzyme

554

10

6.35E-39

69.60%

3 F:small conjugating protein ligase activity

P:ubiquitin cycle; P:regulation of protein metabolic process;

P:ubiquitin cycle; P:regulation of protein metabolic process;

P:ubiquitin cycle; P:regulation of protein metabolic process;

P:ubiquitin cycle; P:regulation of protein metabolic process;
P:ubiquitin cycle; P:regulation of protein metabolic process;

P:ubiquitin cycle; P:regulation of protein metabolic process;

P:ubiquitin cycle; P:regulation of protein metabolic process;
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MG1D2041887

ubiquitin-conjugating enzyme e2

578

10

2.32E-53

76.20%

MGID1985696

ubiquitin-conjugating enzyme e2 z-like

730

10

3.72E-27

55.10%

MGID2027441
MGID2045222
MGID1984819

ubiquitin-conjugating enzyme e2z
ubiquitin-fold modifier 1
ubiquitin-fusion protein

MGID2057562

ubiquitin-protein ligase e3

MGID2061456
MGID2053073

ubiquitin-protein ligase e3
ubiquitin-protein ligase-like

MGID1985376

F:ubiquitin-protein ligase activity; P:ubiquitin cycle; P:regulation
4 of protein metabolic process; P:protein ubiquitination
P:regulation of protein metabolic process; F:small conjugating
3 protein ligase activity; P:post-translational protein modification
C:cytoplasm; C:nucleolus; P:apoptosis; P:ubiquitin-dependent
protein catabolic process; F:ubiquitin-protein ligase activity;
P:regulation of protein metabolic process; P:protein
7 ubiquitination
1 P:ubiquitin cycle
1 P:protein modification process

1036
472
758

10
10
10

1.20E-31
5.51E-13
7.02E-16

52.10%
68.20%
69.20%

636

10

1.69[-16

57.30%

2152
830

10

2. 91E-08
5.99E-06

65.80%
54.57%

u-box domain protein

887

10

1.77E-06

51.70%

MGID1964714

U-bOK domain protein

762

10

1.10E-08

59.00%

MGID2020548

u-box domain protein

854

10

8.83E-08

53.50%

MGID2022434

u-box domain protein

838

10

1.36E-05

58.80%

6 complex
F:ubiquitin-protein ligase activity; C:ubiquitin ligase complex;
4 F:binding; P:protein ubiquitination

MGID1958259

von willebrand factor type a domain containing prote

836

10

6.68E-21

64.70%

F:ubiquitin-protein ligase activity; C:ubiquitin ligase complex;
4 P:protein ubiquitination; P:intein-mediated protein splicing

MGID2021019

von willebrand factor type a domain containing prote

784

10

1.05E-25

59.00%

MGID2056311

wd sam and u-box domain containing 1

830

10

1.47E-12

69.90%

F:ubiquitin-protein ligase activity; C:ubiquitin ligase complex;
4 P:protein ubiquitination; P:intein-mediated protein spliCing
F:ubiquitin-protein ligase activity; C:ubiquiti n ligase complex;
3 P:protein ubiquitination

60.00%

P:protein amino acid phosphorylation; P:response to stress;
P:protein ubiquitination; F:ATP binding; F:ubiquitin-protein ligase
activity; F:protein serine/threonine kinase activity; C:ubiquitin
8 ligase complex; P:serine family amino acid metabolic process

62.30%

F:receptor activity; P:protein amino acid phosphorylation;
P:protein ubiquitination; F:ATP binding; F:ubiquitin-protein ligase
activity; F:protein serine/threonine kinase activity; C:ubiquitin
ligase complex; P:signal transduction; P:serine family amino acid
9 metabolic process

MGID104206

MGI02053718

wd sam and u-box domain containing 1

wd sterile alpha motif and u-box domain containing 1

680

810

MGID1987113

wd40 repeat protein

673

MGID1976985

wd-40 repeat protein

760

MGID2080865

ww domain containing protein

819

10

10

10

10

6.93E-14

1.46E-09

3.37E-05

43.50%

1. 12E-29

51.60%

F:hydrolase activity, hydrolyzing O-glycosyl compounds;
P:carbohydrate metabolic process; P:protein ubiquitination;
5 F:ubiquitin-protein ligase activity; C:ubiquitin ligase complex
P:innate immune response; P:protein ubiquitination; C:intrinsic
to membrane; P:signal transduction; F:ubiquitin-protein ligase
activity; F:transmembrane receptor activity; C:ubiquitin ligase
7 complex

42.90%

F:protein binding; P:ubiquitin-dependent protein catabolic
process; p:ubiquitin cycle; P:locomotion; F:ubiquitin-protein
ligase activity; P:embryonic development ending in birth or egg
hatching; P:entry of virus into host cell; C:ubiquitin ligase
9 complex; P:protein ubiquitination

5.87E-06

571

10

3.07E-10

53.90%

zinc finger (c3hc4-type ring finger) family protein

1073

10

9. 77E-08

65.30%

MGID2019194

proteasome (prosome macropain) subunit beta type

1022

10

3.09E-48

65.20%

MGID2066412

Iproteasome subunit beta type 7-a precursor

583

10

1.58EAl

75.90%

MGID1943053

zinc finger

MGID2028256
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C:Golgi apparatus; F:protein binding; P:protein ubiquitination;
5 P:signal transduction; F:ubiquitin-protein ligase activity
C:cytoplasmic membrane-bounded veSicle; F:zinc ion binding;
3 F:protein binding
1 F:zinc ion binding
C:cytoplasm; F:ubiquitin protein ligase binding; P:protein
autoubiquitination; F:chaperone binding; P:protein
polyubiquitination; F:ubiquitin-protein ligase activity;
P:embryonic development ending in birth or egg hatching;
9 C:nucleus; C:ubiquitin ligase complex
F:ubiquitin-protein ligase activity; C:ubiquitin ligase complex;
3 P:protein ubiquitination
F:protein binding; P:protein ubiquitination; F:ubiquitin-protein
ligase activity; F:zinc ion binding; C:plastid; C:ubiquitin ligase

P:ubiquitin-dependent protein catabolic process; C:axon; F:zinc
ion binding; P:negative regulation of axon extension; F:DNA
binding; F:ubiquitin-protein ligase activity; C:PML body;
F:transcription activator activity; F:protein binding; P:positive
regulation oftranscription, DNA-dependent; C:cytoplasm;
12 P:protein ubiquitination
P:defense response to fungus; F:ubiquitin-protein ligase activity;
P:response to chitin; F:zinc ion binding; F:protein binding;
6 P:protein ubiquitination
C:proteasome core complex; F:threonine-type endopeptidase
activity; P:ubiquitin-dependent protein catabolic process;
4 C:nucleus
C:proteasome core complex; F:threonine-type endopeptidase
activity; P:ubiquitin-dependent protein catabolic process;
4 C:nucleus

